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Abstract 
Articular cartilage injury and progressive degeneration, combined with the clinical needs that result from 
an aging population and increasing rates of diagnosed osteoarthritis, have created a burgeoning demand 
for therapies aimed at cartilage repair. One approach that has gained traction is the delivery of clinically 
relevant cell types such as mesenchymal stromal cells to the injury site using hydrogels, which are water-
swollen polymer networks that can be engineered to suit a wide variety of applications. Previous insights 
have led us to identify the roles of parameters such as cellular density, matrix degradation, mechanical 
loading, and even cell-cell communication in engineered cartilage formation and maturation. These 
hydrogels often employ biomaterials such as hyaluronic acid that are native to the body and intended to 
influence cell behavior. However, hydrogel-based therapies to date have predominantly focused on 
permitting or facilitating the eventual maturation of cartilage tissue by enabling matrix remodeling and 
distribution; meanwhile, the need for materials with controlled and timely presentation of cues that are 
essential for correct initial lineage commitment and early differentiation by cells has often been 
overlooked. 
This dissertation describes the design and characterization of hyaluronic acid hydrogels that incorporate 
developmentally relevant and tunable cell-matrix and cell-cell cues that are critical in the early lineage 
commitment and differentiation of mesenchymal stromal cells. In particular, emphasis is given to the 
presentation of such cues over time at the cell-hydrogel interface, where cells encapsulated in these 
hydrogels actively interact with and even contribute to their microenvironments. 
First, we examine tunable cell-matrix interactions in hydrogels by demonstrating that the biological 
activity of cell-laden hydrogels formed using crosslinkable modified hyaluronic acid, which provides cell-
matrix cues relevant to cartilage development, may be altered as a function of the extent, type, and 
location of macromer modification. In both early gene expression and long-term in vitro culture, we show 
that this can alter mesenchymal stromal cell differentiation and subsequent construct maturation. 
Building on this, we explore a hyaluronic acid-based hydrogel with additional tunable cell-cell interaction 
mimicry via N-Cadherin mimetic peptides. We demonstrate the ability of this cue to also enhance both 
early differentiation and long-term neotissue formation by cells in a dose- and timing-dependent manner, 
where higher concentrations further promote the maturation of the engineered construct as long as the 
signal is stably presented to influence cell behavior during early timepoints. Finally, we examine the 
spatial deposition of pericellular matrix at the cell-hydrogel interface using live-cell metabolic labeling to 
determine when, and for how long, the cues that are engineered into hydrogels may in fact be presented 
to cells. We show that cells may physically displace the hydrogel from their microenvironment as they 
begin to synthesize and deposit pericellular matrix, and that this can occur as soon as 3 days after 
encapsulation, with important implications for hydrogel design towards cartilage tissue engineering 
applications. 
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ABSTRACT 
 
ENGINEERING THE INTERFACE: HYALURONIC ACID HYDROGELS THAT MEDIATE MSC 
CHONDROGENESIS FOR CARTILAGE TISSUE ENGINEERING 
 
Mi Y. Kwon 
Jason A. Burdick, Ph.D. 
 
Articular cartilage injury and progressive degeneration, combined with the clinical 
needs that result from an aging population and increasing rates of diagnosed 
osteoarthritis, have created a burgeoning demand for therapies aimed at cartilage repair. 
One approach that has gained traction is the delivery of clinically relevant cell types such 
as mesenchymal stromal cells to the injury site using hydrogels, which are water-swollen 
polymer networks that can be engineered to suit a wide variety of applications. Previous 
insights have led us to identify the roles of parameters such as cellular density, matrix 
degradation, mechanical loading, and even cell-cell communication in engineered 
cartilage formation and maturation. These hydrogels often employ biomaterials such as 
hyaluronic acid that are native to the body and intended to influence cell behavior. 
However, hydrogel-based therapies to date have predominantly focused on permitting or 
facilitating the eventual maturation of cartilage tissue by enabling matrix remodeling and 
distribution; meanwhile, the need for materials with controlled and timely presentation of 
cues that are essential for correct initial lineage commitment and early differentiation by 
cells has often been overlooked.  
This dissertation describes the design and characterization of hyaluronic acid 
hydrogels that incorporate developmentally relevant and tunable cell-matrix and cell-cell 
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cues that are critical in the early lineage commitment and differentiation of mesenchymal 
stromal cells. In particular, emphasis is given to the presentation of such cues over time 
at the cell-hydrogel interface, where cells encapsulated in these hydrogels actively 
interact with and even contribute to their microenvironments. 
First, we examine tunable cell-matrix interactions in hydrogels by demonstrating 
that the biological activity of cell-laden hydrogels formed using crosslinkable modified 
hyaluronic acid, which provides cell-matrix cues relevant to cartilage development, may 
be altered as a function of the extent, type, and location of macromer modification. In 
both early gene expression and long-term in vitro culture, we show that this can alter 
mesenchymal stromal cell differentiation and subsequent construct maturation. Building 
on this, we explore a hyaluronic acid-based hydrogel with additional tunable cell-cell 
interaction mimicry via N-Cadherin mimetic peptides. We demonstrate the ability of this 
cue to also enhance both early differentiation and long-term neotissue formation by cells 
in a dose- and timing-dependent manner, where higher concentrations further promote 
the maturation of the engineered construct as long as the signal is stably presented to 
influence cell behavior during early timepoints. Finally, we examine the spatial deposition 
of pericellular matrix at the cell-hydrogel interface using live-cell metabolic labeling to 
determine when, and for how long, the cues that are engineered into hydrogels may in 
fact be presented to cells. We show that cells may physically displace the hydrogel from 
their microenvironment as they begin to synthesize and deposit pericellular matrix, and 
that this can occur as soon as 3 days after encapsulation, with important implications for 
hydrogel design towards cartilage tissue engineering applications. 
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CHAPTER 1 
INTRODUCTION 
	
1.1. SIGNIFICANCE 
Articular cartilage injury and subsequent degeneration is cited as the most 
frequent cause of disability among adults in the US, with up to 53 million adults reporting 
doctor-diagnosed arthritis and nearly 23 million adults reporting limitations in activity due 
to cartilage degeneration.1 Articular cartilage is a connective tissue that lines surfaces at 
the ends of long bones to enable smooth movement, but it exhibits poor inherent 
regenerative capacity due to its avascularity, alymphaticity, and a sparse native cell 
population consisting of chondrocytes with no neuronal connections.1,2 Normal articular 
cartilage exhibits three major zones of matrix and cell organization; damage due to injury 
typically begins as a focal defect in the superficial and/or middle zones, which later 
progresses to a full-thickness defect through the subchondral bone marked by 
histological changes to all zones of the tissue (Figure 1.1).1  
There are numerous clinical treatment options for patients with articular cartilage 
damage, such as microfracture, cartilage grafting, autologous chondrocyte implantation 
(ACI), and matrix-assisted autologous chondrocyte implantation (MACI); however, each 
of these therapies has inherent limitations.3-6 In particular, despite some promising 
results and improvements in recent years, the formed cartilage from these clinical 
interventions is still markedly inferior to native articular cartilage in both biochemical 
content and mechanical properties, and it often degrades over a period of months to 
years. Collectively, although some marked progress has been made, the clinical 
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interventions that are currently available do not fully address the need for stable cartilage 
tissue repair. 
 
 
Figure 1.1. Structure and compartmental organization of articular cartilage in 
diarthrodial joints. Articular cartilage lines the surfaces of long bones and is 
surrounded by synovial fluid that is encapsulated within a synovial membrane (a). 
Cartilage tissue consists of chondrocytes within several layers of extracellular matrix, 
including superficial, middle, and deep zones, with a histologically visible tidemark 
marking the calcified region and subchondral bone (b, c). Damage and subsequent 
degradation of the tissue results in histological changes such as fissuring and 
fragmentation, and vascular invasion of the calcified region (d). Adapted from Martel-
Pelletier et al.7 
 
 
	 3	
1.2. CURRENT CLINICAL APPROACHES TO CARTILAGE REPAIR 
Strategies to repair cartilage defects began with early surgical procedures that 
aimed to induce or encourage endogenous repair mechanisms, such as in the case of 
microfracture, where the subchondral bone is punctured to release progenitor cells and 
blood into the defect.8 The FDA and many clinicians consider microfracture to be the 
gold standard for cartilage repair to date, but prospective comparative studies now 
show that microfracture may only delay cartilage degeneration in the short-term - 
more than 5 years after surgery, treatment failure is expected regardless of the size of 
the cartilage lesion.9-10 While microfracture continues to be a ubiquitous approach to 
surgical repair of cartilage, its shortcomings have ultimately encouraged the 
development of novel procedures that aim to achieve more robust repair (Figure 
1.2).11 
Figure 1.2. Clinically available techniques for cartilage repair. A full-thickness 
cartilage defect (a) is first debrided (b) to leave only healthy and stable tissue margins 
that encourage tissue integration. From here, a number of approaches can be used: (c) 
microfracture can release blood and progenitors from the underlying subchondral bone, 
(d) ACI can introduce and seal autologous chondrocytes into the defect site, or (e) MACI 
can provide a 3D scaffold along with autologous cells to encourage tissue formation. 
Adapted from Makris et al.13 
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Approaches that were further developed involved both grafting of autologous 
tissue (i.e., autologous osteochondral transplantation or mosaicplasty) that is 
harvested from a healthy tissue site, and, more recently, cell-based therapies such as 
ACI.3,4,12 ACI is a procedure in which a patient’s own chondrocytes are implanted into a 
debrided lesion in the host tissue. To perform this technique, a full-thickness sample 
from a low-weight-bearing region of the joint is harvested via biopsy punch during a 
first arthroscopic procedure to obtain a chondrocyte population that is then 
expanded in vitro to yield up to 50 million cells.13 A second operation is performed to 
then implant these chondrocytes into the defect and seal them in place using a 
membrane (often a periosteal flap). Using a patient's own cells avoids potential 
immune responses or the possibility of viral infections from transplanting allogeneic 
cells or foreign materials, and as opposed to autologous osteochondral implantation 
that requires significantly more tissue, the small biopsy minimizes complications for 
the chondrocyte donor.14,15  
Studies of ACI in the clinic have yielded mostly positive results - a study 
comparing ACI to autologous osteochondral transplantation (mosaicplasty) found ACI 
to have superior clinical results 10 years postoperatively, and ACI exhibits superior 
outcomes relative to microfracture for the treatment of larger cartilage defects (i.e., >3 
cm2 in size).16-21 For smaller defects, however, ACI does not seem to yield clinical 
benefit compared to microfracture, even though ACI is generally reported to improve 
structural repair.16,21,22 Importantly, this technique requires two operations and a 
prolonged recovery time of up to 12 months to ensure maturation of the neotissue, 
and even then, outcomes are often influenced by uncontrolled hypertrophy of the 
periosteal flap.13,23 
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Notably, neither microfracture or ACI employ 3D scaffolding to control where 
cells reside and to instruct the formation of extracellular matrix (ECM). Some additional 
innovations based on these therapies have been developed in the clinic to address this, 
as scaffold-based approaches are noted to generally better fill cartilage defects, 
exhibit fewer donor site complications (i.e., periosteal flap harvest not typically used), 
and involve a potentially less challenging procedure with shorter recovery times for 
patients due to increased graft stability.13 Additionally, because the chondrocytes are 
cultured in a 3D environment, they are less prone to dedifferentiation and therefore 
produce a more hyaline cartilage similar to that of articular surfaces.24 Furthermore, in 
vitro culture of cells in these scaffolds prior to implantation may assist in quality 
control of scaffold-based repair.13 
Matrix-induced autologous chondrocyte implantation (MACI) is a cell-based 
therapy that supplements ACI by providing chondrocytes with a supportive 3D scaffold 
material for matrix formation.13 MACI also requires two surgical procedures, however: 
the first surgery collects autologous tissue for chondrocyte isolation, and this cell 
population is expanded in vitro and subsequently cultured on an absorbable porcine-
derived mixed collagen (type I/III) membrane. These membranes are specifically 
engineered to promote chondrocyte infiltration on one side and minimize friction on 
the surface that faces the joint space.13 The second procedure includes a mini-
arthrotomy to debride the lesion area, followed by positioning and securing of the 
seeded matrix with the cell-laden side facing the subchondral bone. Whether or not 
MACI is overall superior to other approaches is yet to be seen in the clinic, and the 
the added expense associated with this technique is a non-trivial consideration for its 
adoption.24-26 One prospective randomized clinical trial comparing ACI and MACI 
reported comparable clinical, arthroscopic and histological outcomes with both 
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procedures, but the MACI-treated group did report a lower rate of graft hypertrophy.26 
Meanwhile, a separate study found that Lysholm and Guillquist knee functionality 
scores showed better outcomes with ACI than MACI.27 Another study did find 
outcomes with MACI to be superior to microfracture for patients with larger (i.e., >4 
cm2) defects after 2 years.28	
Meanwhile, a another approach called autologous matrix-induced 
chondrogenesis (AMIC) improves upon the microfracture technique by introducing an 
acellular scaffold into the lesion immediately after microfracture to help improve 
mechanical stability, control cell migration, and hopefully influence cartilage production 
to fill the the defect site with robust tissue.6 One clear advantage of this procedure is 
that it only requires a single operation: in this operation, a mini-arthrotomy debrides 
the defect site, microfracture releases blood components and bone marrow containing 
MSCs into the defect, and then a mixed collagen type I/III matrix is sutured or glued 
into the defect.6 The implanted collagen matrix is thought to stabilize the resulting 
blood clot, helping to promote early mechanical stability and cartilage regeneration. 
Case studies have found AMIC to be both safe and effective in treating full-thickness 
cartilage defects.29-31 
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1.3. CARTILAGE TISSUE ENGINEERING FOR TISSUE REPAIR 
Cartilage tissue engineering seeks to meet the clinical need for repair of 
damaged cartilage tissue by employing unique combinations of materials, cells, and 
signals to generate new cartilage tissue (Figure 1.3). Combinations of these various 
elements produce a variety of interesting approaches such as scaffold-free techniques, 
self-assembly, ex vivo culture, and cell-free scaffold engineering. Some of the more 
recent clinical approaches discussed here, such as MACI and AMIC, fall within this 
paradigm as well. 
Figure 1.3. Paradigm for tissue engineering of articular cartilage. The major 
elements of approaches that use tissue engineering are cells, stimulants, and scaffolds. 
Different cell types (autologous, allogeneic, and stem/progenitor) have been tested in 
vitro and in vivo for their chondrogenic potential. A variety of biochemical and 
biomechanical stimulants have been employed to influence cell differentiation and 
construct maturation. Scaffolds support and improve the formation of neotissue by 
maintaining or influencing cell phenotypes, delivering cells, and/or recruiting cells from 
the host. Adapted from Kwon et al.37 
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A variety of cell types have been proposed as candidates for cartilage repair, 
including chondrocytes,32 adult progenitor cells such as mesenchymal stromal cells 
(MSCs) from various sources,33,34 induced pluripotent stem cells,35 and even 
fibroblasts.36 With clinical relevance in mind, chondrocytes and MSCs have emerged as 
leading candidates among the cell types studied. Chondrocytes are the resident cells in 
cartilage tissue that are essential for cartilage ECM production and maintenance and 
thus represent a logical choice for cartilage engineering. Isolating chondrocytes directly 
from the joint, however, proves difficult and also creates secondary injury to the joint, 
leading to further tissue degradation.11 
As a result, non-articular “heterotopic” chondrocytes such as nasoseptal or 
auricular chondrocytes have attracted interest as an alternative cell source. These have 
proved easier to harvest with lower risks related to donor-site morbidity.38-41 It remains to 
be seen whether these heterotopic chondrocytes can be induced to produce tissue that 
is functionally appropriate for orthopaedic applications. One of the additional challenges 
of using chondrocytes for transplantation is maintenance of phenotype during their 
expansion in vitro by means of, for instance, chondrocyte sorting,42 cytokine 
stimulation,43 or control of oxygen exposure;44 chondrocytes expanded too extensively 
may also lose their capacity to re-differentiate.45 Moreover, chondrocytes fail to form 
bone tissue in the subchondral zone of full-thickness osteochondral defects.32 
MSCs are a clinically relevant multipotent cell type that can be readily derived 
from a variety of adult tissues.46,47 Bone marrow-derived MSCs can undergo 
chondrogenesis by induction with soluble factors such as cytokines, ideally within a 3D 
culture environment (e.g., cell pellets, micromasses, or encapsulation into 3D scaffolds) 
that is developmentally relevant. For in vitro culture, the addition of soluble factors such 
as TGF-β generally stimulates enhanced chondrogenesis in a dose-dependent manner; 
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at the appropriate dose, this enhances chondrogenesis regardless of culture method or 
scaffold, but the degree of chondrogenesis is still scaffold-dependent.48 For example, 
MSCs produce greater quantities of sulfated GAGs in alginate over agarose gels in 
response to TGF-β.48 To date, numerous scaffold materials have been used in 
conjunction with media containing TGF-β and other chondrogenic supplements towards 
the differentiation and phenotype maintenance of cells, including: agarose,48,49 alginate,48 
poly(ethylene glycol) (PEG),50 poly(glycolic acid) (PGA),51 silk,52,53 poly(DL-lactic-co-
glycolic acid)-collagen (PLGA-collagen) meshes,54 gelatin/chondroitin/hyaluronic acid tri-
copolymer,55 and electrospun polycaprolactone (PCL).56 In addition to TGF-β, the cycling 
of growth factors (BMP-6 and IGF-1) during in vitro culture can also influence 
chondrogenesis.57 Cultures of MSCs with components of the joint cavity, like synovial 
fluid or synovial cells, exhibit enhanced chondrogenesis in vitro as well.57 
 
1.4. MSC-LADEN HA HYDROGELS FOR CARTILAGE TISSUE ENGINEERING 
Due to their biological relevance to the origins of cartilage tissue in development, 
as well as their clinical relevance as a cell type that can be readily harvested and 
expanded, MSCs have gained significant interest in cartilage tissue engineering as an 
alternative to chondrocytes. In 1998, bone marrow derived MSCs were found to undergo 
chondrogenesis when cultured in cell aggregates in the presence of TGF-β1.58 However, 
one major limitation of these MSCs is the mechanical integrity of the matrix they produce 
in the engineered environments that have been developed to encapsulate and deliver 
them thus far.59 In a long-term agarose culture, for instance, chondrogenesis was 
observed in the MSC-laden gels, but the amount of matrix produced and mechanical 
properties were inferior to that produced by chondrocytes from the same donor.59 The 
glycosaminoglycan (GAG) content and the equilibrium modulus of these MSC-laden gels 
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plateaued with time, which suggests diminished chondrogenic capacity rather than 
delayed differentiation of these cells. 
In general, the use of inductive biomaterials in the cells-in-hydrogels approach to 
tissue engineering has been deemed to be favorable compared to that of inert but 
permissive materials, e.g., alginate and polyethylene glycol (PEG) (Figure 1.4).60,61 For 
this approach, hyaluronic acid (HA), a linear polysaccharide that consists of disaccharide 
repeats of D-glucuronic acid and N-acetyl-D-glucosamine, has emerged as one of the 
most studied inductive biomaterials.62 In fact, among the numerous cell-material 
formulations developed toward this end, hydrogels that make use of this native cartilage 
ECM component have been used to successfully mimic characteristics of cartilage 
developmental structure and signaling, and formulations using this macromer with low 
gel densities (to reflect minimal early ECM deposition) and high cell seeding densities 
(approaching that in a developing embryo), coupled with transient presentation of pro-
chondrogenic factors, have demonstrated the greatest final mechanical functionality of 
those studied.60,61,63 
The primary hydroxyl and carboxylic acid groups on the HA backbone are readily 
functionalizable for the fabrication of hydrogels with highly tunable properties and such 
functionalized HA macromers have been used for photocrosslinking as well as covalent 
tethering of a variety of crosslinkers, peptides, and even full-length proteins that mimic 
aspects of the native microenvironment.64-69 For instance, photopolymerization of HA can 
be achieved via the modification of HA with methacrylate pendant groups (i.e., MeHA), 
and by further varying the molecular weight and macromer concentration of the modified 
HA, a wide range of properties can be obtained.60,64,65 Increasing the macromer 
concentration can significantly increase the network compressive modulus and 
degradation time but decrease the viability of encapsulated cells.64 Degradability of the 
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network can also influence cell behavior in these scaffolds such that cells in dynamic 
systems with decreasing gel concentration over time produce more matrix components; 
these variations in hydrogel scaffold properties can thus affect neocartilage formation, 
where evidence of chondrogenesis is typically characterized by enhanced type II 
collagen and aggrecan expression and accumulation.70,71  
 
 
 
 
 
Figure 1.4. Comparison of MSC chondrogenesis in HA versus PEG hydrogels. 
Immunohistochemistry of MSCs cultured in HA or PEG hydrogels for 14 days in vitro. 
Deposition of type II collagen and chondroitin sulfate by MSCs is increased in an HA-
based material compared to an inert PEG gel. Adapted from Chung et al.61 
 
Substantial efforts have been made to characterize the effects of these various 
gel properties on cells’ ability to produce neotissue: screens of 1, 2, and 5 wt% MeHA 
hydrogels seeded with bovine MSCs found that MSCs within 5 wt% MeHA hydrogels 
significantly upregulated mRNA expression of type II collagen and resulted in the highest 
overall proteoglycan deposition relative to lower concentration hydrogels.72 However, the 
high network density also impeded the distribution of the deposited matrix and resulted 
in inferior bulk mechanics compared to the other conditions. Indeed, the 1 wt% hydrogel, 
although not optimal for matrix production and possessing the lowest initial mechanical 
properties, resulted in the highest equilibrium compressive modulus (0.12 MPa) and 
dynamic modulus (1.05 MPa) of all conditions after 6 weeks of in vitro culture.72 Thus, it 
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is important to balance the initial properties with the ability to accumulate matrix within 
these hydrogel systems to obtain the best final properties in engineered tissues, towards 
their utility in clinical applications.  
Analogous findings were obtained in studies in vivo.60 For instance, in an in 
vivo rabbit cartilage defect model, the quality of tissue repair using MSCs encapsulated 
in HA-gelatin hydrogels depended on the supporting scaffold - defects treated with 
MSCs in the absence of any supporting scaffold exhibited hyaline-like cartilage on the 
periphery but fibrous repair tissue in the middle of the defect, whereas defects that were 
treated with a scaffold containing MSCs resulted in elastic and mechanically stable 
translucent cartilage with zonal architecture and substantial integration with the 
surrounding cartilage.73   
In addition to investigating the effects of gel properties, the effects of varying cell 
parameters in these constructs have also been explored - in one study, a higher cell 
seeding density of 60 million cells/mL (60M) was compared to a standard density of 20 
million cells/mL (20M) within 1wt% MeHA hydrogels. Hydrogels containing 60M cells 
reached a significantly higher equilibrium compressive modulus and dynamic modulus 
compared to the ones containing 20M cells—presumably due to increased cell-cell 
proximity and thus increased paracrine signaling and extracellular matrix 
connectivity.74,75 Interestingly, the GAG concentration was only ~25% greater and the 
collagen content was surprisingly halved in the 60M group, implying that the increase in 
mechanics was more likely due to enhanced collagen organization and connectivity. 74,75 
Importantly, the effect of higher network densities was not overcome even by this 3-fold 
difference in cell density - the mechanical properties of constructs after culture did not 
increase in gels containing 60M versus 20M cells encapsulated in in 2wt% and 5wt% 
MeHA hydrogels.74 
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Hydrogel environments may also alter or influence cellular mechanosensitivity 
and responsivity to various mechanical loading regimes. Mechanical properties of bovine 
MSC-seeded MeHA hydrogels improved significantly after continuous loading in 
comparison to the moduli of identical samples under delayed loading and static culture 
conditions, such that the MeHA-based constructs exhibited significant improvements in 
mechanical properties even with early application of dynamic loading whereas this was 
not the case with agarose gels.76 The different responses to compressive loading within 
MSC-seeded HA gels compared to other systems like agarose and PEG may be due to 
specific receptor mediated interactions with HA, including CD44.77 Although the 
underlying mechanisms remain yet to be fully defined, the finding that compressive 
mechanical loading can significantly enhance mechanical properties within HA hydrogels 
while not in inert ones provides some important clues and valuable insight into culture 
environments. 
However, without considering the full microenvironmental context (e.g., cell-
matrix, cell-cell interactions) required for this cell population to differentiate into a desired 
cell type, the expected phenotypic outcome is incomplete commitment even in the 
presence of pro-chondrogenic differentiation factors. This would, in turn, limit matrix 
deposition and potentially promote matrix heterogeneity within the construct. In fact, this 
is what has been observed in many of the aforementioned studies, with limited 
chondrogenesis and heterogeneity in extracellular matrix deposition.78 This poses a 
major challenge for cell delivery and tissue engineering with adult MSCs. 
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1.5. CARTILAGE DEVELOPMENT AND HOMEOSTASIS 
To design appropriate cartilage tissue engineering strategies, we should look to 
our understanding of the adult tissue composition and structure, as well as an 
understanding of how the tissue develops. Mature articular cartilage contains a sparse 
resident population of chondrocytes and a dense ECM that comprises most of the tissue 
volume.79 This ECM is comprised largely of type II collagen (15 to 22% of wet weight), 
proteoglycans containing aggrecan (4 to 7%), and high fluid content (65 to 80%).80 
The development of articular cartilage occurs in the context of direct cell-matrix 
and cell-cell interactions that are present as this tissue forms out of the mesenchymal 
lineage.81 Before differentiation, or chondrogenesis, MSCs produce a mesh that is 
mainly composed of HA.77 HA is remodeled in the mesenchyme throughout the early 
stages of chondrogenesis in the developing embryo to help orchestrate both cell-cell 
interactions and subsequent matrix deposition.77,82,83 HA-cell interactions are mediated 
via the principal cell-surface receptor CD44, which is understood to induce chondrogenic 
differentiation via interactions with other cell-surface receptors relevant to 
chondrogenesis, as well as via nuclear translocation of transcription factors such as 
Smad4, c-Myc, and E2F4 (Figure 1.5) .84-87  
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Figure 1.5. Generalized HA signaling pathway mediated by CD44-HA interactions. 
HA interactions with CD44, which can interact with and activate other receptors on the 
cell surface, can influence the transcription of genes required for chondrogenic matrix 
synthesis via intermediates such as transcription factors c-Myc, E2F4, and Smad4 (not 
pictured). Adapted from Responte et al.87 
 
The first phase of cartilage development, referred to as the condensation phase, 
is marked by the aggregation of mesenchymal cells, and changes in both HA-binding 
activity and CD44 expression coincide with this reduction in intercellular space at regions 
marked for future cartilage deposition.88 The cell-surface protein N-cadherin is 
considered to be the key component in directing these cell-cell interactions.89,90 
Interestingly, MSCs increase N-cadherin expression upon exposure to media containing 
pro-chondrogenic factors.91 The structures of the classical cadherins, including N-
Cadherin, include an extracellular binding domain that mediates cell-cell interactions in a 
calcium dependent manner, as well as intracellular domains that interacts with signaling 
mediators such as β-catenin (directly via the cytoplasmic tail), p120 catenin (directly via 
the juxtamembrane region), and α-catenin (indirectly via β-catenin; Figure 1.6).92 
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Figure 1.6. Schematic of N-Cadherin-catenin complex. N-Cadherin is a Ca2+-
dependent single-pass transmembrane protein that mediates cell-cell interactions via its 
extracellular domain, which is composed of 5 tandem repeats with the HAV (histidine-
alanine-valine) motif that confers homotypic specificity on the N-terminus. The 
cytoplasmic domain is capable of sequestering β-catenin at the cell membrane, and it 
can thus also interact with the cytoskeleton via α-catenin. Adapted from DeLise et al.92 
 
N-cadherin signaling intersects with the Wnt signaling pathway via its interactions 
with β-catenin.91 When ligands for Wnt are present, β-catenin translocates to the nucleus 
where it can act at TCF/LEF promoters to activate target genes (e.g., MMP3, MMP7, 
ADAM10, Twist, Slug, Tiam1, Fibronectin, and cyclin D1).93 Functionally, both the 
extracellular homotypic interaction with other cadherins and the intracellular interactions 
with the catenin complex are essential for N-cadherin signaling - expression of deletion 
mutants of N-cadherin that lack either the extracellular interaction domains or the 
intracellular β-catenin binding site results in decreased cellular condensation and 
impaired chondrogenesis.94,95 In addition to deletion of either its intracellular or 
extracellular domains, the degree of expression of full-length N-Cadherin and its 
subsequent ability to bind in the face of other soluble factors both affect chondrogenesis 
as well - the significant overexpression of full- length protein or inhibition of N-Cadherin 
interactions via blocking antibody treatment inhibit condensation and/or 
chondrogenesis.61,96 In particular, the evolutionarily conserved His-Ala-Val (HAV) 
sequence in the first extracellular domain (ECD1) of N-cadherin has been identified as 
essential to the homotypic interaction that mediates cell-cell adhesion in this context.97 
	 17	
Notably, in the mesenchyme, the cell-surface metalloprotease ADAM10 temporally 
regulates N-Cadherin interactions by cleaving the extracellular domain that is 
responsible for cell-cell binding,98 thereby regulating both the β-catenin membrane-
bound and cytoplasmic pool levels.89,98,99 
An additional layer of spatiotemporal complexity in chondrogenesis is the fact 
that MSCs synthesize, deposit, and even remodel both their PCM and ECM as they 
differentiate.100 Various cell types are capable of organizing their pericellular matrix 
within hours; chondrocytes in particular are capable of organizing a stable pericellular 
coat of matrix components in as few as 30 minutes, and they are able to synthesize a 
pericellular matrix that fully surrounds the cell membrane in as few as 24 hours.101,102  
	
1.6. CONCLUSIONS 
Articular cartilage injury is a widely prevalent condition that leads to a 
progression of degenerative changes in the joint space. Current treatment methods fall 
short of long-term tissue repair, and they often miss the complex spatiotemporal 
microenvironmental cues required for cartilage development, repair, and homeostasis. In 
response to the fact that cartilage is cell-sparse and has poor inherent regenerative 
capacity, cell-laden hydrogels have emerged as a suitable approach to cartilage repair. 
These hydrogel environments are being engineered with microenvironmental cues to 
promote cell differentiation, matrix synthesis, and construct maturation. Materials 
designed for the fabrication of these hydrogels can make use of the current 
understanding of developmental processes, specifically by addressing both the cell-cell 
and cell-matrix interactions that are required for chondrogenesis, as well as the timing of 
presentation of such cues. 
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CHAPTER 2 
RESEARCH OVERVIEW 
 
2.1. SPECIFIC AIMS 
	
Cell-laden hyaluronic acid (HA) hydrogels have been adopted as a promising and 
extensively studied approach to cartilage repair.1 Advances in the designs of these 
hydrogel environments now consider how they can mimic or recapitulate 
microenvironmental cues that promote relevant cell differentiation, matrix synthesis, and 
construct maturation. Specifically, these can include interactions between cells and the 
HA that forms the hydrogel via surface receptors (e.g., CD44), as well as the cell-cell 
interactions that are essential in the early stages of cartilage tissue development. 
The use of HA in these approaches introduces potential biological activity to the 
hydrogel, such as through binding with the cell-surface receptor CD44 - indeed, this 
biologically relevant interaction may serve to explain why HA hydrogels are superior to 
polyethylene glycol (PEG) hydrogels when directly compared toward cartilage tissue 
engineering with increased extracellular matrix (ECM) synthesis and chondrogenic 
differentiation of MSCs observed when HA is used.2 However, the modification of HA 
through the primary alcohol or carboxylic acid groups is needed to enable crosslinking 
into hydrogels. These groups may play a role in the interactions with CD44; thus, 
modification would likely influence the final macromer’s actual biological activity and 
therefore its ability to promote chondrogenesis. For instance, the modification of the 
highly charged and hydrophilic carboxylic acid on the HA backbone with hydrophobic 
groups may alter its solubility, range of possible conformational states, and receptor 
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affinities.  This has in fact been exploited for the development of HA-based macromers 
with longer half-life, efficacy, or cargo delivery properties that are now used in 
commercial fillers and viscosupplements.3 There is still a great need to further 
understand how HA modification influences its activity in the context of cartilage repair. 
Meanwhile, the introduction of direct cell-cell interactions into the cell 
microenvironment is challenging due to difficulties in controlling cell behavior in 
aggregates and maintaining cell viability in large pellets. An alternative approach is to 
simulate cell-cell interactions  within 3D hydrogels where cells are uniformly suspended 
as single cells and therefore unlikely to come into direct contact with other cells. 
Specifically, the conserved short sequence, His-Ala-Val (HAV), on the adhesive domain 
on N-Cadherin can be exploited to mimic N-Cadherin-like binding activity via the 
incorporation of short peptides.4-7 Incorporation of these N-Cadherin mimetic peptides in 
HA hydrogels has indeed promoted early chondrogenic gene expression and 
subsequent matrix production of MSCs in culture and in vivo4 and resulted in increased 
β-catenin recruitment to the membrane and subsequent translocation to the nucleus to 
mediate downstream N-Cadherin signaling.8 However, N-Cadherin signals in the 
developing limb exhibit wide spatiotemporal variation, with high persistent levels of 
Ncad-mediated cell-cell contact possibly even reducing collagen and proteoglycan 
deposition.9 Prior to this thesis, the magnitude and timing of the presentation of these N-
Cadherin mimetic signals, which are two critical aspects of this essential interaction that 
directly influence signaling, were yet to be explored. 
As these various types of modifications (e.g., reactive groups, peptides) are 
increasingly used to functionalize materials such as HA for applications in tissue 
engineering, it remains unclear when, and for how long, the actual presentation of these 
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signals occurs. The spatial arrangements of these newly synthesized matrices in a 
hydrogel setting where the polymer initially occupies this space in the cell 
microenvironment is not well characterized. Recently, high-resolution imaging of total 
nascent pericellular matrix (PCM) synthesized by cells in hydrogels have been 
developed to probe spatiotemporal matrix organization, and the use of these methods in 
the context of tissue engineering has yielded valuable insights into cell-to-cell variations 
in PCM deposition and retention.10 Such methods for visualization and quantification of 
total matrix synthesis and deposition by cells, in combination with the ability to visualize 
the spatial localization of the hydrogel itself, help inform how we can engineer cues to be 
biologically relevant in their presentation. 
The overall goal of this thesis is to advance the design of cell-laden HA hydrogels 
for cartilage tissue engineering by investigating the influence of the extent and timing of 
the presentation of critical early cues in the context of chondrogenesis. Specifically, as 
outlined in the following aims, we evaluate these parameters using both innovative 
techniques as well as in vitro models that enable observation of both early differentiation 
and bulk construct maturation. We also utilize single-cell assessments to characterize 
the dynamic MSC interactions with these early hydrogel cues over time. 
 
Aim 1: Probe the influence of HA modification on CD44-mediated MSC 
interactions with HA hydrogels 
Hypothesis: Modifying HA decreases binding to CD44 as a function of modification level 
and location and influences chondrogenesis of MSCs when encapsulated in HA 
hydrogels.  
	 29	
It is known that MSCs bind to HA through CD44 receptors, and that HA 
hydrogels are superior in supporting ECM synthesis by fully differentiated chondrocytes 
as well as by MSCs;11,12 yet, the influence of HA modifications (e.g., norbornene or 
methacrylate, used to crosslink HA into hydrogels) on these interactions is not well 
understood. It has been reported that a minimum number of 4 disaccharide repeats is 
needed on HA for CD44 binding; thus, modification is expected to influence these 
interactions.13 To better understand these interactions, HA with varying degrees and/or 
sites of modification with norbornene and methacrylate groups are synthesized and used 
in soluble form or as hydrogels with matched mechanics, swelling, and cytocompatibility. 
The effects of the degree of modification are examined first by observing the binding 
avidity of modified HA to either CD44 or directly to the surface of MSCs. Atomic force 
microscopy using receptor-functionalized beads on hydrogels containing HA with varying 
degrees of modification is then used to evaluate CD44 interactions with HA when 
crosslinked into hydrogels. Lastly, the influence of HA modification level on the 
chondrogenesis of MSCs encapsulated in these hydrogels is explored with outcomes of 
gene expression, biochemical content, mechanics, and histology. These studies provide 
a perspective on the design and evaluation of modified biopolymers, where the degree 
of modification of the biopolymer may be a key consideration in its interactions with cells. 
 
Aim 2: Investigate the role of the magnitude and timing of N-cadherin signals to 
MSCs within HA hydrogels towards chondrogenesis 
Hypothesis: Varying the amount and extent of HAV peptide presentation within HA 
hydrogels alters chondrogenesis of encapsulated MSCs. 
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We previously showed that modification of hydrogels with a peptide (i.e., HAV) 
that mimics N-Cadherin influences MSC chondrogenesis and matrix production;4,8 
however, this was presented to cells only at one concentration and with a stable linker. 
To better understand the role of HAV in altering MSC chondrogenesis both the HAV 
magnitude and the timing of HAV are examined using stable and transient peptides 
when coupled to HA hydrogels. Importantly, in the mesenchyme, cell-surface 
metalloprotease ADAM10 temporally regulates N-Cadherin interactions by cleaving the 
extracellular domain of N-Cadherin, thereby exerting control over the β-catenin 
membrane-bound and cytoplasmic pool levels.14-16 Thus, the timing of HAV is modified 
by the incorporation of ADAM10-cleavable peptides, so that its presentation is self-
regulated by cells via ADAM10. The role of HAV signal magnitude and timing is tested 
using hydrogels with matched mechanics, swelling, and total peptide content with 
longitudinal assessments of MSC gene expression, matrix elaboration, and construct 
properties. These studies elucidate how the magnitude and timing of presentation of this 
important early cell-cell cue in materials influences chondrogenesis and information 
gained can be used to better design appropriate hydrogel approaches for cartilage 
repair.  
 
Aim 3: Investigate the deposition of pericellular matrix by cells within HA 
hydrogels using metabolic labeling techniques.   
Hypothesis: Early pericellular matrix produced by cells encapsulated within HA 
hydrogels forms a barrier between the cell membrane and the hydrogel, temporally 
altering the presentation of hydrogel signals to cells.  
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As hydrogels comprised of bioactive molecules (e.g., HA) or with peptide 
modifications (e.g., HAV) are developed, it is important to understand how long these 
signals are actually presented to cells encapsulated within hydrogels. Towards cartilage 
tissue engineering, cells synthesize and deposit a PCM17 that alters their local 
microenvironment; yet, it is not well understood how this influences the presentation of 
engineered signals too cells. Nascent pericellular matrix (e.g., proteins, proteoglycans) 
deposited by cells can be visualized via metabolic labeling and hydrogel positioning can 
be monitored with encapsulated fluorescent beads. Parallel longitudinal studies using 
bead-labeled gels in combination with metabolic labeling are performed to visualize and 
quantify temporal changes in pericellular matrix deposition and the distance between the 
cell membrane and the hydrogel. This approach enables examination of this critical cell-
material interfacial region in hydrogels over time, and is used to assess this interface 
where critical hydrogel parameters, such as crosslink density and macromer 
concentration are varied.  These results will help inform hydrogel design and the 
introduction of bioactive signals to modulate cellular behavior.  
 
2.2. CHAPTER OUTLINE 
	
Chapter 1 provides an overview of the clinical landscape for cartilage repair as 
well as various cartilage tissue engineering approaches being developed, including the 
use of MSC-laden HA hydrogels. It also summarizes the relevant biological aspects of 
cartilage development and homeostasis that may be used in designing new tissue 
engineering strategies. Chapter 3 consists of a focused summary of highlights in current 
and emerging advances in hydrogel design for cartilage tissue engineering. In particular, 
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unique crosslinking methods, processing techniques, and the incorporation of 
biologically relevant signals to influence cell behavior are discussed.  
Chapter 4 describes the scientific work proposed in Aim 1, describing the effects 
of the extent and type of HA modification on its interactions with CD44. Chapter 5 
describes the research proposed in Aim 2, which characterizes the influence of the 
dosing and timing of N-Cadherin mimetic peptide interactions on MSC chondrogenesis 
in HA hydrogels. Chapter 6 describes the work proposed in Aim 3, exploring the 
relationship between various hydrogel properties and the elaboration of PCM at the cell-
hydrogel interface. 
Chapter 7 provides a summary of the work presented and discusses the overall 
impact of this work on the design of HA hydrogels towards cartilage tissue engineering. 
Limitations and future directions of this work that may further inform HA hydrogel design 
will also be described. 
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CHAPTER 3 
RECENT ADVANCES IN HYDROGELS FOR CARTILAGE TISSUE ENGINEERING 
 
Adapted from: 
Vega SL, Kwon MY, Burdick JA. Recent advances in hydrogels for cartilage tissue 
engineering. Eur Cell Mater. 2017;33:59-75. 
 
3.1. INTRODUCTION 
 
In simplistic terms, articular cartilage is a tissue consisting of a single cell type 
(chondrocyte) embedded within an extracellular matrix (ECM). However, the structure is 
more complex and includes three depth-dependent layers: the superficial zone, the 
middle zone, and the deep zone, with changes in ECM content, structure and 
chondrocyte behavior with depth. In the middle zone – the largest region, cartilage tissue 
is stiff, avascular, and features a low density of rounded chondrocytes surrounded by an 
ECM consisting of glycosaminoglycans (GAGs) and type II collagen.1,2 Cartilage damage 
due to trauma typically begins as a focal defect, which later progresses to a full-
thickness defect once the lesion comes into contact with surrounding bone. Due to low 
cellularity, low vascularization, minimal proliferative capacity of residing chondrocytes, 
and low cell migration to areas of damage, articular cartilage is intrinsically unable to 
repair itself.3 
 Current strategies to repair focal and full-thickness cartilage defects have 
evolved from surgery aimed to induce endogenous repair mechanisms (e.g., 
microfracture), towards osteochondral transplantation, and more recently to cell-based 
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repair techniques, such as autologous chondrocyte implantation (ACI).4,5,6 ACI is a 
procedure in which patient chondrocytes are implanted into a debrided cartilage lesion.7 
Both microfracture and ACI lack 3D scaffolds to define where cells reside and to instruct 
matrix formation; however, there have been advances in these therapies in recent years. 
Matrix-induced autologous chondrocyte implantation (MACI) is a cell-based therapy that 
supplements ACI by providing chondrocytes with a supportive scaffold material for 
matrix formation.8 Autologous matrix-induced chondrogenesis (AMIC) on the other hand 
supplements microfracture with an acellular scaffold in the lesion in an effort to increase 
mechanical stability at the site, cell migration, and cartilage production.9 Despite 
promising results, these clinical techniques are not without their limitations, including the 
surgical procedures and the quality of the formed cartilage. 
Towards further expanding on the use of biomaterials in cartilage repair, 
hydrogels have gained a great deal of interest in cartilage tissue engineering.10 
Hydrogels are 3-dimensional (3D) polymer networks that are highly swollen and porous 
on the molecular scale, allowing for the diffusion of various solutes and nutrients. Their 
fabrication can be cell amenable, allowing for the encapsulation of different cell types 
(e.g., chondrocytes, stem cells). Lastly, an assortment of hydrogel parameters can also 
be tuned, including polymer chemistry, crosslinking density, degradation, mechanical 
properties, and release kinetics of biochemical factors, towards improving their utility in 
tissue repair.11 Seminal studies have characterized the effects of hydrogel properties 
(e.g., macromer molecular weight, macromer concentration) on neocartilage formation,12 
and have also studied differences between the composition of hydrogels towards 
cartilage formation. For example, several groups report that type II collagen hydrogels 
induce a higher amount of chondrogenic outputs in comparison to type I collagen 
hydrogels with similar properties.13,14 
	 36	
To serve as constructs to replace articular cartilage, hydrogels have been used 
as either acellular scaffolds or as cell-laden biomaterials.11 For either strategy, hydrogel 
implants must integrate with surrounding tissue and support the production of cartilage. 
Acellular constructs are almost exclusively assayed in vivo, where the goal is structural 
and mechanical properties similar to native cartilage while allowing efficient load transfer 
or to recruit cells for cartilage repair.15,16 Cell-laden hydrogels present residing cells with 
either developmental cues to trigger chondrogenesis, or microenvironmental cues that 
mimic native cartilage to maintain a chondrogenic phenotype and encourage matrix 
formation. Hydrogels are advancing to present these signals either as bound to the 
polymer or through the controlled release of molecules. Also, these cultures may be 
performed in vitro, such as with bioreactors, or may be implanted directly for tissue 
growth.   
With the rapid advances being made towards hydrogels for cartilage tissue 
engineering, the goal of this review is to cover current and emerging developments in 
hydrogel design for cartilage repair. It is not meant to be comprehensive, but rather 
highlight representative advances in the field in recent years with a particular focus on 
the hydrogel design. Specific areas include the use of unique crosslinking to produce 
hydrogels with high mechanical properties, the improved processing of hydrogels into 
macroporous structures, and the incorporation of biological signals to improve cell 
behavior. 
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3.2. IMPROVEMENTS IN HYDROGEL STRUCTURE 
 
One of the key design criteria for hydrogels towards cartilage regeneration is 
mechanical integrity. Traditional hydrogel designs based on networks of a single polymer 
generally result in hydrogel constructs with mechanical properties far inferior to those of 
native cartilage. Also, the increase in mechanics through increased crosslink density 
may compromise the viability of encapsulated cells through reduced diffusion. Towards 
increasing the mechanical properties of hydrogels to approach those of hyaline cartilage, 
the focus is shifting from conventional hydrogels that use a single polymer for hydrogel 
fabrication (Figure 3.1a), to more complex hydrogel systems with mixtures of multiple 
polymers, often including two or more independent networks. These systems not only 
often achieve higher mechanical properties than with networks of single polymers, but 
may exhibit superior integration with surrounding tissue in vivo. In this section we 
examine recent advances within the framework of different network types (Figure 3.1). 
 
3.2.1. INTERPENETRATING NETWORKS 
Hydrogels based on interpenetrating networks (IPNs) are comprised of two or more 
separate crosslinked networks not covalently bound to each other, but rather partially 
intertwined such that chemical bonds have to be broken to separate the components 
that make up the networks (Figure 3.1b). Consequentially, the mechanical properties of 
IPN hydrogels tend to be greater than those created with individual component 
networks, which makes them appealing for cartilage tissue engineering applications. In 
recent years, the design of IPNs for hydrogel formation has turned to the incorporation of 
two or more additional networks to either better mimic the physical properties of native 
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tissue or to recapitulate the presentation of bioactive cues available to cells in the 
hydrogel constructs.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Schematic depicting different designs utilized in hydrogels. (a) 
Traditional single polymer networks, (b,c) multiple networks, and (d-f) mixtures of 
polymers. Double networks may be linked together, but this is not a requirement.  
Generally, the network design controls properties such as mechanics and degradation. 
 
Recent examples of IPNs include work done by Ingavle et al., in which they 
explored the incorporation of methacrylated chondroitin sulfate, a major component of 
the cartilage ECM, as the second network after diffusion into an existing agarose-
PEGDA network.17 Incorporating chondroitin sulfate into the network significantly 
increased the viability of encapsulated chondrocytes for at least six weeks, and 
promoted greater biosynthesis of collagen and GAGs in the pericellular matrix.17 
Reinforcing networks such as those provided by methacrylated hyaluronic acid (HA) 
within a fibrin hydrogel have been demonstrated as well (Figure 3.2a).18 Here, the 
investigators found that the incorporation of a crosslinked HA network increased the 
compressive moduli of hydrogel constructs and modulated gene expression of 
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encapsulated human mesenchymal stem cells (MSCs) by decreasing expression of 
dedifferentiation marker type I collagen and increasing expression of the chondrogenic 
transcription factor Sox9.18 
 
	
 
 
 
 
 
 
 
 
Figure 3.2. Examples of network types applied in cartilage tissue engineering. (a) 
SEM micrograph of a fibrinogen hydrogel with (bottom) and without (top) interpenetrating 
methacrylated HA network.18 (b) MSCs encapsulated in gelatin methacrylamide 
hydrogels exhibit more aggrecan (green) with increasing concentrations of 
methacrylated HA, which acts as a dual network.31 (c) Hydrogel molecular structures 
and crosslinking schemes can become quite complex, as seen by this schematic 
depicting supramolecular hydrogels prepared with CB[6]-HA, DAH-HA, and drug 
conjugated Dexa-CB[6].39 
 
In addition to IPNs of two networks, several groups have also investigated how 
tri-component IPNs increase mechanical properties and cartilage formation using both 
non-cell instructive19,20 and cell-instructive materials.21 In a non-cell instructive scaffold 
comprised of gelatin, alginate, and polyacrylamide, Dinescu et al. reported higher cell 
proliferation, lower cytotoxicity, and greater chondrogenic gene expression (Sox9, type II 
collagen) of human adipose-derived stem cells than in one- or two-component 
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hydrogels.19 The authors attributed these findings to the tri-component network’s ability 
to better retain its internal structure and porosity in long-term culture.19 Guo et al. further 
used this tri-component IPN concept to better approximate the diversity of biomaterials 
present in articular cartilage.21 The authors demonstrated the feasibility of generating a 
tri-component IPN using only cell-instructive components (collagen combined with 
methacrylate-modified chondroitin sulfate and HA).21 By comparing to a semi-IPN using 
the same components (where the chondroitin sulfate and HA were not methacrylated) 
and by varying the extent of methacrylation, they demonstrated tunable mechanics with 
the tri-component IPNs, increased gene expression of chondrogenic markers (i.e., 
aggrecan, type II collagen, and Sox9), downregulation of dedifferentiation marker type I 
collagen, and increased collagen and GAG synthesis by encapsulated rabbit 
chondrocytes that correlated with the bulk mechanics of the IPN constructs.21 
 
3.2.2. SEMI-INTERPENETRATING NETWORKS 
Unlike IPNs, semi-IPNs consist of a crosslinked network with either linear or 
branched polymers entrenched within the network (Figure 3.1c). As such, the polymers 
and network can theoretically be separated from one another without breaking chemical 
bonds. One of the most common macromolecules distributed in these networks is HA. In 
a recent study, high molecular weight HA was distributed within injectable networks of 
photopolymerized methacrylated chitosan (MeGC).22 An optimum formulation and 
gelation protocol was developed, and the presence of entangled (but unbound) HA (350 
kDa) incorporated into the chitosan network resulted in greater proteoglycan and GAG 
staining (as measured by alcian blue and safranin O) in the lacunae of chondrocytes 
encapsulated and cultured for up to 21 days.22 
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Another approach towards utilizing the properties of semi-IPNs is exploiting their 
ability to leach low-molecular weight macromolecules over time, as demonstrated by 
Skaalure et al. in a degradable poly(ethylene glycol) (PEG) hydrogel with low-molecular 
weight HA (29 kDa).23 By comparing PEG networks infiltrated by either low- or high-
molecular weight HA (2 MDa), the authors found that leaching of low molecular weight 
HA over a 28-day period led to the greatest soluble GAG deposition during construct 
maturation, while collagen biosynthesis was comparable to that generated in constructs 
with high molecular weight HA (which remained in the network during this period).23 
Conceptually similar approaches taken by Little et al. suggest that low-molecular weight 
HA and chondroitin sulfate in a fibrin-alginate hydrogel may exert post-transcriptional 
effects on collagen expression to influence construct composition as cells deposit matrix 
over time.24 
 
3.2.3. DOUBLE NETWORKS 
A double network consists of two networks with significantly different mechanical 
properties crosslinked together (Figure 3.1d). Typically, the first network provides a rigid 
structure and the second network is ductile, resulting in greater toughness than the 
corresponding single networks alone would have achieved since the network can yield 
under mechanical load.25 These types of networks have gained interest in cartilage 
tissue engineering due to their superior mechanical properties over traditional hydrogels, 
including those that can approach the mechanics of native hyaline cartilage.26 Double 
networks are also conceptually appealing since cartilage and other skeletal tissues 
inherently incorporate double networks into their ECM in order to achieve their robust 
mechanical properties.26 
	 42	
Commonly utilized double networks for cartilage tissue engineering consist of a 
combination of two acrylamide polymers, poly(2-acrylamido-2-methylpropanesulfonic 
acid) (PAMPs), poly(acrylamide) (PAAm), and/or poly(N,N-dimethylacrylamide) 
(PDMAAm).27 Work with these double network hydrogels has recently extended to in 
vivo studies in both rabbit and sheep models of critical size defects, in which acellular 
plugs comprised of this double network implanted in defects resulted in enriched GAG 
and type 2 collagen content as measured by histological staining after 4 weeks.28 In all 
cases, the double-network plug was not infiltrated by cells, and instead seemed to serve 
as a support material for tissue regeneration above and around it. 
A direct comparison between double network hydrogels and traditional single 
network hydrogels of either only PAMPS or PDMAAm demonstrated that double network 
hydrogel constructs resulted in superior cartilage repair by histological scoring.29 The 
tissue formed in the presence of double networks also exhibited similar gene expression 
profiles30 and tissue surface roughness to native cartilage, even as observed by confocal 
laser scanning microscopy. Furthermore, combinatorial therapies using double network 
hydrogels and intra-articular injections (e.g., HA) have shown potential in tissue quality 
as measured by histological scoring and the volume of cartilage generated by double 
network hydrogels implanted in cylindrical osteochondral defects in rabbit femoral 
trochlea at both 4 and 12 weeks—again, using acellular plugs of the PAMPS/PDMAAm 
double network.30  
With this said, the application of novel and cell-instructive materials for double 
network construct design in cartilage tissue engineering has not been widely explored 
until recently. Polymers used for double networks are non-degradable, and while this 
stability renders them as potentially useful materials for mechanical support in tissue 
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defects, this stable and rigid network may limit cell infiltration and impede long-term 
matrix deposition and distribution. Despite these properties of double-network hydrogels, 
Levett et al. developed a double network consisting of a combination of gelatin-
methacrylamide and hyaluronic acid-methacrylate.31 This system leveraged the relatively 
higher reactivity of methacrylate groups to create a double network, thus generating 
greater increases in compressive modulus and cartilage matrix component synthesis by 
encapsulated human chondrocytes.31 New hydrogels making use of this type of network 
are continuously being developed, such as an injectable and cytocompatible double 
network hydrogel based on HA that is formed through the combination of dynamic (i.e., 
guest host pairs) and stable (i.e., covalent) crosslinks.32 
 
3.2.4. DUAL NETWORKS 
Unlike double networks which use two materials with different mechanical 
properties, dual networks are defined as two materials crosslinked together into the 
same network and with similar crosslinking mechanisms (Figure 3.1e). Although dual 
networks do not possess the toughness of double networks, each material in dual 
networks can imbue other useful properties to the hydrogel. For instance, one material 
can enable effective integration with the surrounding tissue, while the other can attract 
cells and encourage migration into the hydrogel. Teixeira et al. utilized a dextran-
tyramine and heparin-tyramine dual network hydrogel to encapsulate bovine 
chondrocytes in vitro and reported improved cell viability and proliferation.33 Additionally, 
they observed increased deposition of chondroitin sulfate and collagen compared to 
cells in a single component dextran-tyramine hydrogel.33 Jin et al. reported similar 
findings using the same dual network polymers ex vivo with bovine articular cartilage 
explants (0.5 x 0.5 x 0.2 cm) to determine tissue-adhesion of the hydrogel constructs.34 
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In a more recent study, in situ forming ethylenediamino-functionalized HA (HA-EDA) and 
divinylsulfone-inulin (INU-DV) dual network hydrogels were used to encapsulate 
chondrocytes, with the first material selected due to its native presence in articular 
cartilage and the second for its biocompatibility and status as a widely-used FDA-
approved polymer.35 
Along the same lines of using HA as the biologically relevant component, Pirinen 
et al. developed a dual network hydrogel using high molecular weight HA (>1,600 kDa) 
and low molecular weight PVA (27 kDa) functionalized with aldehydes and primary 
amines for crosslinking.36 This dual hydrogel system was amenable to tunable swelling 
properties by varying the size of the smaller PVA component, and encapsulation of 
bovine knee chondrocytes showed favorable cell viability for at least 2 weeks in 
culture.36 Similar hydrogel systems (e.g., with HA and gelatin) have also produced 
favorable results in construct formation and maturation. Levett et al. reported that the 
addition of HA as the second component resulted in retention of a rounded chondrocyte 
morphology, greater aggrecan deposition and compressive moduli, and suppression of 
type I collagen accumulation over the course of a 56-day study (Figure 3.2b).31 
 
3.2.5. GUEST-HOST NETWORKS 
Injectable hydrogels are an attractive approach for cartilage tissue engineering 
since they can be delivered via a direct injection or arthroscopically.37 Shear-thinning 
hydrogels are an attractive method towards this as a hydrogel can be disrupted during 
the injection process and then self-heal upon injection. One shear-thinning HA system 
developed is based on the reversible bonds between guest (adamantane modified HA) 
and host (β-cyclodextrin modified HA) polymers, termed guest-host interactions (Figure 
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3.1f).38 These types of interactions rapidly form hydrogels via non-covalent interactions 
in the guest-host bonds. In addition to cyclodextrin-adamantane guest-host pairs, guest-
host interactions between cucurbit[6]uril and diaminohexane have also been 
investigated.39 Both of these interactions are reversible and give rise to shear-thinning 
and re-moldable hydrogels. 
Wei et al. described the assembly of a two-component guest-host hydrogel with 
adamantane-functionalized HA as the first component and monoacrylated β-cyclodextrin 
(assembled into clusters by photopolymerization) as the second component.40 The 
hydrogels formed from these components exhibited nanoclustered interactions that 
allowed for robust drying and re-swelling without changes in water content or shape; 
they also enabled the robust chondrogenesis of encapsulated human MSCs with greater 
collagen deposition compared to a covalently crosslinked methacrylated HA network, 
although the differences in biophysical properties and network structure limit a direct 
comparison.40 Jung et al. demonstrated the use of guest-host interactions between 
curcubit[6]uril and diaminohexane to create hydrogels for the encapsulation of human 
MSCs as well as simultaneous release of dexamethasone for chondrogenesis. Cells in 
this injectable guest-host system, especially with the additional function of controlled 
dexamethasone release, exhibited increased cell proliferation, GAG synthesis, 
chondrogenic gene expression (i.e., type II collagen, COMP, aggrecan, Sox9), and 
neocartilage formation in an in vivo subcutaneous study (Figure 3.2c).39 
 
3.3. ADVANCES IN PROCESSING SCAFFOLDS 
 
Parallel advances in manufacturing technologies and material design have paved 
the way for new possibilities in how hydrogels can be manipulated and formed into 3D 
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macroporous scaffolds. Architectures that aid in the viability, retention, and chondrogenic 
induction of cells have been achieved using several techniques including 3D printing, 
spinning, and doping hydrogels with degradable porogens or microspheres (Figure 3.3). 
Due to their ability to generate unique microenvironments for cells and better 
recapitulate tissue structure on the macroscale, these techniques have become more 
prominent in tissue engineering in general and in cartilage engineering in particular. 
Recent studies making use of some of these more widely adopted methods are outlined 
in the following subsections. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3. Overview of different macroporous scaffold structures used for 
cartilage tissue engineering. To create hydrogel fibers, 3D printing and spinning 
techniques have been employed (blue box). In contrast, porous hydrogels and 
complementary microsphere hydrogels can also be fabricated (red box). To recapitulate 
native cartilage structures (e.g., different regions of cartilage, the osteochondral 
interface), multi-layer hydrogels incorporating several fabrication techniques can also be 
utilized (bottom). 
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3.3.1. HYDROGEL FIBERS 
Fiber fabrication techniques at length scales ranging from 150 nm to 1600 µm 
are typically generated by either spinning or 3D printing. The resultant fibrous networks 
offer a number of potential advantages, from more facile cell infiltration and greater 
hydrogel surface area (and thus improved diffusion of nutrients and other soluble 
factors) to increased mechanical properties. The techniques involve both the 
encapsulation of cells within macro-fibers to the seeding of meshes formed from 
nanofibers. Numerous groups have engineered hydrogel fibers using material 
composites and copolymers that allow for subsequent photo and ionic crosslinking, 
resulting in a wide spectrum of material properties. 
3D printing, or additive manufacturing, typically involves the building of 3D 
structures layer-by-layer with the controlled deposition of materials. A chief concern with 
3D printing of cell-laden hydrogels is the optimization of print parameters and control 
over material properties to enable efficient printing while preserving cell viability and 
phenotype. Schuurman et al. adapted a methacrylated gelatin formulation by introducing 
HA to increase the viscosity of the precursor material and demonstrated print fidelity and 
chondrocyte viability with post-print photocrosslinking.41 Conceptually similar fabrication 
techniques have been explored with other methods, including the use of ionically 
crosslinkable materials in lieu of photocrosslinking. For example, Fedorovich et al. used 
chondrocyte-laden alginate crosslinked with calcium chloride.42 In this case, constructs 
were printed with varying nozzle diameter, print speed, and fiber orientation and then 
cultured or implanted subcutaneously to demonstrate cell viability and tissue formation.42  
Building upon this approach, Markstedt et al. engineered additional shear-
thinning properties into this ionically crosslinkable network by incorporating nanofibrillar 
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cellulose into the alginate precursors to give the material additional shear-thinning 
properties.43 Cui et al. examined the timing of crosslinking in this context as well, 
demonstrating direct 3D printing into osteochondral defects using a PEG dimethacrylate 
(PEGMA) hydrogel in an explant model.44 The authors found greater chondrocyte 
viability and more uniform cell distribution with tandem (simultaneous) crosslinking, 
where crosslinking occurs at the same time as gel extrusion, rather than with traditional 
post-print crosslinking in which the construct can be crosslinked after printing.44 
Thermally responsive hydrogels use temperature to modulate their gelation 
behavior, allowing for the transition from liquid to a hydrogel as a function of temperature 
exclusively. This is particularly appealing in cartilage tissue engineering, since the 
change from ambient temperature to physiological conditions can induce rapid gel 
formation45 or stabilize materials in 3D printing processes. A common composite choice 
for thermoresponsive “bioinks” consists of HA or chondroitin sulfate mixed with a 
thermoresponsive polymer. Numerous groups have tested different thermoresponsive 
materials in this regard, from poly(N-isopropylacrylamide) (pNIPAAM)46 to triblock 
copolymers composed of PEG linked to N-(2-hydroxypropyl) methacrylamide (HPMA).47 
In exploring possible effects of thermoresponsive material structures at the 
nanoscale, Muller et al. showed that nanostructuring a thermoresponsive hydrogel 
allowed for high chondrocyte viability in a printed multilayer mesh and other more 
physiologically-relevant constructs including an ear (Figure 3.4e) and a sheep meniscus 
(Figure 3.4f-g).48 In this case, the authors incorporated both unmodified and acrylated 
Pluronic, crosslinked, and then subsequently washed out the unmodified fraction. In 
each case mentioned, methacrylated HA or chondroitin sulfate was either used as a 
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crosslinker or as an independent reinforcing network to compensate for the generally 
poor mechanics of the thermoresponsive component. 
A number of techniques that use spinning technology have been explored 
towards fabricating hydrogel fibers. A wet-spinning technique was introduced by Han 
and colleagues in which an 8-arm methacrylated PEG precursor was injected through a 
syringe pump into a tris(2-aminoethyl) amine (TAEA) bath.50 Subsequent crosslinking 
yielded microribbons that could be further crosslinked together to form hydrogels with 
complex geometries at both the micro and macro scales, and these hydrogels supported 
adipose-derived stem cell viability as well as proliferation and spreading under various 
conditions with the potential of recapitulating the laminar matrix organization of cartilage 
tissue.50 
	
Figure 3.4. Examples of hydrogel scaffold processing. SEM micrographs of PBLG 
microsphere hydrogels fabricated at a gelatin concentration of (a,b) 1.9 % and (c,d) 3.25 
%.49 3D printing was used to print (e) a human ear and (f,g) sheep meniscus, as seen 
from different angles with Ink8020 after crosslinking.48 
	
Electrospinning has also been used to generate fibrous constructs from 
methacrylated HA that supported human MSC interactions and chondrogenesis, without 
outcomes dependent on the hydrogel fiber properties such as mechanics and 
adhesion.51 Multi-polymer fibrous scaffolds were fabricated using HA hydrogels and 
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implanted in combination with microfracture for tissue repair in a mini-pig model. The 
multi-polymer design allowed for stable fibers to maintain the fiber structure and 
degradable fibers to release chondroinductive factors. Here, the transforming growth 
factor beta 3 (TGF-β3) spun into degradable HA fibers was verified to be active upon 
release, and in vivo it resulted in improved histological scores and type 2 collagen 
content in the repaired defects.52 Fiber spinning and printing have also been combined in 
cell-laden constructs, where, for instance, alternating rounds of electrospinning of 
polycaprolactone (PCL) fibers and printing of fibrin-collagen hydrogels were performed 
to yield scaffolds with greater mechanical properties and improved histological staining 
of GAGs and type 2 collagen in 8-week subcutaneous implant studies in mice.53 
 
3.3.2. POROUS HYDROGELS 
While hydrogel fibers and scaffolds comprised of fibrous networks permit the 
incorporation of pores of varying shapes and sizes, several other methods for generating 
porous hydrogel constructs within the context of cartilage tissue engineering also exist. 
These may be advantageous in some cases since they do not need specialized printing 
or spinning equipment and may produce scaffolds more rapidly. More recently, the 
design of porous hydrogels has turned to dynamic control of macroporosity as well as 
dynamic control of bulk material properties. 
Han et al. developed stimuli-responsive porogens from alginate, gelatin, and HA 
that respond to chelation, temperature, and enzymatic activity.54 Here, the alginate 
porogen was also used to deliver chondrocytes into the hydrogel, and treatment with 
changes in temperature, EDTA, or hyaluronidase activity released chondrocytes from 
the alginate components and subsequently increased hydrogel macroporosity.54 While 
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this controlled degree of macroporosity affected bulk mechanical properties, approaches 
have also been developed where mechanics can be dynamically increased with 
photocrosslinking, such as from 2.6 to 12.5 kPa, without changing porosity.55 In this 
case, across the range of mechanics tested, chondrogenic gene expression by human 
MSCs in porous constructs was slightly upregulated even in the absence of 
chondrogenic media.55 In a different approach, Ahrem et al. treated whole bacterial 
nanocellulose hydrogels with 3D laser perforation to produce a porous construct that 
promoted chondrocyte ingrowth and proliferation.56 Control of hydrogel porosity and 
functionalization of pore interiors with relevant molecules such as type II collagen have 
also been explored in tandem with the use of stimuli-responsive materials. For example, 
Almeida et al. recently showed that “shape-memory” properties can be attained by 
covalent crosslinking of alginate scaffolds by making use of carbodiimide chemistry, 
which along with type II collagen incorporation led to higher sulfated GAG (sGAG) and 
collagen production in comparison to scaffolds functionalized with type I collagen.57 
As a complement or alternative to porous bulk hydrogels, scaffolds comprised of 
microspheres from a range of materials have also been developed. Such scaffolds have 
been studied most often as delivery vehicles or depots for small molecules or proteins, 
but they have also been used as potential cell carriers (i.e., cell microencapsulations). In 
one case, a xanthan gum derivative was selected as the encapsulation material because 
of its established safety record in pharmaceuticals, food, and cosmetics, as well as its 
observed protective effects on joint cartilage via an intra-articular injection.58,59 Murine 
chondrocytes were viable in these microgels as observed for up to 21 days.60 Another 
interesting scaffold comprised of the synthetic peptide poly(g-benzyl-L-glutamate) 
(PBLG) achieved tunable porosity in microspheres by varying amounts of gelatin 
porogen followed by its removal, producing spherical hydrogel scaffolds that could be 
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seeded with chondrocytes throughout their interior (Figure 3.4a-d); in vitro, they retained 
chondrocyte roundness after seeding and supported ECM deposition in culture for 3 to 7 
days, and when injected subcutaneously in vivo they formed tissue with improved 
histological scoring and type 2 collagen content compared to cell-only injections.49 
3.3.3. MULTILAYERED SCAFFOLDS 
The final scale of architectural complexity in cartilage engineering is one that 
attempts to recapitulate the zonal architecture of cartilage in the joint. Regardless of the 
particular technique used to deposit or arrange the material, numerous groups have 
worked to establish two-to-three-layered hydrogel constructs with differential 
characteristics to mimic the zones likely damaged by osteochondral defects. Feasibility 
of a 3D printed bilayer hydrogel construct has been demonstrated, both by 3D extrusion 
of material44 and by projection stereolithography.61 As for trilayer hydrogels, Nguyen et 
al. described a PEG-based hydrogel with the superficial layer containing chondroitin 
sulfate and an matrix metalloproteinase (MMP)-sensitive peptide, the middle layer 
containing PEG and chondroitin sulfate, and the deep layer composed of PEG and HA.62 
In such a construct the investigators showed that with a single stem cell population 
evenly distributed in all layers, type II collagen deposition decreased gradually from 
superficial to deep layers along with an increase in type X collagen and proteoglycans, 
resulting in a gradient of compressive modulus across the construct. 
With all of this said, there are a number of different approaches to zonal design 
of hydrogel constructs, with alternatives including the use of different cell types (e.g., 
chondrocytes, osteogenic progenitors)42 or culture conditions in each layer rather than 
substantially modifying the material characteristics of the layer itself. It remains to be 
seen how advances in the design of hydrogels with this degree of control over 
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architecture will compare with other diverse strategies for hydrogel engineering towards 
cartilage repair. 
3.4. CONTROLLED PRESENTATION AND DELIVERY OF BIOCHEMICAL FACTORS 
 
Cartilage formation is regulated by the dynamic spatial and temporal presentation 
of an assortment of biochemical factors that either interact with receptors at the cell 
surface, or are internalized by cells, resulting in the induction of chondrogenesis. Thus, 
hydrogels are being designed with both biomolecules that are directly tethered to the 
hydrogel and those that are released to encapsulated or surrounding cells.  This control 
over biomolecule spatial introduction and timing can aid in the production of 
heterogeneous constructs to mimic developing or adult tissues and to enhance the 
dynamic processes of differentiation. 
The spatial and temporal presentation of biochemical factors is extremely 
important, since uncontrolled exposure may not only reduce effects on chondrogenesis 
and cartilage formation, but can also induce adverse effects. For example, supra-
physiological levels of TGF-β delivered via injections to murine knee joints resulted in a 
decrease in proteoglycan synthesis, synovial fibrosis, and endochondral ossification.63,64 
To regulate the magnitude and timing of biochemical factors that interact with cell 
surface receptors, several techniques including protease-degradable tethers and 
presenting factors in their latent form65,66 have been recently proposed. To achieve 
controlled release of cartilage-inducing factors that are internalized by cells, novel design 
techniques towards the improved design of carrier vehicles (e.g., microparticles (MPs) or 
nanoparticles (NPs)) loaded with biochemical factors have been proposed. In this 
section we will highlight several recent advances of biochemical factor presentation 
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using these mechanisms and their in vivo and in vitro cartilage regeneration potential 
using cell-laden and acellular hydrogels (Figure 3.5). 
	
Figure 3.5. Overview of controlled presentation of biochemical factors. These 
include cell-cell and cell-matrix interactions, as well as growth factors and other 
molecules that can be either tethered to the hydrogels via affinity or heparin binding, or 
encapsulated in MPs and NPs for controlled release. 
	
3.4.1. COVALENT CONJUGATION AND AFFINITY BINDING OF BIOCHEMICAL 
FACTORS 
In order to present cells with biochemical cues that interact with integrins or receptors at 
the cell surface, these signals are typically incorporated into the hydrogel itself, either by 
covalent tethering or affinity binding via electrostatic interactions as is observed within 
the ECM. Chemical coupling of peptides to hydrogels is one of the simplest approaches 
that can be taken to modify hydrogels with biochemical signals. 
During limb development, the first instance of cartilage formation occurs within a highly 
condensed cell-rich aggregate that is largely devoid of ECM.67 Cell-cell interactions in 
this context are mediated by the adhesion molecule N-cadherin68,69,70 and these 
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interactions regulate signaling events that are critical to the initiation of chondrogenesis. 
Of note, these cell-cell adhesion signals are not present throughout development, but 
rather arise and peak during this condensation phase, after which adhesion-based 
signaling from the formed ECM dominates.71 To this end, Bian et al. recently developed 
an HA hydrogel system that incorporates an N-cadherin mimetic peptide (i.e., HAV) 
(Figure 3.6a), and found that the peptide conjugation promoted both early 
chondrogenesis of human MSCs, as well as cartilage-specific matrix production (Figure 
3.6b).72 This outcome was even observed in vivo and it was shown recently that the 
presence of the N-cadherin signal from the hydrogel also influenced β-catenin signaling 
in human MSCs (Figure 3.6c-d).73 
	
 
 
 
 
 
 
 
 
Figure 3.6. Influence of N-Cadherin mimetic peptides on MSC chondrogenesis. 
Human MSCs were (a) photoencapsulated in hydrogels containing either N-cadherin 
mimics or scrambled sequence controls. (b) After 4 weeks of in vitro culture, N-cadherin 
mimics enhanced chondroitin sulfate (CS) and type II collagen (COL2) by human MSCs, 
as seen by immunohistochemical staining.72 (c-d) Single cell analysis of MSCs in these 
hydrogel environments showed an increase in N-cadherin mediated β-catenin signaling 
after 3 days in culture. (c) Cross-sectional images of MSCs stained for β-catenin (green) 
show that N-cadherin mimics recruit β-catenin to the cell membrane. Additionally, N-
cadherin mimics induced an increase in nuclear β-catenin, as confirmed by (d) 
representative maximum (top) and average (bottom) projections of single MSCs stained 
for actin (red), nucleus (blue) and β-catenin (green).73 Scale bars: b = 50 µm; c,d = 25 
µm. 
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Due to the importance of the temporal presentation of biochemical signals, there 
has been increased interest in regulating the presentation of these biochemical cues via 
enzymatic regulation. Towards this, Salinas et al. used thiol-acrylate 
photopolymerization to tether RGD peptides with an MMP-13 cleavable linker in order to 
induce MSCs towards a chondrogenic phenotype.74 The authors found that MSCs 
encapsulated in these hydrogels produced active MMP-13 between 9 and 14 days in 
culture, resulting in an over ten-fold increase of GAG deposition in comparison to MSCs 
exposed to non-cleavable RGD peptides.74 
Besides peptides, growth factors, such as those from the TGF-β superfamily 
have also been tethered to hydrogels. Although TGF-β plays a key role in promoting 
chondrogenesis, its therapeutic utility is limited by its inherent protein instability, requiring 
high amounts of protein that can cause adverse side effects with inefficient cartilage 
formation. Choi and coworkers compared hydrogels containing TGF-β1 covalently 
tethered to visible blue light-inducible chitosan (MeGC) hydrogels prior to 
photopolymerizing with type II collagen versus MeGC hydrogels with positively-charged 
TGF-β1 ionically conjugated to type II collagen.75 The authors found that the cumulative 
release of TGF-β1 was significantly higher in the covalently bound system, resulting in 
more sGAG production by adipose-derived stem cells in vitro, as well as improved 
integration with surrounding tissue of hydrogels implanted in a rat cartilage defect 
model.75 
 In vivo, control over the bioavailability of biomolecules is dependent on numerous 
factors. For example, growth factors including TGF-β are present as a complex which 
includes a latency associated peptide (LAP), which inactivates TGF-β by masking the 
receptor-binding domains.76 As such, members of the TGF-β superfamily remain inactive 
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and protected from degradation until LAP is removed by one of several mechanisms 
including proteolytic cleavage of LAP. Place et al. sought to recapitulate this natural 
mechanism by coupling TGF-β1 in its latent form to PEGDA prior to crosslinking with 
thiolated HA hydrogels via a Michael addition reaction.65 The authors found that 
encapsulated chondrocytes in these hydrogels were viable for up to 34 days and 
produced type II collagen without the presence of soluble TGF-β1, as confirmed by 
immunocytochemistry.65 
 In addition to covalent conjugation, affinity binding of macromolecules to growth 
factors is an alternative method towards the controlled release of growth factors. To this 
end, dendrimers, a particular type of branched macromolecules, can be functionalized 
with peptides that selectively bind to different molecules.77 Seelbach et al. recently 
investigated the use of dendrimers with affinity binding peptides towards the non-burst 
release of bone morphometric protein 2 (BMP-2) and TGF-β1.78 Briefly, dendrimers 
containing four binding peptides presenting sequences targeting BMP-2 or TGF-β1 
protein binding were covalently conjugated to HA, mixed with poly(N-
isopropylacrylamide)-grafted HA (Hyal-pN) brush copolymers, and then loaded with 
BMP-2 or TGF-β1. The authors found a dependence on the release of these growth 
factors based on the length of the dendrimer arms.  
GAGs are highly negatively charged polysaccharides that can modulate 
macromolecular binding, particularly with positively-charged molecules.79 By regulating 
the degree of GAG sulfation, the extent of this charge can be tuned to control the 
presentation of positively-charged growth factors (e.g., TGF-β1). To this extent, Lim et 
al. showed that MSCs cultured in TGF-β1 containing media and encapsulated in 
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desulfated chondroitin hydrogels featured significantly upregulated gene expression of 
type II collagen and aggrecan when compared to a PEG-based control hydrogel.80 
 
3.4.2. PARTICLES FOR CONTROLLED RELEASE OF BIOCHEMICAL FACTORS 
Carrier vehicles such as MPs and NPs as a method to deliver encapsulated 
factors have been extensively studied and optimized to achieve continuous delivery of 
their payload by controlling the chemical (e.g., charge, degradability) and physical (e.g., 
carrier size, shell thickness) properties of the carriers. In contrast to simple diffusion of 
soluble cues into hydrogel constructs, loaded MPs encapsulated in hydrogels protect 
biochemical factors from degradation and help prevent rapid diffusion and clearance 
from hydrogels, allowing for greater control over the release kinetics of biochemical cues 
into the hydrogel. Although this technique has been used and investigated for decades, 
the utility of MPs81,82 and NPs83-86 has seen recent advances in the use of delivery 
vehicles for cartilage repair. 
 To achieve a more sustained delivery of growth factors, Spiller and coworkers 
recently designed a hybrid scaffold where insulin-like growth factor 1 (IGF-1) was loaded 
into a poly(vinyl alcohol) (PVA) and poly(lactic-co-glycolic acid) (PLGA) hydrogel 
system.87 The authors here used a novel double emulsion technique such that PLGA 
MPs (11.3 ± 6.4 µm) containing IGF-1 directly formed and evenly dispersed throughout 
the PVA hydrogel. The authors showed that the IGF-1 release was linear and sustained 
for at least 45 days, and in vivo studies showed that the hydrogel resulted in the 
formation of thick cartilage layers and exhibited good integration between the formed 
cartilage and the surrounding neocartilage. 
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In addition to IGF-1, there are other biochemical cues that enhance cartilage 
formation and can benefit from a suitable delivery vehicle for their sustained release. 
Nell-like molecule 1 (Nell-1) has previously been shown to induce differentiation and 
growth towards bone and cartilage tissue in vivo.88 In order to showcase the importance 
of sustained release of Nell-1, Siu et al. compared the release of Nell-1 from alginate 
hydrogels either directly encapsulated in the bulk hydrogel, or loaded into chitosan NPs 
(100 – 300 nm in size).85 The authors found that Nell-1 containing NPs induced a 
significantly more gradual release of the protein in comparison to hydrogels where Nell-1 
was directly encapsulated. Additionally, Nell-1 NP containing hydrogels induced an 
increase in GAG synthesis and proteoglycan accumulation in a critical size 
osteochondral defect 12 weeks post-implantation.85 This study showed not only the 
importance of Nell-1 in cartilage formation, but also the need for NPs for controlled 
release. 
 Although design parameters used to control the release kinetics of biochemical 
factors loaded in MPs and NPs have been thoroughly investigated, not much work has 
been done to study the influence of the encapsulating hydrogel on the release profiles of 
biochemical cues loaded in MPs and NPs. To this end, Ahearne and coworkers studied 
how different hydrogel macromers (i.e., fibrin, agarose, and gellan gum) affected the 
efficiency of TGF-β3 loaded MPs to induce chondrogenesis of encapsulated MSCs. 
Piglet MSCs and TGF-β3 loaded gelatin MPs (50 – 70 µm) were encapsulated in fibrin, 
agarose, or gellan gum hydrogels, and the role of the MPs in inducing cartilage 
formation from the MSCs over the course of 21 days in vitro was evaluated.89 The 
authors observed a significant increase in sGAG accumulation in the agarose and gellan 
gum hydrogels in comparison to the fibrin hydrogels. Additionally, histological staining 
with alcian blue showed a stronger and more homogeneous distribution of sGAG in the 
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gellan gum hydrogels, in contrast to a more pericellular presentation of sGAG in the 
agarose hydrogels. This study shows that not just MPs and NPs, but the hydrogel 
macromers as well, are important determinants of the release profiles of biochemical 
factors loaded in these vehicle carriers. 
 
	
3.5. CONCLUSIONS 
 
Although hyaline cartilage is perceived as a simple tissue, developing 
biomaterials that can achieve mechanical properties of native cartilage and complete 
integration with surrounding tissues remains a challenge. Cartilage tissue engineering 
has seen a rapid advance in fabrication techniques that have resulted in hydrogel 
constructs that are improving the quality of produced cartilage (summarized in Table 1). 
To increase the mechanical properties of hydrogels, traditional single network hydrogels 
are being supplemented with either additional networks or mixtures of polymers. These 
techniques have also been used to fabricate hydrogels which can induce integration with 
surrounding tissue while promoting chondrogenesis in vivo. Novel processing techniques 
have also been employed towards fabricating hydrogel fibers and porous hydrogels for 
improved cartilage formation, as well as the fabrication of multilayered hydrogels that 
mimic the zonal architecture of native cartilage. In addition to these advances, the field 
has also seen an increased interest in presenting biochemical cues in a controllable and 
temporal fashion.  
Looking ahead, combinatorial screening approaches to robustly identify 
synergies between the various hydrogel parameters presented in this review would 
enable the development of cell-laden and acellular hydrogels that will eventually 
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adequately recapitulate native cartilage. The technology to achieve this kind of screening 
has been explored for the discovery of hydrogels with a variety of properties such as gel 
tearing energy, cell adhesion and proliferation, and foreign body responses.90-93 So far 
this has been achieved by changing the extent of material modification, the combinations 
of different materials at different ratios, or the amount of a peptide of interest in the 
precursor. Although none of these types of combinatorial hydrogel platforms have been 
directly applied to probe chondrogenesis or cartilage matrix synthesis, they are 
extremely promising for this application. Additionally, a better understanding of cartilage 
both during development and in its mature state will be critical to the success of 
advancing these exciting techniques towards developing hydrogel systems that robustly 
recapitulate native cartilage.  Ultimately, as technology is developed with new polymers 
synthesized and new processing techniques advanced, this field will continue to expand. 
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Improvements in hydrogel structure Advances in the processing of 
hydrogel scaffolds 
IPNs (Dinescu et al., 2015; Guo 
et al., 2012; Ingavle et al., 
2013; Snyder et al., 2014) 
3D printing (Fedorovich et al., 
2012; Kesti et al., 
2015; Markstedt et 
al., 2015; Muller et 
al., 2015; Schuurman 
et al., 2013) 
Semi-IPNs (Little et al., 2014; Park et 
al., 2013; Skaalure et al., 
2014) 
Spinning (Han et al., 2014; Xu 
et al., 2013) 
Double 
networks 
(Arnold et al., 2011; 
Kitamura et al., 2016) 
Porosity (Ahrem et al., 2014; 
Han et al., 2013; 
Marklein et al., 2012) 
Dual 
networks 
(Jin et al., 2011; Levett et 
al., 2014; Moreira Teixeira 
et al., 2012; Palumbo et al., 
2015; Pirinen et al., 2015) 
Microspheres (Fang et al., 2015; 
Mendes et al., 2012) 
Guest-host 
networks 
(Jung et al., 2014; Wei et 
al., 2016) 
Multilayered (Cui et al., 2012; 
Fedorovich et al., 
2012; Nguyen et al., 
2011; Sun et al., 
2015) 
Controlled presentation of biochemical factors 
Mimetic 
peptides 
(Bian et al., 2013; Salinas and Anseth, 2008; Vega et al., 2016) 
MPs / NPs (Ahearne and Kelly, 2013; Siu et al., 2012; Spiller et al., 2012) 
ECM affinity 
binding 
(Choi et al., 2015; Seelbach et al., 2015) 
 
Table 3.1. Summary of hydrogel fabrication techniques for cartilage tissue 
engineering. 
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CHAPTER 4 
INFLUENCE OF HYALURONIC ACID MODIFICATION ON CD44 BINDING TOWARDS 
THE DESIGN OF HYDROGEL BIOMATERIALS  
 
4.1. INTRODUCTION 
 
Hyaluronic acid (HA) is a linear hydrophilic polysaccharide of alternating D-
glucuronic acid and N-acetyl-D-glucosamine that is abundant in a variety of tissues and 
is relevant in both development and wound healing.1 Cells interact with HA via surface 
receptors, including the primary receptor CD44.2 Interactions between CD44 and HA 
occur within the HA-binding domain (HABD, often 25-174aa), which is well-conserved 
across species, and reportedly requires a minimum of a 6-mer (hexasaccharide, or 3 HA 
repeat units) and optimally an 8-mer (octasaccharide, or 4 HA repeat units) for binding.3 
CD44 is understood to play a critical role in pericellular matrix assembly, retention, and 
organization, and its function is required for a range of cellular processes including 
morphogenesis, proliferation, and wound repair.1 CD44 is widely expressed on a variety 
of cell types, including mesenchymal stromal cells (MSCs).4 
HA lends itself to numerous biomedical applications due to these cellular 
interactions and its presence and role in the extracellular matrix of many tissues.5 
Applications include drug delivery and tissue bulking and some HA-based materials are 
already well established in the clinic (e.g., dermal fillers and viscosupplements).6-11 HA 
hydrogels have also been widely explored in tissue engineering, particularly as cell 
carriers where properties such as high water content, injectability into tissues, 
degradability, and the ability to mimic features of the native extracellular matrix are 
important.12-26  
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To fabricate hydrogels using HA, HA macromers with chemical modifications that 
permit crosslinking are typically synthesized. There are numerous examples of HA 
modifications that have enabled covalent crosslinking of HA into hydrogels, including via 
Michael addition reactions or photoinitiated radical polymerizations (e.g., acrylates, 
methacrylates, maleimides), thiol-ene click reactions that may be performed with spatial 
control over crosslinking (e.g., norbornenes), and aqueous Diels-Alder reactions with 
furan- and maleimide-functionalized HA macromers.18,27-30 More recently, non-covalent 
assembly of HA hydrogels has been achieved via HA modifications that permit physical 
interactions, such as with the formation of guest-host complexes (e.g., cyclodextrin and 
adamantane, cucurbit[6]uril and diaminohexane) between modified HA macromers.31-33 
These modifications involve the addition of pendant groups of varying size, charge, and 
hydrophobicity to the HA backbone. 
In addition to the types of modifications themselves, the extent of modification 
(i.e., the proportion of disaccharide repeats that are modified) can also be controlled 
through the synthesis reaction and can be used to alter the crosslink density of the 
hydrogel and final material properties. These reactions often target the carboxylic acids 
or primary alcohols within HA disaccharides.34,35 Carboxylic acid and primary alcohol 
groups are also involved in the interactions between HA and the HA binding domain 
(HABD) of CD44 - the carboxylic acid imbues much of the negative charge that is 
associated with HA and is reportedly involved in interactions with at least two residues 
(Ala102, Ala103) of the HABD, whereas the primary alcohol is involved with at least one 
residue (Tyr109) of the HABD.3,36,37 Thus, the hydrophobicity and charge of the final HA 
macromer may be influenced not just by the modification introduced but also by where 
and how much of it is added to HA.  
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One notable target of tissue engineering approaches with HA hydrogels is the 
repair of cartilage tissue. Mature articular cartilage is avascular, alymphatic, and cell-
sparse, and injury typically results in progressive degeneration and ultimately pain and 
loss of joint mobility.38  Since HA is abundant in healthy cartilage (e.g., chondrocyte 
pericellular matrix) and is involved in cartilage homeostasis, it has been extensively 
studied as a component of hydrogels and scaffolds for cartilage repair.16,17,20,23,39-42 
Mesenchymal stromal cells (MSCs), which express CD44 as their primary receptor for 
HA, are often used together with HA hydrogels.2,43 Prior work has found that MSCs 
encapsulated within HA-based hydrogels exhibited greater expression of cartilage-
specific markers both in vitro and in vivo when compared to those within inert 
polyethylene glycol (PEG) hydrogels.40 Further, the blocking of CD44 with antibodies 
abrogated this increased chondrogenesis in HA hydrogels, further implicating CD44 in 
MSC-hydrogel interactions.41 This work established that the choice of hydrogel affects 
cartilage matrix production and the chondrogenic differentiation of MSCs. 
With all of this in mind, there is clear motivation to better understand the 
influence of the extent and type of HA modification on its binding to CD44, as well as the 
downstream consequences of these interactions on cell behavior (e.g., differentiation of 
encapsulated cells). To address this, we modified HA with either norbornenes (NorHA) 
or methacrylates (MeHA) to various extents, characterized their interactions with CD44 
in a variety of contexts (e.g., soluble form, hydrogel form), and explored the downstream 
effects of HA modification on MSC chondrogenesis when encapsulated in HA hydrogels. 
PEG was used throughout for comparison as there is no direct binding between CD44 
and PEG. Our better understanding of the interactions with CD44 and modified HA 
macromers will help in the design of hydrogels for biomedical applications.	
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4.2. METHODS 
	
 
4.2.1. MATERIAL SYNTHESIS 
NorHA, MeHA, and PEG-diacrylate were synthesized as previously 
reported.27,27,44 Briefly, to synthesize NorHA, sodium hyaluronate (75 kDa, Lifecore, 
Chaska, MN) was converted to HA tert-butyl ammonium salt (HA-TBA) using Dowex 
50W proton exchange resin. Frozen and lyophilized HA-TBA was subsequently 
dissolved in DMSO and reacted with 5-norbornene-2-methylamine, coupling to either the 
carboxylic acid using benzotriazole-1-yl-oxy-tris-(dimethylamino)-phosphonium 
hexafluorophosphate (BOP) to make NorHA1 or to the primary hydroxyl using di-tertbutyl 
dicarbonate (Boc2O) to make NorHA2. To synthesize MeHA, methacrylic anhydride 
(Sigma, St. Louis, MO) was added to HA (75 kDa, Lifecore, Chaska, MN) in deionized 
water, and the pH was maintained between 8.0-8.5 with 5 N NaOH, and reacted on ice 
for 6 h. Each macromer solution was purified via dialysis (MW cut-off 6–8 kDa) against 
deionized water for a minimum of 96 h with 2 changes of water every 24 h. The final 
lyophilized HA macromers were characterized using 1H nuclear magnetic resonance 
(NMR) and then stored at -20° C (Bruker Advance 360 MHz, Bruker, Billerica, MA; 
Figure 4.1). PEG diacrylate (PEG-DA) was synthesized from linear PEG (10 kDa), 
acrylated through reaction of PEG-OH (Fluka) with acryloyl chloride and trimethylamine 
in dichloromethane. This product was precipitated and then characterized by 1H NMR 
(Figure 4.2). 
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Figure 4.1. 1H NMR spectra of modified hyaluronic acid (HA). Spectra for low 
(~10%), medium (~20%), or high (~40%) modifications of (a) NorHA1 (red), (b) NorHA2 
(green), and (c) MeHA (blue). 
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Figure 4.2. 1H NMR spectrum of poly(ethylene glycol)-diacrylate (PEG-DA). Spectra 
for PEG (10 kDa) modified with acrylates on both ends. 
 
4.2.2. STOCHASTIC MODEL TO ASSESS CD44 BINDING TO MODIFIED HA 
Using MATLAB R2016b software, a model was developed and run (n=1000) to 
determine the theoretical number of available binding sites for CD44 interactions with 
modified HA. In this model, the modification of any HA repeat unit is assumed to 
completely inhibit the binding of CD44 due to steric hindrance and/or functional group 
hydrophobicity/charge. Stochastic conversion of HA repeats was assumed for the 
conjugation of pendant groups to HA. Given a minimum of four (non-functionalized) HA 
repeat units in a row required per CD44 binding event, the distribution of binding site 
availabilities along a single 75 kDa HA chain was computed for low (10%), med (20%), 
and high (40%) extents of modification. 
 
4.2.3. CD44 PLATE ASSAY 
Protein G coated plates (Thermo Fisher Scientific, Waltham, MA) were treated 
with recombinant human CD44 Fc chimera protein (1 µg/mL, R&D, Minneapolis, MN) 
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and subsequently covalently crosslinked using bis(sulfosuccinimidyl) suberate (1 mM 
BS3, Thermo Fisher Scientific, Waltham, MA). Macromers modified with FITC-GCKK 
peptide (1:1 molar ratio, peptide:macromer) were added to wells at 200 µg/mL (HA 
backbone concentration, accounting for mass contribution of pendant groups to ensure 
constant HA molar amounts across groups) in PBS for 30 minutes. Wells were washed 
twice for 2 minutes each and then analyzed for FITC signal using a plate reader (Infinite 
M200, Tecan, Männedorf, Switzerland). Values were normalized to the signal for PEG 
macromers for reporting. 
 
4.2.4. FLOW CYTOMETRY 
To determine the presence of CD44 receptors, human MSCs (Lonza 
Walkersville, Inc., Walkersville, MD; original passage number 2) were cultured on tissue 
culture plates to 80% confluency and then trypsinized. MSCs were labeled with 
Alexafluor 488 conjugated CD44 monoclonal antibody (clone IM7, BioLegend, San 
Diego, CA; clone 156-3C11, Cell Signaling, Danvers, MA) for 1 h on ice and analyzed 
using flow cytometry (BD FACSCanto II, Becton Dickinson, Franklin Lakes, NJ). To 
assess modified HA binding to cell-surface CD44, human MSCs were cultured and 
harvested as described above, incubated on ice with FITC-tagged macromers (1:1, 
peptide:macromer) at 200 µg/mL, washed twice for 2 minutes each, and then analyzed 
for FITC signal using flow cytometry.  Values were normalized to the signal for PEG 
macromers for reporting. 
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4.2.5. HYDROGEL FABRICATION 
Macromers were sterilized using a germicidal lamp in a laminar flow hood for 30 
min as needed. NorHA1 and NorHA2 were dissolved in sterile phosphate buffered saline 
(PBS) containing 0.05 wt% 2-methyl-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone 
(Irgacure 2959, I2959, Ciba, Basel, Switzerland) and DL-dithiothreitol (DTT, Millipore 
Sigma) for polymerization, while MeHA and 4-arm PEG maleimide (purity >90%, Jenkem 
USA) were dissolved in a solution of PBS containing DTT (all concentrations of HA 
macromers calculated to account for mass contribution of pendant groups, thus ensuring 
constant HA molar amounts across groups). NorHA1 and NorHA2 were reacted with 
DTT via a light-mediated thiol-ene addition reaction between norbornene groups and 
thiols with ultraviolet light (Eiko, 1.9 mW/cm2, Topbulb, East Chicago, IN) for 10 min to 
produce crosslinked NorHA hydrogels. MeHA and PEG were reacted with DTT via 
Michael-type addition by the addition of triethanolamine (TEOA) buffer to pH 8 to yield 
MeHA and PEG hydrogels, respectively. 
 
4.2.6. HYDROGEL CHARACTERIZATION 
Acellular hydrogels (2 wt%, ~5 mm in diameter and 1 mm thick) were tested in 
unconfined compression using a Dynamic Mechanical Analyzer Q800 (DMAQ800, TA 
Instruments, New Castle, DE). The weight percent was calculated to account for mass 
contribution of pendant groups added to ensure constant HA molar amounts across 
groups. Hydrogels were compressed at 0.5 N/min until they reached 70% of their initial 
thickness and the modulus was determined as the slope of the stress-versus-strain 
curve at low strains (10-20%). Diffusivity measurements were performed on a confocal 
microscope (TCS SP5, Leica, Wetzlar, Germany) using a fluorescence recovery after 
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photobleaching (FRAP) technique. Hydrogels containing 100 µM soluble FITC-dextran 
(average molecular weight 150 kDa) were placed on glass slides and covered with a 
glass cover slip; the 488 nm line of an argon laser was set to 50% power and images 
were captured at 10x with the pinhole fully opened. Pre-bleach images were recorded 
over 6 seconds using 0.1% transmission. A 30µm diameter circular region was bleached 
for 30 seconds at 100 % transmission, and post-bleach images were then captured at 
0.1 % transmission for 120 seconds (Figure 4.3, 60s recovery shown). Data was 
analyzed using a custom MATLAB script that fit recovery profiles using nonlinear least 
squares regression to the Soumpasis equation:  
 
 (1) where F(t) is the normalized fluorescence recovery profile, k is the mobile fraction, τD 
represents the characteristic diffusion time (s), t represents time (s), and I0 and I1 are zero 
and first order modified Bessel functions of the first kind. Effective diffusivities were then 
calculated according to: 
 
(2) where Deff is the effective diffusivity (µm2/s) and w represents the bleach spot radius 
(µm). This protocol was adapted from prior studies that conducted similar analyses.45 
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Figure 4.3. Fluorescence recovery after photobleaching in hydrogels. Hydrogels 
containing FITC-dextran (150 kDa) were imaged at 4 second intervals to assess the 
effect of HA modification on relative diffusivity.  Representative images shown for 
NorHA1 at low modification. 
 
4.2.7. CD44 ATOMIC FORCE MICROSCOPY 
Atomic force microscopy (AFM) was performed using custom CD44-
functionalized beads on cantilevers. Briefly, protein G coated polystyrene beads (mean 
diameter 3.4±0.7 µm, Spherotech, Lake Forest, IL) were treated with recombinant 
human CD44 Fc chimera protein (1 µg/mL, R&D, Minneapolis, MN), which was 
covalently crosslinked using bis(sulfosuccinimidyl) suberate (1 mM BS3, Thermo Fisher 
Scientific, Waltham, MA). CD44-coated beads were washed in deionized water twice for 
2 minutes, plated on glass, dried, and affixed to tipless silicon SPM-sensors (Arrow TL1, 
nominal spring constant 0.03 N/m, NanoAndMore). Hydrogels fabricated from 
macromers were probed with these custom CD44 bead tips in indentation testing at 10 
µm/s with zero dwell time and 1.2±0.9 µm maximum indentation depth, and the 
maximum deflection from baseline in the output retraction curves were used to calculate 
retraction forces on the cantilever.  
 
4.2.8. CELL ENCAPSULATION 
Human MSCs were encapsulated at a density of 20 x 106 cells/mL in 2 wt% 
hydrogels (weight percent calculated to account for mass contribution of pendant groups 
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added to ensure constant HA molar amounts across groups). MSC-laden hydrogels 
were cultured in chondrogenic media (DMEM, 1% v/v ITS+ Premix, 50 µg/ml L-proline, 
0.1 µM dexamethasone, 0.9 mM sodium pyruvate, 50 µg/mL ascorbate, 1% v/v 
penicillin-streptomycin, supplemented with 10 ng/mL TGF-β3). For viability analysis, 
human MSCs encapsulated in hydrogels were stained using a Live/Dead® cell viability 
assay (Invitrogen) according to the manufacturer’s instructions and viability was 
quantified as the ratio of calcein-AM-stained cells to the total cell count. 
4.2.9. CHONDROGENIC GENE EXPRESSION 
After 3 days in culture, samples were homogenized in Trizol (Invitrogen) using a 
handheld tissue homogenizer. RNA was extracted according to manufacturer protocol 
and measured using an ND-1000 spectrophotometer (Nanodrop Technologies). 1 µg 
RNA from each sample was used for cDNA synthesis using reverse transcriptase 
(Superscript II, Invitrogen) and random hexamers as the primers (Invitrogen). 
Polymerase chain reaction (PCR) was then performed using the Applied Biosystems 
7300 system for Real-Time PCR with a 25 µL reaction volume for Taqman (5′-nuclease) 
and SYBR Green reactions (n = 4). Primers and probes for relevant targets 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH, housekeeping gene), type I 
collagen (COL1A1), type II collagen (COL2A1), aggrecan (ACAN), and sox9 (SOX9) 
were selected (Table 4.1). Relative gene expression was assessed using the ΔΔCT 
method, where the fold difference is 2−ΔΔCt. 
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Table 4.1. Primer and probe sequences used for quantitative PCR.  
 
4.2.10. BIOCHEMICAL AND HISTOLOGICAL ANALYSIS 
MSC-laden hydrogels were cultured for 8 weeks and subsequently digested 
using papain (1 mL/construct, 0.56 U/mL in 0.1 M sodium acetate, 10 M cysteine 
hydrochloric acid, and 0.05 M ethylenediaminetetraacetic acid) at pH 6.0 and 60 °C for 
16 h. Samples were then analyzed for the presence of sulfated glycosaminoglycan 
(using dimethylmethylene blue), DNA (using PicoGreen), and collagen 
(orthohydroxyproline, using dimethylaminobenzaldehyde and chloramine T), as 
performed previously.42 For histological analysis, samples were fixed in 10% formalin (24 
h), embedded in paraffin and subsequently stabilized at 4 °C (24 h), and processed 
using standard histological protocols. Histological sections (8 µm) were stained using 
antibodies for type I collagen (Col I, mouse monoclonal anticollagen type 1, Millipore), 
type II collagen (Col II; mouse monoclonal anticollagen type II, Developmental Studies 
Hybridoma Bank), and sulfated glycosaminoglycan (alcian blue, pH 1.0). For 
quantification, images were first converted to 8-bit and then inverted; the mean staining 
intensity within randomly placed frames for each section was measured with Fiji (Figure 
4.4). 
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Figure 4.4. Method for quantification of histology and immunohistochemistry. 
Images are first converted to 8-bit and then inverted using Fiji. Mean staining intensity is 
quantified for each section using a randomly placed frame per section per group (n≥9). 
 
 
4.2.11. STATISTICAL ANALYSIS 
Values are reported as mean values ± the standard error of the mean (s.e.m.). 
Transformation and outlier removal were not performed unless otherwise specified. 
Normalization was performed for each assay using relevant control groups (e.g., gene 
expression was normalized to values for control cells prior to encapsulation). 
StatPlus:mac LE (AnalystSoft) was used for statistical analyses with one-way analysis of 
variance (ANOVA) (and Tukey’s honestly significant difference post hoc test of the 
means) to compare among groups (n ≥ 4), where culture duration and experimental 
group were independent factors. 
	
4.3. RESULTS AND DISCUSSION 
	
Despite the widespread use of HA hydrogels in biomedical applications and the 
well-documented importance of HA on cell behavior, particularly via cell-surface 
receptors such as CD44, few studies have addressed how the modification of HA to form 
HA macromers for processing into hydrogels influences receptor binding.  Here, we 
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aimed to explore the effects of multiple important parameters in the design of HA 
macromers on HA-CD44 interactions in both soluble and hydrogel contexts. These 
included several types of chemical modifications that have been used in the biomaterials 
field, variations in the group on HA that is used for their conjugation, and changes in the 
level of modification on HA. We developed a number of novel methods to help quantify 
the interactions of CD44 with modified HA, such as atomic force microscopy, and also 
investigated how these modifications may influence cell behavior when encapsulated 
within HA hydrogels. 
 
4.3.1. DIVERSE MODIFICATIONS OF HA TO FORM HA MACROMERS 
To examine the effect of modification of HA macromers on their binding to CD44, 
three modified HA macromers were synthesized with expected differences in charge and 
hydrophobicity and at three distinct levels of modification (targeting ~10, 20, and 40% of 
disaccharides on HA).  These included: NorHA1, with HA modified at the carboxylic acid 
with norbornenes (low 13.0%, med 20.7%, and high 40.7% modification); NorHA2, with 
HA modified at the primary alcohol with norbornenes (9.8%, 19.3%, and 38.9% 
modification); and MeHA, with HA modified at the primary alcohol with methacrylates 
(12.5%, 19.8%, and 37.1% modification) (Figure 4.5). For all macromers, the difference 
between the expected extent of modification and the actual value was 3% or 
less.  These macromers were identified for this study as they have all been used 
previously in cell encapsulation and tissue engineering. Additionally, they can all be 
covalently crosslinked into hydrogels using the same crosslinker (here, DTT) to eliminate 
any variables that may confound their comparisons. 
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Figure 4.5. Hyaluronic acid macromers used to investigate CD44 interactions. (a) 
Hyaluronic acid (HA) modified with either norbornenes (NorHA, at either the carboxylic 
acid for NorHA1 or primary alcohol for NorHA2) or methacrylates (MeHA). The extent of 
modification of HA macromers was quantified using 1H NMR and categorized as either 
low (~10%), medium (~20%), or high (~40%). (b) Theoretical framework for stochastic 
modeling of HA modification, where a chain of ~200 disaccharides is modified 
stochastically at various rates and the distance between modifications is quantified for 
n=1000 simulations. (c) Histogram results from all simulations for the various 
modification levels, reported as the number of possible CD44 binding sites per HA chain 
based on the need for 4 unmodified disaccharides for binding (vertical dotted line 
indicates approximate maximum theoretical number of binding sites per HA chain). 
 
The zeta potential of these synthesized HA macromers varied with modification 
types and extents - NorHA1 exhibited changes in effective surface charge of up to 45% 
with increasing extents of modification, while NorHA2 and MeHA did not show as 
pronounced of a trend (Figure 4.6). Additionally, the zeta potentials of MeHA macromers 
were closest to that of unmodified HA (approximately 86% of unmodified). Given that the 
carboxylic acid within the HA disaccharide lends HA much of its negative charge, it is not 
surprising that the zeta potential is markedly altered when this moiety is modified during 
synthesis (i.e., NorHA1). The relatively more negative zeta potential of MeHA may be 
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attributed to both the retention of the carboxylic acid as well as that methacrylates are 
less hydrophobic than norbornenes, which may influence the HA macromers in solution. 
 
Figure 4.6. Extent and type of HA modification alters zeta potential of HA 
macromers. Zeta potential for unmodified HA and all HA macromers (red: NorHA1, 
green: NorHA2, blue: MeHA) in solution to probe the effect of modification on effective 
surface charge.  n ≥ 3, ## P < 0.01 relative to PEG control; ** P < 0.01 for groups 
indicated. 
 
While it was apparent that modification of HA may alter its charge and 
hydrophobicity, we sought to model how this might influence its ability to bind to CD44. 
We expected that the number of possible CD44 binding sites along a macromer, defined 
here as needing 4 consecutive unmodified disaccharides, would decrease with 
increasing extents of modification (Figure 4.5b). Based on this, we developed a 
theoretical stochastic model of CD44 binding to modified HA.  With this model, assuming 
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CD44 molecules would not sterically hinder the binding of other CD44 molecules along 
the length of one chain, an unmodified HA molecule that is 75 kDa would theoretically 
have 198 disaccharides or approximately 50 binding sites available. 
Based on the stochastic model, 10% modification of HA reduces the mean 
number of binding sites available per chain to ~ 37 sites (Figure 4.5c). Modifying to 
greater extents of 20% or 40% would further reduce the mean number of binding sites 
available per chain to ~27 and 11 sites, respectively. Compared to 10% modification, 
there would be a decrease of ~27% with 20% modification and a decrease of ~70% with 
40% modification. Additionally, the average number of consecutive unmodified 
disaccharides is notably reduced with increasing extent of modification, where a high 
extent reduces this average value to below the threshold required for binding (Figure 
4.7). Although useful to represent potential changes in CD44 binding with HA 
modification, this model assumes that modification of a disaccharide unit completely 
abrogates binding by CD44, and this may not be true depending on the pendant group 
that is used and where on the disaccharide it is attached. For example, a bulky, 
hydrophobic pendant group coupled to a moiety that is critical for interactions with CD44 
would result in the greatest disruption of binding and more closely approximate the 
outputs of this model. 
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Figure 4.7. Stochastic models of hyaluronic acid modification. (a) Representative 
diagrams of stochastic model output for one HA chain modified to low, med, and high 
extents (modification denoted with white circles). (b) Histograms of average number of 
consecutive unmodified repeat units (i.e., HA disaccharides) predicted per chain for each 
level of modification (n=1000 simulations), where the dotted line indicates the critical 
number of repeat units (4 disaccharides) necessary for binding to CD44. 
 
4.3.2. CD44 INTERACTIONS WITH HA MACROMERS IN SOLUBLE FORM 
We first characterized CD44 binding to HA macromers in solution to understand 
how HA modifications might disrupt interactions with CD44 in the absence of other 
factors such as crosslinking. Here, PEG was selected as an inert control molecule that 
does not bind CD44. In a first experiment, human CD44 chimera proteins were 
covalently linked to protein G-coated surfaces and allowed to interact with modified HA 
macromers (Figure 4.8a). Quantification of these interactions between FITC-tagged 
modified HA macromers and CD44 indicated that the charge and hydrophobicity of 
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modified HA may indeed affect binding to HA.  For example, med- and high-modified 
NorHA1 macromers were similar to PEG in their binding ability, while all NorHA2 and 
MeHA macromers bound several-fold higher than PEG to CD44, with statistical 
differences across all modification levels (Figure 4.8b). The greatest changes in binding 
were observed with NorHA1, with increased modification resulting in ~38% and ~57% 
decreases between modifications of 10-20% and 10-40%, respectively. 
 
Figure 4.8. Modification of HA influences CD44 binding to HA macromers in 
soluble form. (a) Protein G-coated plates were treated with a soluble CD44-Fc chimera 
for directional presentation of CD44. The plate surface was then exposed to FITC-
modified HA macromers and the resulting fluorescent signal was quantified to assess (b) 
the influence of the extent and type of modification on CD44-HA interactions (red: 
NorHA1, green: NorHA2, blue: MeHA). (c) Human MSCs that express CD44 (shown 
through flow cytometry) were exposed to FITC-modified HA macromers and analyzed 
using flow cytometry to determine (d) the influence of the extent and type of modification 
on interactions between cell-surface CD44 and modified HA (red: NorHA1, green: 
NorHA2, blue: MeHA). n=8 for surface measurements and n=3 for flow measurements 
per group, dotted lines represent PEG controls, * P < 0.05; ** P < 0.01; ## P< 0.01 
relative to PEG control. 
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To probe whether this might have implications in terms of actual receptor-ligand 
interactions in a cellular context, suspended human MSCs expressing CD44 were 
incubated with these same FITC-tagged modified HA macromers and subsequently 
analyzed via flow cytometry (Figure 4.8c). Here, high-modified macromers across all 
modifications were bound by cell-surface CD44 similarly to PEG, as was the med-
modified NorHA1 (Figure 4.8d). In general, macromers with lower extents of 
modification bound more greatly to cells. As with the CD44-surface studies, the largest 
changes in binding (up to ~50%) with increased modification were observed with 
NorHA1 macromers. Importantly, the majority (~63%) of the antibody-binding epitope I/II 
(including the HA binding domain) of CD44 on these MSCs are retained after extended 
trypsinization to harvest cells from 2D culture, and epitopes that are lost are largely 
recovered within 25 minutes (~85%) so that these MSCs are capable of binding HA via 
CD44 even after extended trypsinization (Figure 4.9.46 Epitope III (the variable stem) of 
CD44 was largely insensitive to extended trypsinization, which agrees with previous 
reports (Figure 4.10).47,48 
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Figure 4.9. The HA binding domain of CD44 is cleavable by trypsinization but is 
largely retained with trypsin treatment. (a) Human MSCs are CD44+ and the HA 
binding domain of CD44 is susceptible to removal via trypsinization. (b) Cells were 
treated with trypsin to harvest them from 2D culture (e.g., for encapsulation) and then 
incubated to permit CD44 recovery and/or labeled using a CD44 antibody that binds to 
epitope I of CD44. (c) Sample flow cytometry profiles of CD44 epitope I labeling on cells 
and (d) normalized means of profile data. 
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Figure 4.10. The variable stem region of CD44 is largely insensitive to 
trypsinization. (a) Human MSCs are CD44+ and the variable stem region of CD44 is 
reportedly less susceptible to removal via trypsinization. (b) Cells were treated with 
trypsin to harvest them from 2D culture (e.g., for encapsulation) and then labeled using a 
CD44 antibody that binds to epitope III of CD44. (c) Sample flow cytometry profiles of 
CD44 epitope III labeling on cells and (d) normalized means of profile data. 
 
 
4.3.3. CD44 INTERACTIONS WITH HA MACROMERS IN HYDROGEL FORM 
Following characterization of the interactions between CD44 and soluble HA 
macromers, we wanted to assess whether the changes in CD44 binding that were 
observed in a soluble context also translated to CD44 interactions with hydrogels formed 
from crosslinking of the same HA macromers. To investigate this, it was important that 
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other features of the hydrogels did not change, so that the only variable being compared 
was the modification of HA.  We controlled the crosslinking density by using the same 
dithiol crosslinker to form all hydrogels of interest via either a thiol-ene (i.e., NorHA1, 
NorHA2) or Michael-type addition (i.e., MeHA, PEG) reaction, and all hydrogels were 
formed with the same molar concentration of HA. This allowed us to maintain various 
hydrogel properties such as the elastic modulus (~5 kPa, Figure 4.11a), mass swelling 
ratio (~25, Figure 4.11b), and relative diffusivity (~5 µm2/s, Figure 4.11c) across the 
hydrogels even with different extents and types of modification.  
 
Figure 4.11. Matched properties of HA hydrogels with varying extents and types of 
modification. Hydrogels were fabricated from modified HA macromers (red: NorHA1, 
green: NorHA2, blue: MeHA) using thiol-ene reactions for NorHA and Michael addition 
reactions for MeHA with di-thiol crosslinkers.  The same crosslinker concentrations were 
used to match properties across modification levels.  Hydrogels were analyzed for (a) 
elastic modulus (E), (b) mass swelling ratio, and (c) relative diffusivity (D). n=3 hydrogels 
per group, dotted lines represent PEG hydrogel controls, n.s. indicates no significant 
difference across groups and compared to the PEG hydrogel control. 
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To investigate CD44 binding to HA in hydrogel form, a new method was devised 
using atomic force microscopy (AFM) to investigate the adhesivity of beads coated with 
CD44 to HA hydrogels.  The beads were brought into contact with the hydrogels and the 
force measured upon retraction was used to assess adhesion, measured as the 
maximum adhesion force (Figure 4.12a). Evaluation of this CD44 adhesion to the 
hydrogels fabricated from modified HA revealed that, in agreement with findings from the 
soluble macromer studies, NorHA1 hydrogels exhibited a downward trend in adhesion 
with increasing levels of modification such that a high modification yielded adhesion 
forces that were comparable to PEG hydrogels and were ~59% lower than adhesion to 
hydrogels from the low modified NorHA1 (Figurd 4.12b). In contrast, although hydrogels 
comprised of NorHA2 or MeHA macromers did demonstrate a modest downward trend 
in adhesion, adhesion to these hydrogels was still higher than adhesion to PEG 
hydrogels, regardless of their extent of modification. 
 
 
4.3.4. HA MODIFICATION INFLUENCES CHONDROGENESIS IN HYDROGELS 
After exploring the effects of HA modification on CD44-HA interactions, we 
sought to probe the possible downstream consequences of these effects on outcomes 
relevant to tissue engineering. Because NorHA1 most consistently exhibited marked 
changes in CD44 binding in the various contexts, we selected this macromer for further 
investigation on cell behavior as we would anticipate the large effects at various 
modification levels. Human MSCs were encapsulated in 3D hydrogels from the NorHA1 
macromers and PEG hydrogels were again used as an inert hydrogel control (Figure 
4.13a). Human MSCs demonstrated comparably high cell viabilities (>90%) when 
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encapsulated in 3D NorHA1 hydrogels across the modification levels, as indicated by 
live/dead staining (Figure 4.13b). The gross dimensions of the constructs were also 
comparable across these groups, which was expected since their levels of crosslinking 
and swelling were matched. 
 
 
Figure 4.12. Modification of HA influences CD44 adhesion to HA hydrogels. 
Hydrogels were fabricated from modified HA macromers and characterized using (a) 
atomic force microscopy with CD44 modified beads for (b) quantification of adhesion 
forces (red: NorHA1, green: NorHA2, blue: MeHA). n ≥ 40 indentations across 3 
hydrogels per group, dotted lines represent PEG hydrogel controls, * P < 0.05; ** P < 
0.01; ## P< 0.01 relative to the PEG hydrogel control.  
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Figure 4.13. Extent of HA modification influences early chondrogenesis in 3D 
hydrogels. (a) Human MSCs were encapsulated in HA hydrogels from NorHA1 
macromers (red) using a thiol-ene reaction, as well as PEG hydrogel controls (grey). 
After 3 days of culture, samples were analyzed for (b) live-dead staining (scale bar 250 
µm) and gross appearance of individual specimens (inset scale bar 5 mm), and the 
expression of (c) collagen II (COL2), (d) aggrecan (ACAN), and (e) SOX9 genes 
(reported normalized to GAPDH and 2D control cells prior to encapsulation). n=4 
hydrogels per group, * P < 0.05, ** P < 0.01;  # P < 0.05 and ## P < 0.01 relative to the 
PEG hydrogel control.  
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MSCs expressed COL2A1, ACAN, and SOX9 at 3 days when encapsulated 
within hydrogels and incubated in chondrogenic media (Figure 4.13c-e). COL2 and 
SOX9 gene expression appeared to decrease with increasing extent of modification, 
while ACAN expression did not show a clear trend. Although it represents a nearly 4-fold 
difference, SOX9 expression by MSCs in NorHA1 hydrogels with the highest extent of 
modification was not significantly greater than the expression levels in PEG; meanwhile, 
expression in the presence of low- and med- levels of modification was substantially 
higher than in PEG hydrogels (9- and 7-fold, respectively). All constructs showed 
relatively little expression of COL1, an undesired marker towards articular cartilage 
repair (Figure 4.14). Overall, the expression of all chondrogenic gene expression 
markers in NorHA1 encapsulations tended to be higher than that in the PEG controls. 
 
Figure 4.14. The extent of HA norbornene modification does not substantially 
increase expression of dedifferentiation marker COL1. Expression of 
dedifferentiation marker COL1 in MSCs encapsulated in low-, med-, or high-modification 
NorHA1 hydrogels or PEG hydrogel controls at day 3 post-encapsulation. All 
measurements normalized to 2D control and GAPDH. n.s. indicates no significant 
difference across all groups. 
 
Since cartilage tissue engineering ultimately requires long-term tissue formation 
and repair, we also evaluated these constructs in long-term in vitro culture for up to 8 
weeks. Here, the influence of HA modification on long-term MSC chondrogenesis 
agreed with short-term outcomes, as MSCs encapsulated in NorHA1 hydrogels exhibited 
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smaller increases in sulfated GAG (Figure 4.15a) and collagen (Figure 4.15b) 
deposition when the NorHA possessed higher levels of modification, as determined by 
quantitative biochemical assays. Long-term mechanical properties (Figure 4.15c) of 
NorHA1 encapsulations showed modest increases over PEG controls, likely due to 
variations in the amount of matrix being produced within the hydrogels (Figure 
4.15c).  These biochemical levels matched histological findings for glycosaminoglycans 
and type II collagen, as shown through semi-quantitative image analysis of histological 
sections (Figure 4.15d, 4.16). However, type I collagen was similar across all 
groups.  Notably, the high level of modification led to similar results to that of the inert 
PEG hydrogel controls, implying that the macromer forms hydrogels that act more inertly 
rather than with the bioactivity typically considered by using HA in the hydrogel. 
 
Figure 4.15. Extent of HA modification influences long-term chondrogenesis in 3D 
hydrogels. Human MSCs were encapsulated in HA hydrogels from NorHA1 macromers 
(red) using a thiol-ene reaction, as well as PEG hydrogel controls (grey).  After 8 weeks 
of culture, samples were analyzed for (a) glycosaminoglycan (GAG) content, (b) 
collagen content, (c) compressive modulus, and (d) histological quantification via 
staining intensity. n=4 hydrogels per group, * P < 0.05, ** P < 0.01;  # P < 0.05 and ## P 
< 0.01 relative to the PEG hydrogel control.  
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Figure 4.16. Histological assessment of long-term chondrogenesis in 3D 
hydrogels. Histological images of alcian blue, type II collagen, and type I collagen 
staining (scale bar 250 µm) for MSCs encapsulated in low-, med-, or high-modification 
NorHA1 hydrogels or PEG hydrogel controls and cultured for 8 weeks. n≥ 3 hydrogels 
per group. 
 
The fact that HA is an important functional component of native cartilage tissue 
does indeed make HA-based hydrogels an attractive choice for cartilage tissue 
engineering. However, we established that since the carboxylic acid and primary 
hydroxyl groups are reportedly involved in interactions with residues in the CD44 HA 
binding domain, adding increasing numbers of bulky and hydrophobic pendant groups to 
those sites on a given HA molecule may be expected to perturb its bioactivity.37 It is not 
surprising, then, that NorHA1, where the carboxylic acid is lost and replaced by a 
relatively bulky and hydrophobic norbornene pendant group, showed the greatest 
decreases in binding both in solution and in hydrogels.  Other modifications showed 
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decreased effects on CD44 binding; however, there was still typically a trend with 
increasing modification levels. 
These findings suggest that early cell interactions with HA in these constructs, 
perhaps even starting from the point that cells are introduced into solutions of the 
macromers prior to crosslinking, may be altered by the extent and type of modifications 
made to the macromers used. Interactions between CD44 and HA appear to help drive 
expression of cartilage-specific markers, where expression of CD44 itself even increases 
during chondrogenesis; with this in mind, it would be expected that high extents of 
modification that perturb CD44-HA interactions would have the greatest effects on 
downstream matrix deposition and tissue formation, and our results appear to agree well 
with this.49 Interestingly, however, NorHA1 still enhanced both short- and long-term 
chondrogenesis relative to PEG even at 20% modification, and this may suggest that 
even for bulkier hydrophobic pendant groups added to the carboxylic acid moiety in 
synthesis, there is a permissive window of modification where some level of the 
bioactivity of HA is preserved. 
	
4.4. CONCLUSIONS 
	
In summary, CD44-HA interactions can be altered when HA is modified to 
synthesize HA macromers, with alterations dependent on the extent of modification, type 
of chemical group used for modification, and the site on HA used for modification. These 
effects are observable when the HA macromers are presented to CD44 both in soluble 
form or after crosslinking into hydrogels. Gene expression and long-term biochemical 
and histological analyses of MSCs encapsulated in HA hydrogels strongly suggest that 
modification levels of the HA macromer influences cell-hydrogel interactions and 
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chondrogenic differentiation. Generally, a more hydrophobic pendant group attached to 
a more critical moiety for CD44 binding (e.g., charged acid) on the HA backbone can 
have marked effects on CD44-HA interactions. Importantly, low and moderately modified 
HA hydrogels still promoted significantly greater binding to CD44 when compared to 
inert molecules and upregulated chondrogenesis and cartilage formation were observed 
in HA hydrogels when compared to inert PEG hydrogel controls. We suggest that these 
considerations be incorporated into the design of HA hydrogels for tissue engineering 
with their significance dependent on the application and importance of CD44 binding. 
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CHAPTER 5 
MAGNITUDE AND TIMING OF N-CADHERIN MIMETIC PEPTIDE PRESENTATION 
REGULATE MSC CHONDROGENESIS WITHIN HA HYDROGELS 
 
Adapted from: 
Kwon MY, Vega SL, Gramlich WM, Kim M, Mauck RL, Burdick JA. Dose and Timing of 
N-Cadherin Mimetic Peptides Regulate MSC Chondrogenesis within Hydrogels. Adv 
Healthc Mater. 2018;7:e1701199. 
 
5.1. INTRODUCTION 
	
Human mesenchymal stem cells (MSCs) have gained widespread use as a cell source 
for tissue engineering applications due to their clinical relevance and multipotency.1,2 As 
our understanding of the native cell microenvironment expands, this information can be 
incorporated into the design of tissue-engineered constructs to control MSC 
differentiation. To this end, a variety of soluble, tethered, and physical considerations 
have been incorporated into the design of hydrogels, and prior works have explored the 
effects of combinations of these factors on MSC chondrogenesis; however, although the 
physical nature of hydrogels has become more dynamic, e.g. with cell-mediated 
degradation of crosslinkers to match matrix deposition, investigating the dynamic nature 
of the biological aspects of hydrogels remain a challenge.3-8 
Hyaluronic acid (HA) has emerged as one of the most studied biomaterial components 
for cartilage tissue engineering.8,9 HA is a linear polysaccharide (a non-sulfated 
glycosaminoglycan, or GAG) that is part of the nascent extracellular matrix (ECM) in 
tissues such as cartilage and is present during the condensation phase of limb bud 
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development in the embryo.10,11,12 Cellular interactions with HA are mediated via its 
principal cell-surface receptor CD44 along with others such as CD168 (Rhamm), which 
induces chondrogenic differentiation via nuclear Smad translocation.13,14 HA hydrogels 
are widely known to support improved matrix synthesis by chondrocytes and 
chondrogenic differentiation of MSCs over typical inert materials.15,16 Importantly, HA 
disaccharide repeat units can be easily functionalized, and this has been exploited for 
not only crosslinking of HA, but for the tethering of peptides that mimic components of 
the native ECM.17-20  
Beyond cell-ECM interactions, cell-cell interactions are known to be important during 
mesenchymal condensation and the regulation of chondrogenesis.21 Cell-cell 
interactions during condensation are widely understood to be achieved via homotypic 
binding of NCad, a cell-surface protein that binds the transcription factor β-catenin with 
its cytosolic domain, regulating the localization of this transcription factor for proper 
signaling downstream of cell-cell interaction.22-24 In fact, deletion of the extracellular or 
intracellular domains, or blocking NCad interactions via antibody treatment inhibits 
condensation and subsequent chondrogenesis.23,25 However, the encapsulation of cells 
within hydrogels typically occurs as single cells, which then limits recapitulation of these 
cell-cell interactions; thus, strategies to introduce NCad signaling into these 
environments are needed. Full-length NCad has been successfully incorporated into 
hydrogels, such as the surface functionalization of polyacrylamide and alginate 
hydrogels,26,27 however, the sheer size of N-Cadherin (135 kDa) presents challenges 
when considering incorporation throughout a 3D hydrogel. 
Within the structure of NCad, a conserved three-amino acid sequence, His-Ala-Val 
(HAV), exists on the adhesive interface, and synthetic peptides containing this sequence 
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along with a flanking aspartic acid residue are known to exhibit NCad-like binding 
activity.28-30 The incorporation of HAV into an HA hydrogel did indeed promote early 
chondrogenic gene expression and subsequent matrix production of MSCs in culture 
and when implanted in vivo.31 Furthermore, incorporation of this peptide into hydrogels 
resulted in increased β-catenin recruitment to the membrane and subsequent 
translocation to the nucleus, as is observed with NCad signaling.32  
Despite these findings, the magnitude and timing of the HAV motif presentation, two 
critical aspects of this essential cell-cell interaction and downstream signaling, have not 
been explored. In the developing limb, NCad signaling varies greatly over space and 
time, with a biphasic response to the number of NCad interactions either increasing or 
reducing collagen and proteoglycan synthesis.23 In the mesenchyme, cell-surface 
metalloprotease ADAM10 temporally regulates NCad interactions during development 
by cleaving the extracellular domain of NCad, thereby exerting control over the β-catenin 
membrane-bound and cytoplasmic pool levels.22,33,34 Mutants of N-Cadherin that lack the 
extracellular domain exhibit altered localization of β-catenin and upregulation of 
chondrogenic markers.35 Meanwhile, mutants of N-Cadherin whose extracellular 
domains cannot be cleaved by ADAM10 prevent cartilage aggregate formation, 
proteoglycan synthesis, and expression of both chondrogenic and hypertrophic markers, 
likely due to the fact that cleavage of the extracellular domain of NCad results in 
changes in altered β-catenin localization and, importantly, chondrogenic gene 
expression.34,35 With this in mind, we functionalized HA hydrogels with peptides 
containing the HAV motif at different concentrations to control the magnitude or “dose,” 
and with an efficient ADAM10-cleavable domain to control the timing, to investigate how 
these parameters regulate chondrogenesis and neocartilage production of MSCs in HA 
hydrogels. 
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5.2. METHODS 
	
Materials were acquired from Sigma-Aldrich unless otherwise indicated. 
 
5.2.1. MEHA SYNTHESIS 
HA (75 kDa; Lifecore) was modified with methacrylates as previously described.17 
Briefly, the primary hydroxyl groups of HA macromers were reacted with methacrylic 
anhydride (Sigma-Aldrich) in 20-fold excess under basic conditions. The resulting 
methacrylated HA (MeHA) was then dialyzed (MW cutoff 6-8 kDa) for 4 days and 
lyophilized for storage. The extent of MeHA methacrylation was assessed using 1H NMR 
spectroscopy and determined to be ~37% of repeat units (Figure 5.1). 
 
Figure 5.1. 1H NMR to of methacrylated HA (MeHA). Peak analysis indicates that 37% 
of of disaccharide repeats were functionalized with methacrylates. 
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5.2.2. PEPTIDE DESIGN AND COUPLING TO MEHA 
Stable N-cad mimetic HAV peptides (HAV, Ac-HAVDIGGGC), stable scramble peptides 
(Scr, Ac-AGVGDHIGC), ADAM10-cleavable transient HAV peptides (tHAV, Ac-
HAVDIGGGPRAEA↓LKGGGC), transient scramble peptides (tScr, Ac-
AGVGDHIGPRAEA↓LKGGGC), and stable length-matched HAV peptides (LHAV, Ac-
HAVDIGGGAAKREPLGGGC), where stable peptides = 827.9 g/mol and transient 
peptides = 1765.0 g/mol, with a cysteine residue at the C-terminal end, were obtained 
from GenScript. Purity was confirmed to be >95%, and MALDI analysis was performed 
to verify peptide mass (data not shown); “↓” indicates ADAM10 cleavage site. 
MeHA (100 mg) was dissolved in triethanolamine-buffered saline (TEOA buffer, pH 8) 
and reacted at 37 °C overnight in the presence of either stable (9.28 mg) or transient 
(19.78 mg) peptides, followed by dialysis (4 days) and lyophilization (3 days). This 
coupling ratio was designed to obtain a final peptide concentration of 2 mM in a 1.5 
wt% MeHA hydrogel (i.e., HA content held constant) for all functionalized macromer 
stocks while consuming no more than 20% of available methacrylate groups on the 
MeHA. The activity of ADAM10 on transient peptides coupled to MeHA was verified 
using 0.5 mM fluorescein-modified transient HAV peptide, in PBS containing 2 nM 
ADAM10. 
 
5.2.3. HYDROGEL FABRICATION AND CHARACTERIZATION 
Macromers were sterilized using a germicidal lamp for 40 minutes and subsequently 
dissolved in sterile phosphate buffered saline (PBS) containing 0.05 wt% photoinitiator 
2-methyl-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone (I2959). This hydrogel 
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precursor was pipetted into a 50 µL mold, covered with a glass coverslip, and exposed 
to an ultraviolet (UV) light source (Eiko, ~2.0 mW/cm2) for 10 minutes.  The peptide 
concentration was maintained at 2 mM in all samples (except for hydrogel controls 
without any peptide coupling, denoted as MeHA) and the magnitude or dose of HAV was 
controlled through the ratio of the HAV and scrambled peptides (e.g., HAV 0, HAV 50, 
and HAV 100 denotes samples of 2 mM scrambled, 1 mM HAV/1 mM scrambled, and 2 
mM HAV, respectively). 
Acellular hydrogels (~5mm Ø, ~2 mm thickness) were tested with a Dynamic Mechanical 
Analyzer (DMAQ800, TA Instruments) in unconfined compression. Hydrogels were 
compressed to a maximum of 70% of their initial thickness, and the elastic compressive 
modulus was determined as the slope of the stress versus strain curve at low strain (up 
to 20%) using a sweep with a force ramp of 0.5 N/min to max 15 N. The mass swelling 
behavior of the hydrogels was characterized by the mass ratio of swollen hydrogels 
(after 24 h in PBS) to dry hydrogels. 
 
5.2.4. CELL CULTURE AND ENCAPSULATION 
Human MSCs (Lonza) were expanded to passage 3 in growth media comprised of α-
MEM with 16.7% (v/v) FBS (Gibco), 1% (v/v) L-glutamine (Invitrogen), and 1% (v/v) 
penicillin–streptomycin (Invitrogen). Cells were harvested by rinsing with PBS and 
treating with 0.05 wt% trypsin and then resuspended in 1.5 wt% macromer, 0.05 wt% 
I2959, and 20 M/mL MSCs. This hydrogel precursor was slowly pipetted into 50 µL 
molds, covered with glass coverslips, and exposed to a UV light source (Eiko, ~2.0 
mW/cm2) for 10 minutes for crosslinking. Hydrogels were cultured in vitro in DMEM 
supplemented with 1% penicillin/streptomycin, 1mM sodium pyruvate, 40 mg/ml L-
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proline, 100 nM dexamethasone, 50 µg/ml ascorbic acid 2-phosphate, 1% ITS+, and 10 
ng/mL TGF-β3 (chondrogenic media). For studies with small-molecule ADAM10 inhibitor 
GI254023X, inhibitor was added from stock solutions to a final concentration of 5 µM in 
chondrogenic media. The viability of MSCs in functionalized hydrogels was assessed 
using a live/dead cytotoxicity kit (Invitrogen) according to manufacturer instructions. 
Live/dead images were captured on a Leica SP5 confocal microscope. 
 
5.2.5. GENE EXPRESSION ANALYSIS 
Samples were disrupted in Trizol (Invitrogen) using a handheld tissue homogenizer; 
RNA was extracted according to manufacturer specifications and measured with an ND-
1000 spectrophotometer (Nanodrop Technologies). 1 µg of RNA was taken from each 
sample for cDNA synthesis using reverse transcriptase (Superscript II, Invitrogen) and 
oligoDT as the primer (Invitrogen). Polymerase chain reaction (PCR) was then 
performed using the Applied Biosystems 7300 system for Real-Time PCR with a 25 µL 
reaction volume for Taqman (5′-nuclease) reactions (n=4). Primers and probes for 
releant targets glyceraldehyde 3-phosphate dehydrogenase (GAPDH, housekeeping 
gene), type I collagen (COL1), type II collagen (COL2), and aggrecan (ACAN) were 
selected as shown in Table 5.1. Relative gene expression was assessed with 
ΔΔCT method, where the fold difference is found by 2−ΔΔCt. 
 
Table 5.1. Primer and probe sequences used for quantitative PCR. 
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5.2.6. BIOCHEMICAL AND HISTOLOGICAL ANALYSIS 
After MSC-laden hydrogels were cultured for 8 weeks, they were digested using papain 
(1 mL/construct, 0.56 U/mL in 0.1 M sodium acetate, 10 M cysteine hydrochloric acid, 
0.05 M ethylenediaminetetraacetic acid, pH 6.0) at 60°C for 16 hours. Samples were 
then analyzed for sulfated glycosaminoglycan (sGAG, using dimethylmethylene blue), 
DNA (using PicoGreen), and collagen (orthohydroxyproline, using 
dimethylaminobenzaldehyde and chloramine T reagents) content.21,36 For the 
histological analysis of constructs, all samples were fixed in 10% formalin (24 hours), 
embedded in paraffin and stabilized at 4°C (24 hours), and subsequently processed 
using standard histological protocols. Histological sections (5 µm) were stained using 
antibodies for type I collagen (Col I, mouse monoclonal anti-collagen type 1, Sigma), 
type II collagen (Col II, (mouse monoclonal anti-collagen type II, Developmental Studies 
Hybridoma Bank)), and sulfated glycosaminoglycan (sGAG). For quantification, images 
were first converted to 8-bit and then inverted. Mean staining intensity within randomly 
placed frames for each section was measured with ImageJ (Figure 5.2). 
 
Figure 5.2. Method for quantification of histology and immunohistochemistry. 
Images were converted to 8-bit and subsequently inverted. Mean staining intensity was 
then quantified for each section imaged using a randomly placed frame per section for 
each group  (n ≥ 9). 
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5.2.7. STATISTICAL ANALYSIS 
Values in this work are reported as mean values ± the standard error of the mean 
(SEM). Unless otherwise specified, transformation and outlier removal were not 
performed. Normalization was performed using relevant control groups (e.g. gene 
expression was normalized to that of control cells plated in 2D). StatPlus:mac LE 
(AnalystSoft) was used to perform statistical analyses with one-way ANOVA (and 
Tukey’s honestly significant difference post hoc test of the means) to compare between 
groups (n≥4), where culture duration and experimental group were independent factors. 
	
5.3. RESULTS AND DISCUSSION 
	
Cell-cell contact among progenitor cells in the limb bud during condensation is widely 
understood to require homotypic binding of NCad, a cell-surface adhesion protein that 
binds the transcription factor β-catenin with its cytosolic domain, regulating localization of 
this transcription factor for proper signaling downstream of NCad binding.22-24 Cell-cell 
interactions and subsequent downstream signaling via NCad are well established as 
critical features of chondrogenesis and development, but nuanced control of NCad 
signaling is desirable for the design of inductive materials for cartilage tissue 
engineering. Prior work has established that tethered NCad mimetic HAV peptides in HA 
hydrogels exhibit NCad agonistic activity due to one end being conjugated to the HA 
backbone, resulting in the expected nuclear β-catenin localization in MSCs when 
encapsulated within this material.31,32 Furthermore, blocking studies using antibody 
treatment have confirmed that the observed enhancement of chondrogenic gene 
expression in this system was indeed due to NCad interactions with these peptides.31  
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Here, we drew inspiration from two key features of our understanding of development: (i) 
variations in the amount of NCad interactions present in the limb bud mesenchyme12 and 
(ii) the possibility of regulating NCad interactions over time by the cell-surface 
metalloprotease ADAM10.22,33,34 To mimic both the magnitude and timing of NCad 
signals in hydrogels, we designed photocrosslinkable macromers that allowed us to 
titrate in varying amounts of tethered stable or transient NCad signal into hydrogels via 
HAV peptide presentation while keeping the hydrogel properties constant. 
 
 5.3.1. CADHERIN MIMETIC PEPTIDES INFLUENCE EARLY CHONDROGENESIS IN 
A DOSE-DEPENDENT MANNER 
Hyaluronic acid (HA) was modified with methacrylate groups on ~37% of disaccharide 
repeat units to generate a photocrosslinkable macromer that could also be modified with 
peptides using a Michael addition reaction between the methacrylates and thiols (via 
cysteine residues) on the peptides (Figure 5.1).  Specifically, peptides containing either 
the HAV motif of NCad or a non-active scrambled sequence (Figure 5.3a) were 
incorporated into hydrogels at various ratios at a total concentration of 2 mM. The 
incorporation of peptides at 2 mM did not significantly alter either the mass swelling 
behavior (Figure 5.3b) or compressive modulus (Figure 5.3c) of hydrogels as compared 
to unmodified hydrogel controls, confirming that cellular outcomes are not related to 
changes in network structure or mechanical properties.  Additionally, MSCs used in 
these studies were verified to express cell-surface NCad (Figure 5.4) and were 
encapsulated in the HA hydrogels that were either unmodified or modified with various 
peptide compositions. MSC viability was high in all hydrogel formulations for up to 14 
days of culture, the time period used to assess gene expression (>90%, Figure 5.5). 
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There were no macroscopic changes in construct size or opacity during this 14 day 
period (Figure 5.6). 
 
Figure 5.3. Fabrication of HA hydrogels that incorporate peptides that mimic cell-
cell interactions. (a) Schematic of MSC encapsulation in HA hydrogels from 
macromers modified with methacrylates for crosslinking and a peptide that contains the 
HAV motif to enable interaction with NCad, or a respective scrambled control (Scr). (b) 
Mass swelling ratio and (c) elastic compressive modulus (E) of MeHA hydrogels without 
(grey) or with (red) HAV peptide incorporated at 2 mM. (n ≥ 3 hydrogels per group, error 
bars represent s.e.m.); n.s. denotes no significant differences between groups. 
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Figure 5.4. Expression of NCad and ADAM10 on hMSCs. MSC cell-surface 
expression of (a) NCad (anti-NCad, 1:100, Biolegend) or (b) ADAM10 (anti-ADAM10, 
1:100, Biolegend) using flow cytometry. 
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Figure 5.5. Viability of MSCs encapsulated in HAV hydrogels. Live/Dead viability 
images at 3, 7, and 14 days, during which viability remained consistently high (>90%). (n 
= 3 gels per group) Scale bar = 250 um. 
 
 
Figure 5.6. Gross images of hydrogels with MSCs encapsulated. Images of 
hydrogels 14 days after MSC encapsulation. Metric ruler length in mm. 
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To control the HAV signal magnitude (or “dose”) in MSC-laden hydrogels, three different 
ratios of HAV and scrambled peptide were incorporated onto the HA macromer for a 
final hydrogel concentration of 2 mM: 100% scramble (HAV 0), 50%:50% HAV/scramble 
(HAV 50), and 100% HAV (HAV100) (Figure 5.7a). After 3 days in culture, a dose-
dependent type II collagen gene expression response was observed, with the HAV-free 
(HAV 0) condition similar to hydrogels without peptide (Figure 5.7b). The dose-
dependent increases in gene expression persisted for up to 7 days; however, there were 
no significant differences between groups at 14 days. Aggrecan gene expression was 
greatest for the highest HAV concentration at 3 days; however, these differences 
diminished by 7 days and 14 days, although there were some modest improvements 
over the hydrogels without peptides (Figure 5.7c). No significant changes in type I 
collagen expression were observed over the course of the study (Figure 5.8). This is 
consistent with our previous observations on HAV peptide modification, where early 
markers of gene expression towards chondrogenesis were altered by HAV incorporation 
and that these early changes resulted in long-term differences in matrix production.31 
These trends also agree with what is known about cadherin regulation in development: 
NCad expression increases at the onset of condensation and then diminishes with 
cartilage maturation as cell-cell contacts are lost, so although the HAV peptide 
presentation is stable, its effects are most prominent at the earliest timepoint 
observed.23,31,37,38  
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Figure 5.7. HA hydrogels functionalized with NCad mimetic peptides enhance 
early chondrogenesis in a dose-dependent manner. (a) MSCs were encapsulated in 
hydrogels from MeHA macromers with either HAV or Scrambled peptides incorporated, 
at a magnitude or “dose” of 2 mM of peptide.  The groups included either only the 
Scrambled peptide (HAV 0), a 50:50 mixture of the two peptides (HAV 50), or only the 
HAV peptide (HAV 100).  A control without peptide (MeHA) was also investigated. Gene 
expression for (b) type II collagen (COL2) and (c) aggrecan (ACAN) assessed over a 14 
day culture period in chondrogenic media. (n = 4, error bars represent s.e.m.). *: P< 0.05 
between groups, #: P< 0.05 compared to no peptide (MeHA) control. n.s. denotes no 
significant differences between groups.  
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Figure 5.8. HA hydrogels functionalized with HAV peptides do not increase 
expression of dedifferentiation marker COL1. Expression of dedifferentiation marker 
COL1 in MSCs encapsulated with stable HAV peptides at (a) day 3, (b) day 7, and (c) 
day 14. All measurements normalized to 2D control and GAPDH. Control gel with no 
peptide (MeHA) included as additional control. (n = 4 gels per group) 
 
5.3.2. CADHERIN MIMETIC PEPTIDES INFLUENCE LONG-TERM NEOCARTILAGE 
FORMATION IN A DOSE-DEPENDENT MANNER 
To evaluate the effects of the HAV peptides on long-term cartilage formation, we 
cultured MSC-laden constructs prepared with different ratios of macromers 
functionalized with either the HAV and scramble peptides for 56 days. Quantification of 
matrix components present in cartilage showed a concentration-dependent increase in 
sGAG and collagen (Figure 5.9a). HAV-free (HAV 0) and no peptide control (MeHA) 
groups had similar sGAG and collagen levels, whereas matrix deposition increased up to 
2-fold in sGAG and 9-fold in collagen content for the 2mM HAV group after 56 days of 
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culture when compared to these controls. Unconfined mechanical testing also showed 
that the inclusion of HAV increased the compressive elastic modulus of the constructs 
when compared to the no HAV peptide and no peptide hydrogels, which exhibited a 
similar modulus (~13 kPa) (Figure 5.9b). When compared to the initial hydrogel modulus 
(Figure 5.3c), there was an increase in elastic compressive modulus in all formulations 
after 56 days; however, the increase (~340%) was greatest for the highest HAV 
concentration when compared to MeHA gels (Figure 5.9b).  
 
Figure 5.9. NCad interactions promote long-term neocartilage formation in a dose-
dependent manner.  (a) Quantification of sGAG and collagen content and (b) elastic 
compressive modulus of MSC-encapsulated constructs after 8 weeks of culture. 
Histology and immunohistochemistry (c) quantification and (d) images of sGAG and type 
I and type II collagens after 8 weeks of culture. (n = 5 hydrogels per group, error bars 
represent s.e.m.). Scale bar 500 µm. *: P< 0.05 between groups, #: P< 0.05 compared 
to no peptide (MeHA) control. n.s. denotes no significant differences between groups. 
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Quantification of staining for sGAG and type II collagen showed a dependence on HAV 
concentration (Figure 5.9c). In addition to differences between the HAV-free (HAV 0) 
and low HAV (HAV 50) groups, the presence of HAV peptide (HAV 50, HAV 100) 
increased the staining intensity compared to the MeHA control without peptide for both 
markers, with significantly greater values for the highest HAV group. Representative 
images of immunohistochemistry staining for sGAG and type II collagen revealed more 
intense and uniformly distributed staining with greater doses of HAV, suggesting more 
cartilage matrix elaboration in these constructs compared to scrambled and no peptide 
controls (Figure 5.9d). Quantification of type I collagen sections showed low levels and 
no significant differences in staining intensity between groups investigated (Figure 
5.9c,d). Thus, the changes in early gene expression appear to influence matrix 
production over the long term at the various HAV concentrations investigated. The 
homogeneity of sGAG and collagen distribution also appears to be altered in MeHA vs. 
peptide-modified hydrogels, and this may be due in part to inherent heterogeneity in the 
MSC population and also to differences in ECM synthesis and deposition (e.g. ECM 
crosslinking, masses and volumes of ECM secreted). 
Notably, while too much cell-cell adhesion by overexpression of NCad can result in 
failure to differentiate (a 2-fold increase in NCad enhances chondrogenesis, while a 4-
fold increase inhibits chondrogenesis)39, the doses used in this study stimulated the 
greatest chondrogenesis at the highest concentration. With the peptides designed for 
this study and the hydrogel used, solubility limited the investigation of higher 
concentrations where perhaps inhibited chondrogenesis would be observed. Also, the 
presentation of the peptide or its accessability may be inherently altered as the cells lay 
down their own matrix throughout the hydrogel, in a sense to self-regulate HAV levels.  
The dose dependence in the range probed here, while it does not demonstrate this 
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biphasic response, agrees with this well-known magnitude-dependence of native NCad-
mediated cell-cell interactions in embryogenesis.22 Importantly, the mean increases in 
type II collagen and sGAG synthesis in constructs with the HAV peptide being 9- and 2-
fold, respectively, with collagen content beginning to overtake sGAG content, is 
favorable in light of the fact that the composition of native articular cartilage—where 
there is more type II collagen than sGAGs--is relevant to the final tissue properties; here, 
the increases in type II collagen and sGAG content led to an almost 3-fold enhancement 
of hydrogel modulus.40  
 
5.3.3. TRANSIENT PRESENTATION OF NCAD MIMETIC PEPTIDE ALTERS THE 
INFLUENCE ON MSC CHONDROGENESIS 
To assess how the transient presentation of the N-cad mimetic HAV motif affects early 
chondrogenesis of MSCs, MeHA macromers were functionalized with HAV or scrambled 
peptides containing an additional ADAM10-cleavable domain. Presentation of this 
transient peptide relies on endogenous ADAM10 on MSCs to cleave the peptides and 
thus reduce presentation in a time-dependent fashion (Figure 5.10a). The MSCs used 
were verified to express cell-surface ADAM10 (Figure 5.4). To validate the peptide 
design, acellular hydrogels functionalized with a FITC-tagged form of this cleavable 
peptide were incubated in PBS in the presence or absence of exogenous ADAM10. 
Peptide cleavage was measured as FITC signal in the supernatant and observed over 9 
days with ADAM10 present, with minimal cleavage without exogenous ADAM10 present 
(Figure 5.10b). To ensure that the larger peptides did not change the properties of the 
hydrogels formed, we verified that the incorporation of these peptides did not 
significantly alter their modulus (Figure 5.10c) or mass swelling ratio (Figure 5.10d).  
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Again, cell viability was high in these hydrogels over a 14 day culture period (>90%, 
Figure 5.11) and macroscopic differences in construct size and opacity were not 
observed (Figure 5.6). 
 
Figure 5.10. Fabrication of hydrogels with transient presentation of NCad mimetic 
peptides by metalloprotease ADAM10. (a) Schematic of MSCs within hydrogels 
containing transient peptides regulated by ADAM10, and transient NCad mimetic HAV 
peptide and control scrambled peptide sequences. (b) Release of FITC-labeled transient 
peptide coupled to the MeHA macromer from bulk hydrogels by ADAM10 and compared 
to control buffer without ADAM10. (c) Elastic modulus (E) and (d) mass swelling ratio of 
MeHA hydrogels without (grey) or with (orange) transient HAV peptide incorporated at 2 
mM. (n ≥ 3 hydrogels per group, error bars represent s.e.m.); n.s. denotes no significant 
differences between groups. 
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Figure 5.11. Viability of MSCs after encapsulation in tHAV hydrogels. Live/Dead 
viability images at 3, 7, and 14 days, during which viability remained consistently high 
(>90%). (n = 3 gels per group) Scale bar = 250 um. 
 
To control the signal magnitude of transient HAV (tHAV), three different ratios of tHAV 
and transient scrambled peptide were incorporated into MeHA macromers: 100% 
transient scramble (tHAV 0), 50%:50% transient HAV/transient scramble (tHAV 50), and 
100% transient HAV (tHAV 100) (Figure 5.12a). In contrast to our observations in the 
stable (non-transient) groups, after 3 days in culture there were no significant differences 
in expression of chondrogenic gene markers type II collagen (Figure 5.12b) and 
aggrecan (Figure 5.12d). There was a significant increase in the expression of type II 
collagen and aggrecan in all peptide-containing groups by 7 days, and subsequently no 
temporal differences in expression between 7 and 14 days. As observed with the stable 
HAV peptides, however, no significant changes in type I collagen expression were 
observed in these groups for the duration of the study (Figure 5.13). These observations 
are consistent with the understanding that, in development, premature or induced 
shedding of N-Cadherin-mediated interactions results in impaired chondrogenesis.37,38 
To verify that the length of the peptide sequence did not influence these findings, MeHA 
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was functionalized with a peptide of the same length as the transient peptide that 
contained the HAV motif but now incorporating a scrambled cleavage domain (Length-
matched HAV that is not ADAM10-cleavable, or LHAV) (Figure 5.14). When MSCs were 
encapsulated in this hydrogel, we observed increases in early type II collagen and 
aggrecan gene expression, and subsequent sGAG and collagen deposition, similar to 
the earlier stable HAV studies (Figure 5.14, 5.15). Thus, it appears that the ADAM10 
cleavage of the designed peptide occurs rapidly and fails to influence chondrogenesis in 
the hydrogels, confirming that the duration of peptide presentation is important. 
 
Figure 5.12. Transient NCad mimetic peptides do not enhance early 
chondrogenesis. (a) MSCs were encapsulated in hydrogels from MeHA macromers 
with either transient tHAV or Scrambled peptides incorporated, at a dose of 2 mM of 
peptide.  The groups included either entirely the Scrambled peptide (tHAV 0), a 50:50 
mixture of the two peptides (tHAV 50), or entirely the transient HAV peptide (tHAV 100).  
A control without peptide (MeHA) was also investigated. Gene expression for (b) type II 
collagen (COL2) and (c) aggrecan (ACAN) assessed over a 14 day culture period in 
chondrogenic media. (n = 4, error bars represent s.e.m.). *: P< 0.05 between groups, #: 
P< 0.05 compared to no peptide (MeHA) control. n.s. denotes no significant differences 
between groups. 
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Figure 5.13. HA hydrogels functionalized with tHAV peptides do not increase 
expression of dedifferentiation marker COL1. Expression of dedifferentiation marker 
COL1 in MSCs encapsulated with transient HAV (tHAV) peptide at (a) day 3, (b) day 7, 
and (c) day 14. All measurements normalized to 2D control and GAPDH. Control gel 
with no peptide (MeHA) included as additional control. (n = 4 gels per group) 
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Figure 5.14. HA hydrogels with length-matched HAV (LHAV) peptides enhance 
early chondrogenesis. (a) Comparison of peptide sequences, demonstrating equal 
peptide length but lack of cleavable domain (indicated by ↓) in LHAV peptides. 
Expression of (b) COL2 and (c) ACAN in hydrogels containing tHAV peptides vs. LHAV 
peptides, with no peptide (MeHA) condition as control. (n = 4 hydrogels per group, error 
bars represent s.e.m.). *: P< 0.05 between groups, #: P< 0.05 compared to no peptide (-
) control, n.s. denotes no significance between groups. 
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Figure 5.15. LHAV interactions promote long-term neocartilage formation. 
Quantification of (a) biochemical (GAG, collagen) content and (b) histology and 
immunohistochemistry of tHAV 100 hydrogel vs. a scramble control peptide with intact 
HAV motif but scrambled ADAM10-cleavable sequence (LHAV100). (n = 5 hydrogels per 
group, error bars represent s.e.m.). #: P< 0.05 compared to no peptide (MeHA) control, 
n.s. denotes no significance between groups. 
 
To further explore the role that HAV timing plays on MSC chondrogenesis, constructs 
were treated with the small-molecule ADAM10 inhibitor GI254023X to further stabilize 
the presentation of HAV to encapsulated MSCs, as well as cell-surface NCad (Figure 
5.16a). Gene expression at an early culture time of 3 days was used, since changes in 
chondrogenesis were clearly different with the presence of the stable HAV peptide in this 
time frame.  With respect to type II collagen expression (Figure 5.16b), the addition of 
the ADAM10 inhibitor did not alter expression in hydrogels without peptide (MeHA) or 
	 131	
those with the incorporation of 2mM of the stable HAV peptide (HAV 100); however, 
there was elevated expression of type II collagen in the transient HAV group (tHAV 100), 
indicating that expression is rescued when peptide cleavage is blocked.  With respect to 
aggrecan expression (Figure 5.16c), the addition of the ADAM10 inhibitor resulted in 
decreased aggrecan expression in hydrogels without peptide (MeHA) or those with the 
incorporation of 2mM of the stable HAV peptide (HAV 100), likely due to some specific 
alteration in the transcriptional program for aggrecan production in the presence of the 
inhibitor. However, this decrease in aggrecan expression was rescued in the transient 
HAV group, as the decreased expression was counteracted by enhanced 
chondrogenesis when peptide cleavage is blocked (and thus HAV presentation is 
maintained).  In other words, inhibiting ADAM10-mediated cleavage of peptide did 
enhance chondrogenesis in the form of both type II collagen and aggrecan expression. 
Interestingly, there was no statistical difference in the expression of either aggrecan or 
type II collagen between the stable and transient HAV groups in the presence of the 
inhibitor.  Taken together, these results indicate that cellular control of HAV presentation, 
here via the protease activity of ADAM10, can mediate MSC chondrogenesis.   
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Figure 5.16. Inhibition of ADAM10 recovers early chondrogenic gene expression in 
cell-laden hydrogels with cleavable peptides. (a) Schematic of MSCs within 
hydrogels containing transient peptides regulated by ADAM10 and in the presence of 
ADAM10 inhibitor GI254023X. Gene expression of (b) type II collagen (COL2) and (c) 
aggrecan (ACAN) after 3 days of culture in chondrogenic media for control hydrogels 
without peptides (MeHA) or 2mM of either transient HAV (tHAV 100) or stable HAV 
peptides (HAV 100), alone (solid bars) or with inhibitor (dashed bars).  (n = 4 hydrogels 
per group) #: P< 0.05 compared to respective untreated control; other comparisons were 
consistent with prior studies. n.s. denotes no significant differences between groups. 
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5.3.4. TRANSIENT TIMING OF NCAD MIMETIC PEPTIDE PRESENTATION ALTERS 
ITS INFLUENCE ON LONG-TERM NEOCARTILAGE FORMATION 
To evaluate the effects of transient NCad-mimetic HAV (tHAV) peptides on long-term 
cartilage formation, MSC-laden constructs were prepared with different ratios of 
macromers functionalized with either tHAV or transient scramble peptides and cultured 
for 56 days. No peptide control (MeHA) groups had similar sGAG content to all transient 
peptide groups, and similar Col II content to transient HAV-containing groups (Figure 
5.17a). Thus, they did not show the concentration-dependent increase in cartilage matrix 
that was observed with hydrogels functionalized with stable HAV peptides.  Unconfined 
mechanical testing also did not show any concentration-dependent increase in modulus 
(~16 kPa), with the no peptide control group exhibiting a slightly lower modulus than the 
transient peptide-containing groups (~12 kPa) (Figure 5.17b). Quantification and images 
of staining for sGAG and type II collagen showed that the HAV-concentration 
dependence observed with stable HAV peptides was mitigated, while again type I 
collagen exhibited no transient HAV-concentration dependence (Figure 5.17c,d). In 
agreement with our observations of early gene expression, MSC-laden hydrogels 
functionalized with the control LHAV mimetic peptide showed significant increases in 
sGAG and collagen content after long-term culture, as measured by biochemical assays, 
histology, and immunohistochemistry (Figure 5.15).  Thus, this work suggests that the 
timing of the HAV peptide is indeed important to its effect on encapsulated MSCs, as 
rapid cleavage limits the influence on cell behavior. 
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Figure 5.17. Transient NCad interactions do not enhance long-term neocartilage 
formation. (a) Quantification of sGAG and collagen content and (b) elastic modulus of 
constructs after 8 weeks of culture. Histology and immunohistochemistry (c) 
quantification and (d) images of sGAG and type I and type II collagen after 8 weeks of 
culture. (n = 5 hydrogels per group, error bars represent s.e.m.). Scale bar 500 µm. *: P< 
0.05 between groups, #: P< 0.05 compared to no peptide (MeHA) control. n.s. denotes 
no significant differences between groups. 
 
The findings of this study indicate that the inclusion of an HAV peptide into hydrogels 
enhances chondrogenesis in a magnitude dependent manner, as long as the peptide 
presentation is sustained to influence MSC behavior.  Enhanced sGAG, collagen, and 
mechanics were observed, although the values did not reach those of native cartilage 
tissue.41 Although the ADAM10 regulated presentation of the HAV peptide here did not 
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enhance chondrogenesis, it does emphasize the importance of timing to enhance MSC 
response.  Potentially, self regulation in such systems—through the deposition of matrix 
that occurs in 3D as chondrogenesis and cartilage formation proceed—is sufficient, and 
this mimics the transition from cell-cell to cell-ECM interactions during development, 
which can be different than how mechanical signaling occurs in 2D HA cultures of 
MSCs.42 One important consideration in these studies is that HAV peptide was shown as 
chondroinductive in the presence of TGF-β3; whether the peptide is chondroinductive 
alone, particularly in vivo, remains a consideration for future investigation. Additionally, 
further enhancing NCad signaling in hydrogels via variations in peptide design and 
presentation could be considered. For instance, NCad dimerization on the cell surface is 
important for proper signal transduction, and, accordingly, cyclic tandem repeat-
containing peptides have been reported to exert greater agonist activity,43 which was not 
included in the current study. The spatial clustering of mimetic peptides in the hydrogel 
microenvironment to encourage adherens junction formation and stability may also need 
to be optimized to enhance peptide-cell interaction on cell signaling, as this stable 
cluster formation is important in cadherin signaling in general.44 
	
5.4. CONCLUSIONS 
	
The findings in this study demonstrate that tethered NCad mimetic peptides that mimic 
cell-cell interaction via NCad binding both enhance the early expression of chondrogenic 
markers and promote long-term cartilage matrix production in a strong magnitude-
dependent fashion. Furthermore, these results suggest that the timing and duration of 
presentation is critical: highly transient peptides with the same NCad mimetic moiety did 
not exert the same effects on MSC chondrogenesis and matrix production, whereas the 
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blocking of this cleavage with protease inhibition enhanced outcomes. These findings 
underscore the potential of nuanced material design to guide differentiation by providing 
biochemical signals that capture the complex cell microenvironment found during tissue 
development. 
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CHAPTER 6 
UNDERSTANDING THE TEMPORAL EVOLUTION OF PERICELLULAR MATRIX AT 
THE CELL-HYDROGEL INTERFACE 
 
 
6.1. INTRODUCTION 
	
In tissues throughout the body, the pericellular and extracellular matrices guide cell 
behavior. In both developing and mature cartilage tissue, matrix synthesis and 
turnover occur continuously, and these processes are in fact essential for tissue 
homeostasis.1 This balance can be disturbed by injury-induced damage and 
subsequent degradation of the cartilage matrix, which due to limited self-repair 
processes in cartilage has necessitated the development of clinical interventions.2,3 
Cartilage tissue engineering seeks to meet this ongoing clinical need, and the design 
of hydrogels that encapsulate relevant cell types has become a well-characterized 
approach to repair cartilage tissue.3 
Within this context, cells must not only synthesize large quantities of matrix, but also 
retain, assemble, and remodel this matrix within the pericellular space. How an 
engineered construct matures depends on the cells’ abilities to perform these 
functions, particularly as individual cells deposit matrix that eventually interacts and 
integrates to achieve functional tissue properties.4,5 Just as the matrix influences cell 
behavior in native tissues in vivo, the structure and composition of the matrix 
surrounding cells in these in vitro constructs can also regulate the extent of 
chondrogenesis and thus the maturation of the construct.6 Along those lines, the initial 
engineered hydrogel biochemical and biophysical properties play an important role in 
construct maturation, as it has been noted that the hydrogel crosslink density can 
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have a profound effect on matrix formation and distribution, either permitting or 
restricting the distribution of deposited matrix.7,8 
Matrix formation in these hydrogels is commonly reported using bulk biochemical 
measures collected over time, but such population-level measurements of matrix 
synthesis do not provide spatial information regarding the deposition and organization 
of matrix by individual cells at their surfaces. They also do not reveal how this matrix 
deposition affects the cell-hydrogel interface that often contains engineered cues to 
influence cell behavior (e.g., hyaluronic acid, HAV peptide to mimic N-cadherin).9,10 
Methods such as autoradiography with radiolabeled sulfate and proline can provide 
insight into the localization of proteoglycans and collagens around individual cells, 
and this has demonstrated temporal changes in the rate and spatial distribution of 
secreted matrix.11-13 However, this approach involves the use of radioisotopes that 
require additional measures for handling, and moreover, the punctate appearance of 
autoradiographic signals offers limited resolution in probing the structure and 
organization of this cell-secreted (nascent) matrix. 
A metabolic labeling approach that relies on residue-specific incorporation of 
noncanonical amino acids into protein synthesis enables high fidelity fluorescent 
visualization of nascent pericellular matrix (PCM) protein deposition and remodeling.14 
This can easily be achieved during in vitro culture by limiting the canonical amino acid 
from the media and replacing it with its non-canonical analog.14,15 The endogenous 
translation machinery then incorporates the analog into proteins during synthesis. 
Among the diverse non-canonical amino acids that have been identified, there are 
some that contain bio-orthogonal functional groups that, following incorporation into 
newly synthesized protein, can then be labeled with highly selective fluorescent tags 
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via strain-promoted [3+2]azide-alkyne cycloaddition to allow visualization of nascent 
proteins with microscopy.15 
In contrast to site-specific methods that require genetic manipulation or engineered 
biosynthetic machinery that only substitutes residues at targeted locations, this 
method results in global incorporation of this analog across the nascent proteome.14 
This labeling capability was previously used to investigate protein synthesis and 
intracellular protein trafficking in cell monolayers,15-18 bacteria,19,20 larval zebrafish,21 
and drosophila.22 Among these recent works, the azide-bearing non-canonical 
methionine analog azidohomoalanine (AHA) in particular exhibited no toxicity to either 
live mammalian cells  or whole mammalian organisms at the low concentrations 
required for labeling of methionine-containing proteins.16,17 Similarly, metabolic 
labeling of glycans has been demonstrated in numerous contexts using the synthetic 
analogs of sugars, such as in the case of the mannose analog N-
azidoacetylatedmannosamine-tetraacylated (ManNAz).23-26 Both of these methods 
may utilize copper-free click chemistry for fluorescent staining that is compatible with 
live cells, which is important to maintain the labeling of matrix to the extracellular 
space. 
In the context of hydrogels for cartilage tissue engineering, many cell types are able to 
rapidly synthesize and assemble PCM within these hydrogel microenvironments,27,28 and 
it is important to understand how this affects the timing of presentation of biochemical 
moieties that are engineered into these hydrogels to modulate cell behavior.29 In fact, the 
deposition and elaboration of nascent PCM proteins has been described in a tissue 
engineering context (albeit via staining fixed cells),30 as well as to understand the 
influence of PCM deposition and remodeling by cells to regulate their own 
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mechanosensing capabilities and fate.31 However, the effect of this PCM protein 
deposition on the cell-hydrogel interface is still not well understood. In addition to 
proteins, the glycan component of the nascent PCM is of particular importance in 
tissue engineering because the distributed glycan network contributes 50-75% of the 
equilibrium modulus of cartilage.32 Again, the formation and distribution of these 
glycans, as well as their own potential effects at the cell-gel interface, have been 
minimally explored.  
To investigate both proteins and sugars at the cell-hydrogel interface, we make use of 
primary bovine chondrocytes (bCHs) as a model cell type that secretes a robust and 
relatively homogenous PCM and is therefore optimal to address the questions at hand.30 
We utilize imaging techniques enabled by live-cell labeling using the non-canonical 
amino acid AHA and non-canonical sugar ManNAz to visualize PCM elaboration by cells 
within hydrogels with the intent to better understand: (i) how the hydrogel design 
influences PCM evolution, and (ii) the spatiotemporal displacement of the hydrogel from 
the cell membrane by the PCM. Further, hydrogels can be visualized using embedded 
nanometer-scale fluorescent beads in combination with this labeling chemistry, and thus 
the temporal changes in chondrocyte interactions with their microenvironments in HA 
hydrogels can be assessed at the single-cell level.	
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6.2. METHODS 
 
6.2.1. MATERIAL SYNTHESIS 
Norbornene-modified HA (NorHA) was synthesized by first converting sodium 
hyaluronate (75 kDa, Lifecore, Chaska, MN) to HA tert-butyl ammonium salt (HA-TBA) 
using Dowex 50W proton exchange resin. HA-TBA was then reacted in the presence of 
(3 equivalent), 4-(dimethylamino)pyridine (1.5 equivalent) and ditert-butyl dicarbonate 
(Boc2O, 0.4 equivalent). The product was purified by dialyzing against deionized water 
for ~2 weeks, adding sodium chloride (NaCl) (1 g NaCl per 100 mL of solution), and then 
precipitating with 10-fold excess acetone at 4°C. The precipitate was re-dissolved in 
deionized water, frozen at -80°C, and then lyophilized. The macromer was characterized 
by 1H nuclear magnetic resonance (NMR) (Bruker Advance 360 MHz, Bruker, Billerica, 
MA; Figure 6.1) and then stored at -20°C. 
 
 
 
 
 
 
 
 
 
Figure 6.1. 1H NMR of norbornene-modified hyaluronic acid (NorHA). Peak analysis 
indicates ~25% modification of disaccharide repeats with norbornene pendant groups. 
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6.2.2. HYDROGEL FABRICATION 
Macromers were sterilized using a germicidal lamp in a laminar flow hood for 30 min. 
NorHA was dissolved in sterile phosphate buffered saline (PBS) containing 0.05 wt% 2-
methyl-1-[4-(hydroxyethoxy)phenyl]-2-methyl-1-propanone (Irgacure 2959, I2959, Ciba, 
Basel, Switzerland) and DL-dithiothreitol (DTT, Millipore Sigma) for crosslinking. The 
degree of crosslinking was controlled via the ratio of thiols in DTT to norbornene groups 
(XDTT). 
 
6.2.3. MECHANICAL ANALYSIS 
Hydrogels (5 mm diameter cylinders) underwent compression testing using a Dynamic 
Mechanical Analyzer Q800 (DMAQ800, TA Instruments, New Castle, DE). Samples 
were preloaded (0.01 N) and compressed via force ramp (0.5 N min−1) until they reached 
70% of their initial thickness. The compressive moduli were calculated as the slope from 
10% to 20% strain. 
 
6.2.4. CELL ENCAPSULATION 
Primary bovine chondrocytes (bCHs) were isolated from juvenile bovine knees 
(Research 87, Boylston MA) and encapsulated at a density of 5 x 106 cells/mL in NorHA 
hydrogel films (~660 µm thickness) that were cut into 5 mm x 5 mm constructs and 
cultured in 48-well plates. When stated, red-fluorescent polystyrene beads (nominal 
diameter ~	 0.190 - 0.210µm, emission 600-650 nm, Bangs Laboratories) were co-
encapsulated with cells at ~3 x 1010 beads/mL to visualize the hydrogels. Constructs 
were cultured in ‘AHA media,’ a chondrogenic media consisting of glutamine-, 
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methionine- and cystine-free high-glucose DMEM, 0.1 µM dexamethasone (Sigma 
Aldrich), 4 mM GlutaMAXTM supplement (Thermo Fisher), 0.201 mM L-cystine (Sigma 
Aldrich), 100 µg/mL sodium pyruvate (Cellgro), 1.25 mg/mL bovine serum albumin 
(BSA), 0.1% ITS+ premix, 50 µg/mL ascorbate 2-phosphate, 40 µg/mL L-proline, and 
1% penicillin-streptomycin-amphotericin, further supplemented with 10 ng/mL TGF-β3 
and 0.1 mM L-azidohomoalanine (AHA), or ‘ManNAz media’ consisting of glutamine-, 
methionine- and cystine-free high-glucose DMEM), 0.1µM dexamethasone, 4 mM L-
glutamine, 0.201 mM L-cystine 100 µg/mL sodium pyruvate, 1.25 mg/mL BSA, 0.1% 
ITS+ Premix, 50 µg/mL ascorbate 2-phosphate, 40 µg/mL L-proline, and 1% penicillin-
streptomycin-amphotericin, further supplemented with 10 ng/mL TGFβ-3, and 0.05 mM 
N-azidoacetylmannosamine tetraacylated (ManNAz). Constructs were incubated for up 
to 7 days in the designated media for either protein or glycan live-cell labeling.  
 
6.2.5. CELL VIABILITY 
For viability analysis, bCHs encapsulated in hydrogels were stained using a Live/Dead® 
cell viability assay (Invitrogen) according to the manufacturer’s instructions. Viability was 
quantified from confocal stacks acquired using a Leica SP5 II confocal microscope and 
reported as the ratio of calcein-AM-stained cells to the total cell number.  
 
6.2.6. NASCENT MATRIX STAINING 
Constructs were harvested by first staining live cells using a fluorophore-conjugated 
cyclooctyne (DBCO-488) in PBS containing 1% BSA.	Hydrogels were washed twice in 
PBS, followed by a 40 min incubation in 30 µM DBCO-488 at 37°C /5% CO2. After three 
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washes with PBS, hydrogels were fixed in 10% formalin for 30 min at room temperature 
followed by three washes in PBS and storage at 4°C. These fixed constructs were then 
stained with a plasma membrane stain (CellMask Deep Red, 1:1000 dilution, Invitrogen) 
and a nuclear stain (Hoechst 33342, 5 µg/mL, Thermo Fisher) for 40 minutes and 
subsequently washed twice with PBS immediately prior to imaging. 
 
6.2.7. IMAGING AND QUANTIFICATION 
Constructs were imaged using a Leica SP5 II confocal microscope to acquire z-stacks of 
nuclei, cell membrane, beads, and labeled PCM. Bead encapsulation was validated by 
selecting random 50 µm x 50 µm squares at least 20 µm removed from the cells and 
PCM signals (n≥3 squares) in images acquired at 190x1.4 NA (0.15 µm per pixel) and 
quantifying mean bead densities at each timepoint. Average local PCM thickness at the 
midsection of each cell was measured radially (n=5 measurements per cell) as the 
distance that the PCM extends past the outer edge of the cell membrane. The bead-to-
membrane distance was quantified as the distance between the outer edge of the cell 
membrane to the closest proximal bead at the cell midsection. Radial intensity profiles 
were generated by collecting and averaging intensity profiles (n=5 per cell) across the 
midsections of n≥20 cells per group, where each profile was normalized to its max 
intensity and truncated to only include the signal starting at the outer edge of the cell 
membrane (Figure 6.2) 
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Figure 6.2. Radial profile analysis of nascent PCM deposition. The membrane and 
PCM signal is parsed from the mid-plane of each cell, and the intensity of this signal is 
quantified using radial profile analysis (n=5 profiles per cell). Representative radial 
profiles use dotted lines to indicate the mean intensity and shaded regions to indicate 
the 95% confidence interval. 
	
6.3. RESULTS AND DISCUSSION 
	
6.3.1. DEPOSITION OF NASCENT MATRIX PROTEINS OCCURS EARLY IN 3D 
HYDROGELS  
To visualize early nascent matrix deposition, we adapted a labelling technique where 
methionine analogs containing reactive azide groups (L-azidohomoalanine, AHA) are 
incorporated into proteins as they are synthesized by cells and then labelled via a bio-
orthogonal strain-promoted cyclo-addition with a fluorophore-conjugated cyclooctyne 
(DBCO-488) (Figure 6.3a). To demonstrate spatiotemporal nascent matrix deposition, 
we encapsulated bovine chondrocytes (bCHs) in 4wt% 5 kPa norbornene-modified HA 
(NorHA) hydrogel films covalently crosslinked via a thiol-ene reaction. The viability of 
encapsulated cells remained high at ~93% for up to 7 days of culture in AHA media 
(Figure 6.3b). DBCO-488 labeling in analog-supplemented chondrogenic media 
revealed nascent protein deposition in the pericellular space, which was heterogenous 
across cells (Figure 6.3c).  
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Figure 6.3. Metabolic labeling of nascent PCM proteins. (a) Chondrocytes are 
encapsulated in a NorHA hydrogel and cultured in chondrogenic media containing the 
synthetic methionine analog AHA. This analog is incorporated during nascent protein 
synthesis and can be subsequently stained using strain-promoted click chemistry with a 
DBCO dye. (b) Cell viability at day 7 (n=3, mean ± s.e.m.) and (c) imaging of cell 
distribution and a cortical ring of nascent proteins accumulated during 7 days of culture. 
 
Nascent proteins were visualized as early as 1 day after encapsulation and culture in 
chondrogenic media, with increased thickness of the matrix (monitored as the distance 
between the cell membrane and the edge of these proteins) over the culture for up to 7 
days with some fibrillar structures protruding into the hydrogel (Figure 6.4a,b). This layer 
increased over time and by day 7, cells had assembled a protein layer with a thickness 
of ~4 µm (Figure 6.4c).  
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Figure 6.4. Cells rapidly deposit nascent proteins at the cell surface. (a) Images of 
nascent proteins surrounding chondrocytes after encapsulation in hydrogels and culture 
for up to 1 week. Scale bar 10 um (left), 5 um (right). (b) Radial profile analysis of 
proteins and cell membranes (arrows indicate the end of the protein layer), and (c) 
quantification of the thickness of this protein layer over time. n=20 cells, mean and 95% 
confidence interval shown in (b); mean ± SD in (c), **p≤ 0.01,  ****p ≤ 0.001. 
 
6.3.2. DEPOSITION OF NASCENT MATRIX GLYCANS OCCURS EARLY IN 3D 
HYDROGELS 
In addition to adapting a method for protein labeling, we also sought to visualize glycan 
deposition in hydrogels using a synthetic mannose analog containing reactive azide 
groups (N-azidoacetylmannosamine tetraacylated, ManNAz) that can be incorporated 
into glycans as they are synthesized. These can then be stained via the same bio-
orthogonal strain-promoted cyclo-addition with a fluorophore-conjugated cyclooctyne 
(DBCO-488; Figure 6.5a). We encapsulated bCHs in 4wt% 5 kPa NorHA hydrogel films 
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that were then incubated in analog-supplemented chondrogenic media. Cell viability 
remained high for up to 7 days of culture at ~90% (Figure 6.5b), and DBCO-488 labeling 
revealed a glycan ring around cells in addition to heterogeneity across cell populations 
(Figure 6.5c).  
 
Figure 6.5. Metabolic labeling of nascent glycan synthesis. (a) Chondrocytes are 
encapsulated in a NorHA hydrogel and cultured in chondrogenic media containing the 
synthetic mannose analog ManNAz. This analog is incorporated during nascent glycan 
synthesis and can be be stained using strain-promoted click chemistry with a DBCO dye. 
(b) Cell viability at day 7 (n=3, mean ± s.e.m.) and (c) imaging of cell distribution and a 
cortical ring of nascent glycans accumulated during 7 days of culture.  
 
Much like nascent proteins, nascent glycans were visualized as early as 1 day after 
encapsulation and culture in chondrogenic media (Figure 6.6a). This rapidly increased 
thickness up to 3 days, and the layer of glycans that developed was nearly 9 µm thick 
after 7 days (Figure 6.6b,c). This was approximately twice the thickness of the 
measured protein layer. 
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Figure 6.6. Cells rapidly deposit nascent glycans at the cell surface. (a) Images of 
nascent glycans (cyan) surrounding chondrocytes after encapsulation in hydrogels and 
culture for up to 1 week. (b) Radial profile analysis of glycans and cell membranes, and 
(c) quantification of the thickness of this glycan layer over time. Scale bar 10 um (left), 5 
um (right). n = 20 cells, mean and 95% confidence interval shown in (b); mean ± SD in 
(c), ****p ≤ 0.001. 
 
6.3.3. PCM DISTRIBUTION IS INFLUENCED BY HYDROGEL PROPERTIES 
Next, based on prior work, we probed whether the properties of the hydrogel 
environment influence the distribution of this nascent PCM. Specifically, we probed the 
effects of crosslink density and macromer concentration, as these parameters alter the 
hydrogel’s structural properties and may thus either facilitate or impede the distribution 
of matrix components. We quantified the spatiotemporal protein and glycan profiles for 
bCHs encapsulated in 4 wt% NorHA (modulus ~ 5 kPa) and 2 wt% NorHA (modulus ~20 
kPa) hydrogels (to compare changes in crosslink density) and compared them to those 
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in the 4 wt% NorHA (~5 kPa) hydrogel (to compare changes in macromer concentration 
(Figure 6.7a). The modulus was varied by altering the level of crosslinker in the 
formulations. The mean viability across the hydrogel formulations studied was ≥90% for 
up to 7 days in both AHA and ManNAz media (Figure 6.7b).  
 
Figure 6.7. Validation of hydrogel properties and cell viability. (a) Elastic moduli of 
all hydrogel formulations studied, and (b) cell viability data at Day 7 after bCH 
encapsulation in various hydrogel formulations and incubation in either AHA and 
ManNAz media. 
 
Increased crosslinking density in 4 wt% 20 kPa gels resulted in decreased cortical 
protein thickness (Figure 6.8). Similar trends were observed in glycans (Figure 6.9). 
These differences were greatest at the latest timepoint studied: at day 7, the mean PCM 
thickness was ~1.8 fold (4.5 µm versus 2.5 µm) for proteins and ~1.5 fold (4 µm versus 6 
µm) for glycans (Figure 6.8, Figure 6.9). On the other hand, there were no differences 
in nascent protein elaboration in the 2 wt% 5 kPa versus the 4 wt% 5 kPa constructs, 
engineered to have similar crosslink density (as measured through mechanics) but 
different concentrations of the macromer, which suggests that macromer concentration 
does not play a role in this regime (Figure 6.10). This was measured only with proteins 
to date, given that they were expected to show the greatest differences. 
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Figure 6.8. Crosslink density alters nascent protein deposition. (a) Images of AHA-
labeled cells in 4 wt% 5 kPa (left, low crosslink density) and 4 wt% 20 kPa (right, high 
crosslink density) hydrogels at Day 7.  (b) Representative cell showing nascent protein 
staining in hydrogels with low (5 kPa) or high (20 kPa) crosslink density. (c) 
Quantification of cortical protein thickness. Scale bar 10 um (left), 5 um (right). n = 20 
cells, mean ± SD, ***p≤ 0.001. 
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Figure 6.9. Crosslink density alters nascent glycan deposition. (a) Images of 
ManNAz-labeled cells in 4 wt% 5 kPa (left, low crosslink density) and 4 wt% 20 kPa 
(right, high crosslink density) hydrogels at Day 7. (b) Representative cell showing 
nascent glycan staining in hydrogels with low (5 kPa) or high (20 kPa) crosslink density. 
(c) Quantification of glycan ring thickness. Scale bar 10 um (left), 5 um (right). n = 20 
cells, mean ± SD, ***p≤ 0.001. 
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Figure 6.10. Macromer concentration does not alter nascent protein deposition. (a) 
Nascent protein staining in hydrogels with low (2 wt%) or high (4 wt%) macromer 
density. (b) Quantification of cortical protein thickness. Scale bar 10 um (left), 5 um 
(right). n = 20 cells, mean ± SD. 
 
6.3.4. NASCENT PCM PHYSICALLY DISPLACES THE HYDROGEL OVER TIME 
To investigate the relationship between matrix elaboration and the physical location of 
the hydrogel at the cell-hydrogel interface, we co-encapsulated bCHs with fluorescent 
beads of appropriate size (~0.2 µm). Because the size of the beads is much bigger than 
the average mesh size in the hydrogel formulations studied, beads are immobilized in 
the network upon gelation, but they did not perturb crosslinking due to a lack of reactive 
groups on their surface. To probe the stability and distribution of these beads, we 
encapsulated beads in 4wt% 5 kPa gels and quantified bead stability as the bead 
concentration in confocal images of hydrogel films over time at 0, 1, 3, and 7 days. 
Beads were well-distributed, and their number remained highly consistent at ~127-132 
beads/50 µm x 50 µm ROI over the duration of the study (Figure 6.11a,b), confirming 
that beads are immobile and do not aggregate or degrade over time in the hydrogel.  
	 157	
Figure 6.11. Fluorescent bead immobilization in hydrogels. (a) Confocal 
visualization of beads embedded in NorHA hydrogels for up to 7 days of incubation. (b) 
Quantification of beads per ROI (50 x 50 µm) over time. Mean ± SD.  
 
These constructs were stained, fixed, and imaged using confocal microscopy at day 0, 1, 
3, and 7 days to evaluate PCM deposition and bead displacement (Figures 6.12, 6.13). 
The patterns in the mean thicknesses of nascent proteins and glycans in these 
constructs were consistent with those in constructs without beads. By day 3, there were 
relatively modest differences in the minimum bead distance from the cell surface, and by 
day 7 this distance had markedly increased to a mean of >1 µm (Figures 6.12c, 6.13c).  
This pattern of bead displacement was consistent across timepoints and labeling 
conditions, and at day 7, the bead distances in AHA-labeled constructs were comparable 
to those in the ManNAz-labeled ones. Notably, the spatiotemporal profile of bead 
displacement from the cell surface seemed to correlate with protein deposition more so 
than that of the glycan component.  For example, beads consistently co-localized with 
the extensive glycan ring, whereas they were nearly always excluded from the dense 
protein layer. In all cases, beads seldom, if ever, localized in the cytoplasm of cells. 
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Figure 6.12. Nascent protein deposition physically displaces the hydrogel over 
time. (a) Nascent protein staining in hydrogels visualized with encapsulated fluorescent 
beads (right image without nascent proteins shown to facilitate easier visualization of the 
beads). (b) Method for calculating perpendicular bead distance from the cell membrane. 
(c) Quantification of the distance between the cell membrane and the closest bead. 
Scale bar 10 um (left), 5 um (middle, right). n = 20 cells, mean ± SD, *p≤ 0.05, ****p ≤ 
0.001. 
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Figure 6.13. Deposited nascent glycan can co-localize with the hydrogel. (a) 
Nascent glycan staining in hydrogels visualized with encapsulated fluorescent beads 
(right image without nascent glycans shown to facilitate easier visualization of the 
beads). (b) Method for calculating perpendicular bead distance from the cell membrane. 
(c) Quantification of the distance between the cell membrane and the closest bead. 
Scale bar 10 um (left), 5 um (middle, right). n = 20 cells, mean ± SD, *p≤ 0.05, ****p ≤ 
0.001. 
 
6.3.5. HYDROGEL DISPLACEMENT IS INDEPENDENT OF GEL PROPERTIES 
Finally, in order to build upon the observations we made above, we sought to probe the 
relationship between the properties of the hydrogel itself and this displacement of the 
hydrogel from the cell-hydrogel interface. We varied the same parameters (i.e., crosslink 
density, macromer concentratioin) as shown above (Figure 6.7). Comparisons of the 
spatiotemporal profiles of both bead displacement and nascent PCM formation in 4 wt% 
5 kPa, 2 wt% 5 kPa, and 4 wt% 20 kPa NorHA hydrogels revealed that in spite of the 
differences in matrix elaboration, the displacement of the hydrogel from the cell surface 
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was consistent under all conditions tested (Figures 6.14, 6.15). For instance, in AHA-
labeled constructs, the mean displacement at 7 days was ~1 µm for 4 wt% 5 kPa, ~1 µm 
for 4 wt% 20 kPa, and ~1 µm for 2 wt% 5 kPa hydrogels, which suggests that the 
evolution of this cell-hydrogel interface is a robust phenomenon that occurs independent 
of macromer concentration and crosslinking density in 3D hydrogels. 
 
Figure 6.14. Crosslink density does not alter gel displacement from the cell-
hydrogel interface. (a) Measurement of bead positions in hydrogels with low (5 kPa) or 
high (20 kPa) crosslink density. (b) Nascent protein staining in hydrogels containing 
beads (right image without nascent proteins shown to facilitate easier visualization of the 
beads). Quantification of (c) closest bead distance from the cell membrane and (d) 
cortical protein thickness. Scale bar 10 um (left), 5 um (middle, right). n = 20 cells, mean 
± SD, ***p≤ 0.001. 
 
 
 
	 161	
 
Figure 6.15. Macromer concentration does not alter gel displacement from the 
cell-hydrogel interface. (a) Measurement of bead positions in hydrogels with high (4 
wt%) or low (2 wt%) macromer concentrations. (b) Nascent protein staining in hydrogels 
containing beads (right image without nascent proteins shown to facilitate easier 
visualization of the beads). Quantification of (c) closest bead distance from the cell 
membrane and (d) cortical protein thickness. Scale bar 10 um (left), 5 um (right). n = 20 
cells, mean ± SD. 
	
6.4. CONCLUSIONS 
	
Numerous engineered hydrogels have been used to investigate how biologically 
and/or developmentally relevant cues can regulate cell behavior and fate. For 
instance, the secretion of PCM proteins in the context of progenitor cell differentiation 
is a topic of ongoing interest in which hydrogel cues are known to influence PCM 
deposition, assembly, and subsequent tissue maturation.29,30,32-36 In general, the direct 
interactions that these cells are assumed to have with their engineered 
microenvironments are used to explain observed phenotypes or fates.10,32,36,37 
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However, prior work has found that the cell-hydrogel interface is dynamic, and that 
interactions with the nascent extracellular proteins that cells deposit into their 
microenvironments can persistently influence cell behavior, how they sense their 
microenvironment, and even determine their fate.31 It was hypothesized that nascent 
proteins may accumulate until engineered cues are masked, negating their direct 
influence on cell behavior after some time.10,36 This would mean that any cues 
engineered into hydrogels may have a limited window of influence on cells, but this 
consideration is often overlooked in the selection and incorporation of biochemical 
cues into hydrogels. 
Here, our results indicate that this may indeed occur, where the engineered hydrogel 
interfaces that are presented to cells in 3D hydrogels can be physically displaced from 
the cell surface as nascent PCM begins to be deposited and assembled not long after 
encapsulation. We observed this displacement by adapting methods for nascent PCM 
protein and glycan labeling to visualize the spatiotemporal deposition and distribution 
of these different PCM components by cells, and then by examining the formation of 
this PCM in the presence of bead markers that enable us to visualize the hydrogel. 
The results lend us insights into the dynamic nature of this cell–hydrogel interface, 
where we hypothesized that engineered cues may eventually become displaced from 
the cell surface by competing signals produced by the cell itself. Here, we found that 
although these cells produce PCM rich in both proteins and glycans, with deposits of 
both components increasing over time, the extent and pattern of elaboration of each 
of these components differs markedly. Specifically, the protein component generally 
remains compact and dense near the cell surface, whereas the glycan ring extends 
significantly further from the cell. In particular, the elaboration of secreted proteins 
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correlates well with the displacement of the hydrogel from this important interface as 
early as day 1 (Figure 6.4).  
Although our data show how nascent PCM accumulation can physically separate the cell 
from the hydrogel, how engineered cues such as cell-adhesive peptides34 influence the 
secretion and assembly of this nascent matrix remains unknown. In addition, whereas 
the hydrogels explored here are covalently crosslinked and largely elastic, additional gel 
properties such as viscoelasticity and chemical/noncovalent crosslinking may have an 
important influence on how this PCM is deposited, assembled, and elaborated over 
time.30,31 A cell’s ability to synthesize, adhere to, and remodel its PCM plays an 
important role as well, and this can vary widely among different cell types as well as by 
donor species, age, in vitro passage conditions, disease state, and the composition of 
the hydrogel itself.31,38-41 Whereas the juvenile bovine chondrocytes used here quickly 
produced robust PCM, human adult cells likely exhibit a different spatiotemporal profile 
of matrix synthesis and elaboration. In addition, the HA backbone used to generate the 
macromers used here possesses affinity for cell-surface CD44 receptors,42 which may 
help serve to tether and retain the gel network at the cell surface for a longer duration 
than an inert scaffold would be able to. Further studies are needed to evaluate how the 
cell-hydrogel interface evolves with cell types that are clinically relevant for tissue 
engineering (e.g. human mesenchymal stromal cells, or MSCs) and with different 
hydrogel compositions with varied potential adhesion (e.g. adhesive peptide 
modifications or biologically inert materials such as PEG) to the cell surface. 
An important limitation of the metabolic labeling agents used in these studies is that the 
label is restricted to either methionine-containing proteins or to all mannose-containing 
glycans. Although the proteins found in the cartilage-like matrix (i.e. collagen II and 
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aggrecan core protein) that is produced by chondrocytes are relatively methionine-
poor,30 it was still possible to label and visualize them under these conditions. 
Meanwhile, some fraction of the mannose-containing glycans that a cell synthesizes is 
expected to end up on N-glycosylated proteins (e.g. cell-surface-bound glycoproteins); 
many proteins are glycosylated as such, and thus are technically visualized by ManNAz, 
but the relative abundance of these is low compared to proteoglycans. Importantly, the 
matrix glycosaminoglycans could indeed be visualized using this approach: the 
distribution patterns of ManNAz-labeled glycans were mostly dispersed well beyond the 
cell surface. Another limitation of these methods is that they label nonspecifically; in 
order to elucidate what specific proteins or glycans are being deposited, additional 
characterization can be performed. 
Taken together, these findings highlight the potential differences in the spatial 
distributions of protein and glycan components of the nascent PCM in hydrogels, and 
they suggest that cellular interactions with the biochemical signals that are often 
engineered into hydrogels can be altered over time due to nascent matrix deposition that 
displaces the gel from the cell surface. This may help explain why the influence of some 
engineered cues, such as in hydrogels functionalized with covalently bound peptides, 
appear to be restricted to earlier timepoints in these systems.10,36 These findings may 
help inform the design of biochemical cues in hydrogels in favor of signals that are 
biologically and/or developmentally relevant to the window of opportunity that 
corresponds to these changes at the interface. 
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CHAPTER 7 
CONCLUSIONS, LIMITATIONS, AND FUTURE DIRECTIONS 
 
7.1. OVERVIEW 
	
The work presented in this dissertation investigates the interface between cells 
and engineered hydrogels towards the engineering of cartilage tissue. As outlined in 
Chapter 1, the clinical landscape for cartilage repair and limitations in current cartilage 
repair approaches has spurred the development of cartilage tissue engineering 
approaches.  Many of these approaches utilize cell-laden hydrogels, and the 
consideration of important biological signals during cartilage development and 
homeostasis can inform the design of improved tissue engineering strategies.1,2 As 
described in Chapter 3, a number of emerging advances in hydrogel design for cartilage 
tissue engineering applications have sought to incorporate such biologically relevant 
signals to influence cell behavior. This thesis expands upon the application of cell-laden 
hyaluronic acid (HA)-based hydrogels in this context by exploring the influence of the 
extent and timing of the presentation of critical early developmental cues in the context 
of chondrogenesis.  
Chapter 4 investigated the interactions of cells with the base polymer (i.e., HA) that is 
used to fabricate hydrogels.  Specifically, this work described how the extent and type of 
HA modification influences interactions with the important cell-surface receptor CD44, as 
well as the downstream consequences for mesenchymal stromal cell (MSC) 
chondrogenesis in hydrogels fabricated using modified HA. Chapter 5 focused on critical 
cell-cell interaction cues that are present in cartilage development but typically absent in 
hydrogels by incorporating N-Cadherin mimetic peptides with varied dosing and timing 
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and then characterizing their influence on MSC chondrogenesis. Chapter 6 
characterized the elaboration of pericellular matrix (PCM) at the cell-hydrogel interface 
by cells themselves, which occurs early in chondrogenesis and may inform our 
understanding of the timing of engineered cues presented to cells in hydrogels. The 
remainder of this chapter will highlight the main conclusions, limitations, and future 
directions relevant to each of these aims.	
	
	
7.2. SPECIFIC AIM 1 
	
PROBE THE INFLUENCE OF HA MODIFICATION ON CD44-MEDIATED MSC 
INTERACTIONS WITH HA HYDROGELS. 
 
7.2.1. CONCLUSIONS 
In this aim, we describe how chemical modifications that are made to HA, which 
are used to then crosslink HA into hydrogels, can in fact alter HA-CD44 interactions. 
Using a variety of interaction and adhesion assays (e.g., HA binding to CD44 coated 
surfaces, HA binding to CD44-presenting cells, CD44 bead adhesion to HA hydrogels, 
cellular responses when embedded in HA hydrogels), we determined that this depends 
on three parameters: the extent of modification, the type of modification added, and the 
site on the HA backbone that is modified. In general, a more hydrophobic pendant group 
attached to a more critical site for CD44 binding (e.g., the charged carboxylic acid) on 
the HA backbone exhibited marked effects on these interactions. The effects of the 
degree of modification were observed first by measuring the binding avidity of modified 
HA to either immobilized CD44 or to the surface of MSCs, and then we assayed the 
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effects of HA modification of HA-CD44 adhesion when this modified HA is crosslinked 
into hydrogels. Importantly, HA hydrogels containing moderately (here, ~20%) modified 
macromers still promoted greater binding to CD44 relative to inert molecules, and they 
also upregulated chondrogenesis and cartilage formation in HA hydrogels when 
compared to inert PEG hydrogel controls. However, higher modifications (e.g., ~40%) on 
the carboxylic acid led to outcomes of binding and down-stream cellular responses that 
were similar to that of inert PEG hydrogels. These findings indicate the importance of 
understanding how these modifications to HA influence cell behavior when used as 
biomaterials that interact with cells and may point to the importance to understanding 
modifications to biopolymers in general. 
 
7.2.2. LIMITATIONS AND FUTURE DIRECTIONS 
The HA-CD44 interactions described in this chapter lay the groundwork for a 
much wider variety of modifications to be tested for their ability to preserve this important 
and biologically relevant interaction. Here, the studies were confined to two pendant 
groups, two sites on the HA backbone, and three extents of modification, but a brief 
survey of the field quickly reveals that the variations on these three parameters that have 
been incorporated and tested in hydrogels for biomedical applications are far more 
extensive and ongoing.3,4 In our studies, norbornene was selected as a bulky 
hydrophobic pendant that may be expected to alter this interaction, whereas 
methacrylate was selected as a well-characterized pendant group that was expected to 
have less of an effect; these effects on CD44-HA interactions, however, may in fact be 
more pronounced with even larger and/or more hydrophobic pendant groups or further 
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attenuated with more hydrophilic ones.5 Screens that assay engineered HA-based 
materials for their ability to effectively bind CD44 may aid in material design.  
The HA hydrogels investigated in this study were fairly stable in these cultures; 
however, the degradation of HA hydrogels may influence how a cell responds to these 
signals at a dynamic interface.  For example, cells invading into a hydrogel may change 
how their receptors interact with HA.  Additionally, we limited this study to CD44, as this 
is the primary receptor that is often implicated in biological activity in HA.  However, 
other receptors are important as well, such as CD168, which is implicated in motility and 
signaling.  There may be secondary interactions playing a role in our findings as well, as 
other proteins and biomolecules can also bind to HA that may influence cell interactions 
beyond only CD44. 
We suggest that these aspects of macromer design should be considered in the 
design of HA hydrogels for tissue engineering applications, but the biological relevance 
and role of HA interactions with CD44 is in fact highly cell-, tissue-, and disease state-
dependent due at least in part to wide variation in CD44 isomer expression.6 Evaluation 
of this relevance in a variety of biological contexts is necessary to determine where this 
interaction must be preserved and prioritized, and while the studies here focused on 
characterizing these interactions in vitro, their ultimate relevance in vivo needs to be 
determined as well. In applications where this interaction proves to be biologically 
relevant, additional work can focus on engineering materials that minimize the effects of 
modification, whether by identifying pendant groups that best preserve the interaction or 
by developing strategies to reliably incorporate and present unmodified HA as a cue in 
these systems.  
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7.3. SPECIFIC AIM 2 
	
INVESTIGATE THE ROLE OF THE MAGNITUDE AND TIMING OF N-CADHERIN 
SIGNALS TO MSCS WITHIN HA HYDROGELS TOWARD CHONDROGENESIS 
	
7.3.1. CONCLUSIONS 
In this aim, we demonstrated that the mimicry of N-Cadherin-mediated binding 
between cells that is essential to normal cartilage development can be achieved using 
tethered N-Cadherin mimetic peptides that both enhance the early expression of 
chondrogenic markers and promote long-term cartilage matrix production in HA 
hydrogels in a strong dose-dependent fashion. In particular, stably presented mimetic 
peptides exerted their influence on chondrogenic gene expression mainly at early 
timepoints up to 7 days, although this seems to be sufficient to drive enhanced matrix 
elaboration up to 8 weeks. Furthermore, we found that the duration of presentation 
appears to be critical to these effects, such that highly transient peptides (engineered to 
degrade in response to ADAM10, a protease that regulates N-cadherin expression in 
cells) with the same NCad mimetic moiety do not exert the same influence on MSC 
chondrogenesis and downstream matrix formation. Meanwhile, when we controlled the 
cleavage of this transient peptide signal via protease inhibition, this inhibition of mimetic 
peptide cleavage enhanced the outcomes measured, further reinforcing the importance 
of the duration of presentation. Overall, this work identifies the importance of temporal 
design on the inclusion of biological signals into engineered hydrogels, which should be 
considered in material design for tissue engineering. 
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7.3.2. LIMITATIONS AND FUTURE DIRECTIONS 
The dose dependence and timing dependence of N-Cadherin mimetic peptide 
cues in hydrogels for cartilage tissue engineering underscore the potential for nuanced 
material design to guide differentiation by providing biochemical signals that reflect the 
nuances of the cell microenvironment in tissue development. However, one limitation of 
these studies is that there is no optimization of dosing or additional control of timing. The 
highest concentration of peptide incorporated in these studies was limited by the 
solubility of the peptide cue, and this would need to be addressed with further studies of 
the peptide design to permit the incorporation of higher densities of signal in our 
hydrogels. Meanwhile, the ADAM10-cleavable peptide design employed here permitted 
rapid local removal of the peptide signal from the hydrogel by each cell, but since this 
particular sequence seems to be so efficiently cleaved that it abrogates the effect of the 
signal almost entirely, new iterations of this type of peptide may need to consider 
cleavable sequences that are less efficiently or more selectively cleaved. 
One approach that may be useful to explore the large parameter space of such 
engineered hydrogel signals is high-throughput screening techniques.  During my 
dissertation studies I was involved in the development of such a technique to screen 
encapsulated cell response to variations in peptide (e.g., RGD, HAV) concentrations. 
Techniques such as this will help to understand how peptide concentrations, as well as 
the synergy between peptides influence cell behavior.  As part of this work, MSC 
chondrogenesis was explored and then scale to discrete hydrogels to show that the 
screening approach translates to individual constructs.  In the future, such techniques 
can be expanded even further to accelerate our understanding of biochemical and 
biomechanical signals in 3D hydrogels on encapsulated cell behavior. 
	 175	
Towards understanding of cell interactions with N-cadherin, there are also a 
number of additional spatial considerations that were not studied here but are believed 
to be important for signaling: at the single-protein scale, for instance, dimerization may 
play a role in the mimicry of N-Cadherin interactions and determine how effectively this 
signal is transduced. N-Cadherins on the cell surface form dimers for proper signal 
transduction, and, accordingly, cyclic tandem repeat-containing peptides have been 
reported to exert greater agonist activity,7 but this type of peptide was not included in the 
studies performed here. Additionally, the spatial clustering of numerous mimetic peptides 
in the hydrogel microenvironment to encourage adherens junction formation and stability 
may also need to be designed to enhance peptide-cell interactions and downstream cell 
signaling, as this stable cluster formation is important in cadherin signaling.8 Looking 
forward, the principles for nuanced material design that are explored in this aim may be 
applicable for other biochemical cues as well: parameters such as the variations in 
peptide design, dosing, and duration of presentation could be used to establish similar 
dose dependence and nuanced presentation for other cues. 
Notably, all of these studies were performed in vitro, and while prior work has 
established that this mimetic peptide exerts pro-chondrogenic effects in in vivo settings 
as well,9 additional studies need to be done in an in vivo setting that is clinically relevant 
for cartilage repair to better understand the utility of these types of signals for cartilage 
tissue engineering. 
Finally, even the stably presented peptides that were used in these studies 
appear to exert their effects mostly at early timepoints, and these temporal studies of the 
N-Cadherin mimetic peptides raise a question of whether cells may, in fact, be able to 
self-regulate their experience of their microenvironment in such systems via their 
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deposition of matrix as chondrogenesis proceeds. Such matrix deposition could 
effectively mimic the essential transition from cell-cell to cell-ECM interactions during 
development and thus, in certain contexts, obviate the need to engineer interventions to 
regulate the presentation of cues. This in fact motivated the studies conducted in Aim 3 
of this thesis. 
	
	
7.4. SPECIFIC AIM 3 
	
INVESTIGATE THE DEPOSITION OF PERICELLULAR MATRIX BY CELLS WITHIN 
HA HYDROGELS USING METABOLIC LABELING TECHNIQUES 
	
7.4.1. CONCLUSIONS 
In this aim, we demonstrated the deposition and distribution of pericellular matrix (PCM) 
by cells in 3D hydrogels and how this early PCM deposition alters the way cells 
experience the cell-hydrogel interface over time. We adapted metabolic labeling 
techniques to identify important differences in the spatial distributions of early protein 
and glycan components of the nascent PCM in HA hydrogels, and we also found that 
cellular interactions with the hydrogel environment may only persist for a limited time 
before their own PCM deposition displaces the hydrogel from the cell surface—here, in 
as few as 3 days. The displacement of the hydrogel is robust and independent of 
hydrogel properties such as crosslink density or macromer concentration, such that the 
hydrogel was displaced from the cell surface ~1 µm in every hydrogel tested by day 7 of 
culture. This agrees well with prior findings that the influence of some engineered cues, 
such as in hydrogels functionalized with covalently bound peptides like the N-Cadherin 
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mimetic peptides described in Aim 2, appear to be restricted to earlier timepoints in 
these systems.9,10 Overall, these findings are quite important as they indicated that an 
understanding of not only the initial cell-hydrogel interface is important, but also how this 
interface changes over time based on deposited matrix. 
	
7.4.2. LIMITATIONS AND FUTURE DIRECTIONS 
In this aim, we demonstrated that the engineered hydrogels that we present to 
cells in 3D can be physically displaced from the cell surface as cells begin to deposit and 
assemble nascent PCM soon after encapsulation, but a number of limitations to these 
studies pertain to the properties of the hydrogels and cells that were used. The hydrogel 
formulations explored here are covalently crosslinked and largely elastic and limited to 
only a few compositions, and additional gel properties such as viscoelasticity and 
chemical/noncovalent crosslinking may influence how PCM is deposited, assembled, 
and elaborated over time.11,12 In addition, engineered cues such as peptides9 that are 
tethered to the base material can influence the secretion and assembly of this nascent 
matrix, but the finer aspects of these effects remain largely unknown, and these types of 
engineered cues were not explored here. Meanwhile, the HA used here possesses 
some affinity for cell-surface CD44 receptors,13 which may in fact help serve to tether 
and retain the gel at the cell surface for a longer duration than an inert scaffold would be 
able to. Future work will need to consider these additional gel properties and how they 
can influence the deposition and distribution of PCM. 
As for the cell type used, the cell’s ability to synthesize, adhere to, and remodel 
its PCM can vary widely among different cell types as well as by species, age, passage 
conditions, disease state, and even the composition and design of the hydrogel 
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itself.12,14-17 For the purposes of the questions at hand, we selected primary juvenile 
bovine chondrocytes for their ability to synthesize a uniform and robust PCM, but this 
cell type is not clinically relevant. Future work may address how this cell-hydrogel 
interface evolves for cell types with various capacities for matrix production, such as the 
MSCs used in other Aims.  We expect that the rate of PCM deposition and heterogeneity 
across cells may vary based on the cells investigated. 
 Finally, a limitation of the metabolic labeling strategy employed in our studies is 
that the label is not specific to particular proteins or glycans of interest (e.g. collagen or 
sulfated glycosaminoglycans), but they are simultaneously restricted to proteins that 
contain methionine or glycans that contain mannose, respectively.11,18 Additional studies 
may help elucidate the specific composition of the labeled PCM, probe for any 
components that may be present but are methionine- or mannose-poor, and provide 
further insight into the spatial deposition of specific matrix components over time.  As an 
example, the labeled proteins and glycans can also be stained for molecules of interest 
(Figure 7.1) or techniques such as proteomics can be used to better understand which 
proteins are being deposited in the PCM. 
	 179	
 
Figure 7.1. Staining of PCM to identify specific matrix components. Bovine 
chondrocytes incubated in hydrogels in vitro in labeling media for 7 days and then 
double stained for nascent matrix using DBCO dye as well as antibodies for collagen 
type II, collagen type VI, and chondroitin sulfate reveal that these proteins colocalize with 
the metabolically labeled PCM. 
	
7.5. OVERALL SUMMARY 
	
Overall, the broad conclusions of this dissertation serve to inform the design of cell-laden 
HA hydrogels for cartilage engineering through the exploration of critical early cues in 
the context of chondrogenesis. We evaluated these parameters using innovative 
techniques and in vitro models that enabled observation of both early differentiation and 
bulk construct maturation in these systems. We also characterized the dynamic cell 
interactions with the hydrogel that can happen over time at single-cell resolution to better 
understand what happens at the cell-hydrogel interface at critical early timepoints. As 
our understanding of this important interface and the presentation of cues continues to 
evolve, studies such as the ones described in this thesis will form the basis for novel 
material designs for cartilage repair. 
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